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Thursday, July 22 – Monday, July 26, 2010 
 
Thursday 7:30 pm 1  Genetic Analysis of Glial Function 
   
Friday 9:00 am 2  Myelinating Cells 
   
Friday 2:00 pm 3  Poster Session I 
   
Friday 4:30 pm Wine and Cheese Party * 
   
Friday 7:30 pm 4  Axon-Glial Interactions 
   
Saturday 9:00 am 5  Glial Function at Synapses 
   
Saturday 1:30 pm 6  Microglia Function in Health and Disease 
   
Saturday 4:30 pm 7  Poster Session II 
   
Saturday 8:00 pm Roundtable Discussion: 
Glia in Health and Disease—Open 
Questions and Future Directions 
   
Sunday 9:00 am 8  Gliovascular Interactions and Astrocyte 
Function 
   
Sunday 1:30 pm 9  CNS Injury and Disease 
   
Sunday 6:00 pm Banquet 
   
Monday 9:00 am 10  Glial Development and Epigenetic 
Mechanisms 
 
Poster sessions are located in Bush Lecture Hall 
* Airslie Lawn, weather permitting 
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PROGRAM 
 
 
THURSDAY, July 22—7:30 PM 
 
 
SESSION 1 GENETIC ANALYSIS OF GLIAL FUNCTION 
 
Chairpersons: B. Popko, University of Chicago, Illinois 
M. Freeman, University of Massachusetts Medical  
School, Worcester 
 
 
7:30 pm ZFP191 is required for CNS myelination 
Brian Popko. 
Presenter affiliation: The University of Chicago, Chicago, 
Illinois. 
 
 
 
1 
   
8:00 pm Gpr126 regulates Schwann cell development and 
myelination in mammals 
Kelly R. Monk, William S. Talbot. 
Presenter affiliation: Stanford University School of Medicine, 
Stanford, California. 
 
 
 
 
2 
   
8:20 pm Synaptic activity controlling locomotory pattern, pausing 
frequency and speed is regulated by C. elegans CEPsh glia 
Menachem Katz, Shai Shaham. 
Presenter affiliation: The Rockefeller University, New York, New 
York. 
 
 
 
 
3 
   
8:40 pm Astrocyte heterogeneity revealed by comprehensive 
genetic analysis of in vivo astrocyte in astroglial reporter 
mice 
Yongjie Yang, Svetlana Vidensky, Lin Jin, Jeffrey Rothstein. 
Presenter affiliation: Johns Hopkins University, Baltimore, 
Maryland. 
 
 
 
 
 
4 
   
9:00 pm BREAK  
   
9:20 pm Cellular and molecular biology of astrocyte morphogenesis 
Tobias Stork, Marc R. Freeman. 
Presenter affiliation: UMASS Medical School, Worcester, 
Massachusetts. 
 
 
 
5 
   
 vi 
9:50 pm Glia delimit shape changes of sensory neuron receptive 
endings in C. elegans 
Carl Procko, Yun Lu, Shai Shaham. 
Presenter affiliation: The Rockefeller University, New York, New 
York. 
 
 
 
 
6 
   
10:10 pm Manipulating Drosophila glia to model human glioma 
Renee D. Read, Webster K. Cavenee, Frank B. Furnari, John B. 
Thomas. 
Presenter affiliation: The Salk Institute for Biological Studies, La 
Jolla, California. 
 
 
 
 
7 
   
10:30 pm BREAK  
 
 
FRIDAY, July 23—9:00 AM 
 
 
SESSION 2 MYELINATING CELLS 
 
Chairpersons: K. Jessen, University College London, United Kingdom 
P. Brophy, University of Edinburgh, United Kingdom 
 
   
9:00 am Schwann cell c-Jun controls the generation of the 
denervated Schwann cell and nerve repair 
Kristjan R. Jessen, Rhona Mirsky. 
Presenter affiliation: University College London, London, United 
Kingdom. 
 
 
 
 
8 
   
9:30 am EphB signalling directs peripheral nerve regeneration 
through Sox2-dependent Schwann cell sorting 
Simona Parrinello, Ilaria Napoli, Patrick Wingfield Digby, Sara 
Ribeiro, David Parkinson, Alison C. Lloyd. 
Presenter affiliation: University College London, London, United 
Kingdom. 
 
 
 
 
 
9 
   
9:50 am Claw paw meets the Adams family—The role of Lgi4 and 
ADAM22 in peripheral nerve development 
Ekim Ozkaynak, Gina Abello, Siska Driegen, Linde Kegel, 
Martine Jaegle, Koji Sagane, John R. Bermingham, Dies Meijer. 
Presenter affiliation: Erasmus University Medical Center, 
Rotterdam, The Netherlands. 
 
 
 
 
 
10 
   
10:10 am BREAK  
 vii 
10:30 am Formation of axonal domains in myelinated nerves of the 
CNS 
Peter J. Brophy. 
Presenter affiliation: University of Edinburgh, Edinburgh, United 
Kingdom. 
 
 
 
 
11 
   
11:00 am Dicer1 and miR-219 are required for normal 
oligodendrocyte differentiation and myelination 
Jason C. Dugas, Trinna L. Cuellar, Anja Scholze, Brandon 
Ason, Adiljan Ibrahim, Ben Emery, Jennifer L. Zamanian, 
Lynette C. Foo, Michael T. McManus, Ben A. Barres. 
Presenter affiliation: Stanford University School of Medicine, 
Stanford, California. 
 
 
 
 
 
 
12 
   
11:20 am The tetraspanin KAI1/CD82 regulates oligodendrocyte 
progenitor migration, differentiation and myelination 
Angeliki Mela, James E. Goldman. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
 
13 
   
12:00 pm Neuregulin switches oligodendrocytes between two modes 
of myelination 
Aryna Luzhynskaya, Iben Lundgaard, Zhen Wang, Charles 
French-Constant, David Attwell, Ragnhildur T. Karadottir. 
Presenter affiliation: University of Cambridge, Cambridge, 
United Kingdom. 
 
 
 
 
 
14 
   
12:20 pm LUNCH  
 
 
FRIDAY, July 23—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
Basic characterization of a novel Cln1/Cln5 deficient mouse model 
Tea S. Blom, Mia-Lisa Schmiedt, Jaana Tyynelä, Anu Jalanko. 
Presenter affiliation: National Institute for Health and Welfare, Helsinki, 
Finland. 
 
 
 
15 
  
GFAP positive processes enter a Schwann cell bridge and correlate 
with regenerated brainstem axons and hind limb locomotion following 
spinal cord transection injury 
Ryan R. Williams, Damien D. Pearse, Mary B. Bunge. 
Presenter affiliation: The Miami Project to Cure Paralysis, Miami, Florida. 
 
 
 
 
16 
  
 viii 
Charcot-Marie-Tooth 1C neuropathy and exosomal trafficking 
Chi-Wing Chow, Hong Zhu, Raymond Yu. 
Presenter affiliation: Albert Einstein College of Medicine, Bronx, New York. 
 
 
17 
  
The function of astrocytes in neural circuit maturation and synapse 
elimination 
Won-Suk Chung, Ben A. Barres. 
Presenter affiliation: Stanford University School of Medicine, Stanford, 
California. 
 
 
 
 
18 
  
Prenatal cocaine exposure alters human and rodent infant 
vocalizations—Implications for underlying neural-glial integrity 
Elizabeth T. Cox, Clyde W. Hodge, Karen M. Grewen, Josephine M. Johns. 
Presenter affiliation: UNC-Chapel Hill, Chapel Hill, North Carolina. 
 
 
 
19 
  
Regulation of oligodendrocyte precursor cell migration by 
homeoprotein Pax6 
Elizabeth Di Lullo, Celine Haton, Michel Volovitch, Alain Joliot, Jean-Leon 
Thomas, Alain Prochiantz. 
Presenter affiliation: College de France, Paris, France. 
 
 
 
 
20 
  
Akt regulates myelin sheath thickness and axon wrapping in the PNS 
Enric Domenech-Estevez, Hasna Baloui, Gurkirat Multani, Jeffrey L. Dupree, 
James L. Salzer. 
Presenter affiliation: NYU-Langone Medical Center, New York, New York. 
 
 
 
21 
  
Ongoing expression of the oligodendrocyte transcriptional regulator 
Myelin Gene Regulatory Factor (MRF) is required for the maintenance 
of myelin integrity in the adult CNS 
Ben Emery, Sara Mulinyawe, Brian Popko, Ben A. Barres. 
Presenter affiliation: The University of Melbourne, Melbourne, Australia. 
 
 
 
 
22 
  
Gamma-secretase is required for microglia Alzheimer's beta amyloid 
clearance 
Dorit Farfara, Dorit Trudler, Niva Segev-Amzaleg, Ronit Galron, Reuven 
Stein, Dan Frenkel. 
Presenter affiliation: Tel Aviv University, Tel Aviv, Israel. 
 
 
 
 
23 
  
Bergmann glia modulate pathogenesis in a transgenic murine model of 
Spinocerebellar ataxia type 7 
Stephanie A. Furrer, Christopher Chang, Bryce L. Sopher, Albert R. La 
Spada, Gwenn A. Garden. 
Presenter affiliation: University of Washington, Seattle. 
 
 
 
 
24 
  
 ix 
Mice deficient for the expression of SCHIP-1 present mild age-
dependent abnormalities of peripheral myelinated fibers and display 
some degree of ataxia 
Pierre-Marie Martin, Fabrice Chareyre, Carmen Cifuentes-Diaz, Marta 
Garcia, Marie Monbureau, Jérôme Devaux, Michiko Kawa-Kawakita, 
Jocelyne Bureau, Michèle Carnaud, Esther Klingler, Matthieu Maroteaux, 
Marco Giovannini, Jean-Antoine Girault, Laurence Goutebroze. 
Presenter affiliation: UMR-S 839, Paris, France. 
 
 
 
 
 
 
 
25 
  
Anti-inflammatory and neuroprotective effects of C/EBPs inhibition in 
microglial cells 
Núria Gresa-Arribas, Marca Straccia, Joan Serratosa, Josep Saura, Carme 
Solà. 
Presenter affilation: Institut d’Investigacions Biomèdiques de Barcelona 
(IIBB), Barcelona, Spain. 
 
 
 
 
 
26 
  
Control of microglia activation through the innate immune receptors 
CD200R1 and TREM-2 
Núria Gresa-Arribas, Josep M. Tusell, Guido Dentesano, Cristina Viéitez, 
Joan Serratosa, Carme Solà. 
Presenter affiliation: Institut d’Investigacions Biomèdiques de Barcelona 
(IIBB), Barcelona, Spain. 
 
 
 
 
 
27 
  
Deficiency of the protein tyrosine phosphatase SHP-1 in normal 
appearing white matter of MS subjects 
Ross C. Gruber, Paul T. Massa. 
Presenter affiliation: SUNY Upstate Medical University, Syracuse, New York. 
 
 
 
28 
  
Iron accumulation in Alexander disease astrocytes 
Eileen M. Guilfoyle, James E. Goldman. 
Presenter affiliation: Columbia University, New York, New York. 
 
 
29 
  
Aberrant activation of mTOR in peripheral neuropathy 
Sean W. Hagerty, Patrice Maurel, James L. Salzer. 
Presenter affiliation: New York University Langone Medical Center, New 
York, New York. 
 
 
 
30 
  
Retinal degeneration alters glial gene expression in the visual cortex 
Michael K. Jarvinen, Ashley Cornett, Catherine A. Johnson, Lindsay M. Cyr, 
Anthony T. Polanco, Joe M. Figuereo, Dylan P. Hillsburg, Kelly L. Doolin, 
Leah A. Terrill, Joseph F. Sucic. 
Presenter affiliation: Emmanuel College, Boston, Massachusetts. 
 
 
 
 
31 
  
 x 
Inflammatory responses are not sufficient to cause delayed neuronal 
death in acutely injured brain 
Hey-Kyeong Jeong, Jun Kim, ilo Jou, Eun-Hye Joe. 
Presenter affiliation: Ajou University School of Medicine, Suwon, South 
Korea. 
 
 
 
 
32 
  
Behavior and functions of microenvironment-regulating cells in spinal 
cord injury—Importance of astrocytes 
Kyoung-Jin Min, Beomsue Kim, Jong-hyeon Kim, Byung-Gon Kim, Ilo Jou, 
Eun-hye Joe. 
Presenter affiliation: Ajou University School of Medicine, Suwon, South 
Korea. 
 
 
 
 
 
33 
  
Inducible ablation of NG2+ glial cells in the adult brain 
Shin H. Kang, Isha Srivastava, Masahiro Fukaya, Lindsay De Biase, 
Hirohide Takebayashi, Dwight E. Bergles. 
Presenter affiliation: Johns Hopkins University School of Medicine, 
Baltimore, Maryland. 
 
 
 
 
34 
  
UDP induces chemokine expression in microglia and astrocytes 
through activation of the P2Y6 receptor 
Beomsue Kim, Hey-kyeong Jeong, Jong-hyeon Kim, Sang Yoon Lee, Ilo 
Jou, Eun-hye Joe. 
Presenter affiliation: Ajou University School of Medicine, Suwon, South 
Korea. 
 
 
 
 
 
35 
  
Early activation of microglia has a central role in the disease 
pathogenesis of Unverricht-Lundborg disease (EPM1) 
Inken Körber, Tarja Joensuu, Anna-Elina Lehesjoki, Outi Kopra. 
Presenter affiliation: University of Helsinki, Helsinki, Finland. 
 
 
 
36 
  
Astrocyte-secreted factors modulate dentate granule cell migration 
Ryuta Koyama, Mari Sajo, Norio Matsuki. 
Presenter affiliation: The University of Tokyo, Tokyo, Japan. 
 
 
37 
  
Alterations in the properties of oligodendrocytes in the neuronal ceroid 
lipofuscinosis CLN8 
Mervi Kuronen, Anna-Elina Lehesjoki, Outi Kopra. 
Presenter affiliation: University of Helsinki, Helsinki, Finland. 
 
 
 
38 
  
An evolutionary conserved enhancer mediates Olig2-dependent Sox10 
expression in oligodendrocyte precursors 
Melanie U. Küspert, Alexander Hammer, Elisabeth Sock, Michael Wegner. 
Presenter affiliation: University of Erlangen-Nuremberg, Erlangen, Germany. 
 
 
 
 
39 
  
 xi 
Anti-neuronal , anti-glial autoantibodies and neuroinflammation in 
experimental spinocerebellar ataxia 
Dmitriy Labunskiy. 
Presenter affiliation: University of Northern California, Santa Rosa, 
California. 
 
 
 
 
40 
  
Estrogen reverses manganese-induced impairment of astrocytic 
glutamate transporters by the enhancement of TGF-α signaling via the 
GPR30 pathway 
Eunsook Y. Lee, Marta Sydoryk, Zhaobao Yin, Haiyan Jiang, Michael 
Aschner. 
Presenter affiliation: Meharry Medical College, Nashville, Tennessee. 
 
 
 
 
 
41 
  
Dendritic cells are early responders to retinal injury 
Ute Lehmann, Neal D. Heuss, Heidi Roehrich, Dale S. Gregerson. 
Presenter affiliation: University of Minnesota, Minneapolis, Minnesota. 
 
 
42 
  
Genetic mosaic analysis reveals a central role of oligodendrocyte 
precursor cells in gliomagenesis 
Chong Liu, Jonathan Sage, Michael R. Miller, Roel G. Verhaak, Simon 
Hippenmeyer, Hannes Vogel, Oded Foreman, Liqun Luo, Hui Zong. 
Presenter affiliation: University of Oregon, Eugene, Oregon. 
 
 
 
 
43 
  
Critical role of histone 3 lysine 9 methylation in oligodendrocyte 
progenitor differentiation 
Jia Liu, Muzhou Wu, Patrizia Casaccia. 
Presenter affiliation: Mount Sinai School of Medicine, New York, New York. 
 
 
 
44 
  
The extracellular matrix molecule, SC1, localizes to different 
populations of reactive astrocytes following transient focal ischemia 
S Lively, L C. Schlichter. 
Presenter affiliation: Toronto Western Research Institute, Toronto, Canada. 
 
 
 
45 
  
MicroRNA-mediated control of oligodendrocyte differentiation 
Q. Richard Lu. 
Presenter affiliation: University of Texas Southwestern Medical Center, 
Dallas, Texas. 
 
 
 
46 
  
Role of Necl-4 complex in PNS myelination 
Xiaosong Meng, Patrice Maurel, James L. Salzer. 
Presenter affiliation: NYU Langone Medical Center, New York, New York. 
 
 
47 
 
 
 
 xii 
Hoxa2 represses rostral hindbrain oligodendrogenesis 
Andres Miguez, Sebastien Ducret, Marie Vidal, Asli Yildirimturk, Bernard 
Zalc, Filippo M. Rijli, Jean-Leon Thomas. 
Presenter affiliation: CRICM/UPMC/INSERM/CNRS, Paris, France. 
 
 
 
48 
  
Identification of glial cells expressing the p75 neurotrophin receptor in 
the control and regenerating optic nerve of the lizard Gallotia galloti 
Maximina Monzón-Mayor, Maria del Mar Romero-Alemán, Elena Santos, 
Carmen M. Yanes. 
Presenter affiliation: University of Las Palmas de Gran Canaria, Las Palmas 
de Gran Canaria, Spain. 
 
 
 
 
 
49 
  
A dual role for the transmembrane semaphorin Sema6a in myelination 
Caroline Moreau-Fauvarque, Frédéric Bernard, Céline Heitz, Yvrick Zagar, 
Laura Dumas, Stephane Fouquet, Xinhua Lee, Zhaohui Shao, Sha Mi, Alain 
Chédotal. 
Presenter affiliation: Institut de la Vision, UMR S968, Inserm, UPMC, Paris, 
France. 
 
 
 
 
 
50 
  
RAF/MEK/ERK signalling controls peripheral nerve regeneration 
switching Schwann cell state in vivo 
Ilaria Napoli, Luke A Noon, Simona Parrinello, Ana-Sara Ribeiro, Laura 
Rosenberg, Marie Harrisingh, Ian J White, Ashwin Woodhoo, Kristjan R 
Jessen, Rhona Mirsky, Alison C Lloyd. 
Presenter affiliation: University College London, London, United Kingdom. 
 
 
 
 
 
51 
  
Role of lymphoid cell kinase (Lck) signaling in Schwann cell 
cytoskeleton organization and myelination 
Jennifer K. Ness-Myers, Nikos Tapinos. 
Presenter affiliation: Geisinger Clinic, Danville, Pennsylvania. 
 
 
 
52 
  
Patched, Dispatched and the Nemo-like kinase module interact to 
regulate glial ensheathment of neurons in C. elegans 
Grigorios Oikonomou, Elliot A. Perens, Yun Lu, Shai Shaham. 
Presenter affiliation: The Rockefeller University, New York, New York. 
 
 
 
53 
  
Regulation of differentiation and proliferation in Merlin null 
schwannoma cells 
Robin D. Doddrell, Oliver Hanemann, David B. Parkinson. 
Presenter affiliation: Peninsula Medical School, Plymouth, United Kingdom. 
 
 
 
54 
  
 xiii 
Drosophila glial glutamate transporter Eaat1 is regulated by Fringe-
mediated Notch signaling and is essential for larval locomotion 
Stephanie M. Stacey, Nara I. Muraro, Emilie Peco, Alain Labbé, Richard A. 
Baines, Donald J. van Meyel. 
Presenter affiliation: McGill University Health Centre Research Institute, 
Montreal, Canada. 
 
 
 
 
 
55 
  
Acutely grafted embryonic progenitors result in more extensive 
oligodendroglial production and myelination in shiverer forebrain 
compared to purified and expanded embryonic oligodendrocyte 
precursor cells 
Magda Petryniak, Gregory Potter, John Rubenstein, David Rowitch. 
Presenter affiliation: UCSF, San Francisco, California. 
 
 
 
 
 
56 
 
 
FRIDAY, July 23—4:30 PM 
 
Wine and Cheese Party 
 
 
FRIDAY, July 23—7:30 PM 
 
 
SESSION 4 AXON-GLIAL INTERACTIONS 
 
Chairpersons: J. Chan, University of California, San Francisco 
E. Peles, Weizmann Institute of Science, Rehovot, Israel 
 
   
7:30 pm Nogo-A establishes spatial segregation and extent of 
myelination during development 
SY Christin Chong, Sheila S. Rosenberg, Yun-An A. Shen, 
Angela T. Hahn, Binhai Zheng, Li I. Zhang, Aaron McGee, Q 
Richard Lu, Jonah R. Chan. 
Presenter affiliation: USC, Los Angeles, California. 
 
 
 
 
 
57 
   
8:00 pm Schwann cell mitochondrial dysfunction disrupts axo-glial 
interactions without interfering with Schwann cell survival 
Andreu Viader, Judith P. Golden, Robert H. Baloh, Jeffrey 
Milbrandt. 
Presenter affiliation: Washington University in St. Louis, St 
Louis, Missouri. 
 
 
 
 
 
58 
   
 xiv 
8:20 pm Schwann cells remodel basement membranes to localize 
peripheral nerves 
Alya R. Raphael, Julie R. Perlin, William S. Talbot. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
59 
   
8:40 pm BREAK  
   
9:00 pm How Schwann cells control the clustering of sodium 
channels at nodes of Ranvier 
Elior Peles. 
Presenter affiliation: Weizmann Institute of Science, Rehovot, 
Israel. 
 
 
 
 
60 
   
9:30 pm Differential mechanisms initiate and maintain assembly of 
nodes of Ranvier 
Yanqing Zhang, Yulia Dzhashiavili, Steven. Armenti, Xiaosong 
Meng, Jeffrey Milbrandt, James L. Salzer. 
Presenter affiliation: New York University Langone Medical 
Center, New York, New York. 
 
 
 
 
 
61 
   
9:50 pm Control of Drosophila midline glial subtype specification 
and axon-glial interactions 
Scott R. Wheeler, Joseph D. Watson, Stephen T. Crews. 
Presenter affiliation: UNC Chapel Hill, Chapel Hill, North 
Carolina. 
 
 
 
 
62 
   
10:10 pm STATisfactory clearance of axonal debris—STAT92E 
governs phagocytic competence of glial cells 
Johnna Doherty, Marc Freeman. 
Presenter affiliation: HHMI, UMass Med School, Worcester, 
Massachusetts. 
 
 
 
 
63 
   
10:30 pm BREAK  
 
 
 xv 
SATURDAY, July 24—9:00 AM 
 
 
SESSION 5 GLIAL FUNCTION AT SYNAPSES 
 
Chairpersons: D. Bergles, Johns Hopkins University, Baltimore,  
  Maryland 
G. Corfas, Children's Hospital, Boston, Massachusetts 
 
   
9:00 am Glial cells initiate spontaneous activity in the developing 
auditory system 
Dwight E. Bergles, Nicolas X. Tritsch. 
Presenter affiliation: Johns Hopkins University, Baltimore, 
Maryland. 
 
 
 
 
64 
   
9:30 am Identification of an astrocyte-secreted protein that is 
sufficient to induce fully functional synapse formation 
Nicola J. Allen, Chandrani Chakraborty, Navid Nouri, Ben A. 
Barres. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
 
65 
   
9:50 am TNFα, glia and synaptic function 
David Stellwagen. 
Presenter affiliation: McGill University, Montreal, Canada. 
 
 
66 
   
10:10 am BREAK  
   
10:30 am Supporting cells regulate synapses formation in the 
vestibular epithelium 
Maria E. Gomez-Casati, Joshua Murtie, Rio Carlos, Konstantina 
Stankovic, M. Charles Liberman, Gabriel Corfas. 
Presenter affiliation: Children’s Hospital Boston, Boston, 
Massachusetts; Harvard Medical School, Boston, 
Massachusetts. 
 
 
 
 
 
 
67 
   
11:00 am Excitability and synaptic communication within the 
oligodendrocyte lineage 
Lindsay M. De Biase, Akiko Nisiyama, Dwight E. Bergles. 
Presenter affiliation: Johns Hopkins School of Medicine, 
Baltimore, Maryland. 
 
 
 
 
68 
   
 xvi 
11:20 am Astrocytic modulation of mGluR5 enhances long-term 
potentiation and learning 
So-Young Lee, Michael M. Halassa, Dustin Hines, Laura R. 
Gainey, Qiudong Deng, Olivier Pascual, Christophe Erneux, 
Nicholas Brandon, Philip G. Haydon. 
Presenter affiliation: Tufts University, Boston, Massachusetts. 
 
 
 
 
 
69 
   
11:40 am Hippocampal short- and long-term plasticity are not 
modulated by astrocyte Ca2+ signaling 
Cendra Agulhon, Todd A. Fiacco, Ken D. McCarthy. 
Presenter affiliation: University of North Carolina at Chapel Hill, 
Chapel Hill, North Carolina. 
 
 
 
 
70 
   
12:00 pm Mutation of a glial-specific NCKX causes defects in glial 
calcium signaling and neuronal hyperexcitability 
Jan E. Melom, J T. Littleton. 
Presenter affiliation: MIT, Cambridge, Massachusetts. 
 
 
 
71 
   
12:20 pm LUNCH  
 
 
SATURDAY, July 24—1:30 PM 
 
 
SESSION 6 MICROGLIA FUNCTION IN HEALTH AND DISEASE 
 
Chairpersons: A. Bessis, Ecole Normale Supérieure, Paris, France 
M. Carson, University of California, Riverside 
 
   
1:30 pm Microglial activation rapidly modulates synaptic activity 
Olivier Pascual, Sarrah Ben Achour, Philippe Rostaing, Alain 
Bessis. 
Presenter affiliation: Institute of Biology, Paris, France. 
 
 
 
72 
   
2:00 pm Synaptic pruning in the CNS—The role of microglia and the 
complement system 
Dorothy P. Schafer, Emily K. Lehrman, Amanda G. Kautzman, 
Axel Nimmerjahn, Ben A. Barres, Beth Stevens. 
Presenter affiliation: Children’s Hospital Boston, FM Kirby 
Neurobiology Center, Harvard Medical School, Boston, 
Massachusetts. 
 
 
 
 
 
 
73 
   
 xvii 
2:20 pm Microglia shape adult hippocampal neurogenesis through 
apoptosis-coupled phagocytosis 
Amanda Sierra, Juan M. Encinas, Juan JP. Deudero, Stella E. 
Tsirka, Mirjana M. Maletic-Savatic. 
Presenter affiliation: Baylor College of Medicine, Houston, 
Texas. 
 
 
 
 
 
74 
   
2:40 pm BREAK  
   
3:00 pm Post-natal regulation of tolerated CNS inflammation in 
response to systemic immune challenge 
Monica J. Carson. 
Presenter affiliation: UC Riverside, Riverside, California. 
 
 
 
75 
   
3:30 pm Role of complement in modulating glial cell activation in 
Amyotrophic Lateral Sclerosis 
Isaac M. Chiu, Michael C. Carroll, Tom Maniatis. 
Presenter affiliation: Children's Hospital, Boston, 
Massachusetts. 
 
 
 
 
76 
   
3:50 pm Selective transfer of membrane vesicles containing 
encephalitogenic antigens from oligodendrocytes to 
microglia 
Mareike Schnaars, Dirk Fitzner, Denise van Rossum, 
Gurumoorthy Krishnamoorthy, Payam Dibaj, Tommy Regen, 
Uwe-Karsten Hanisch, Mikael Simons. 
Presenter affiliation: Max Planck Institute for Experimental 
Medicine, Goettingen, Germany; University of Goettingen, 
Goettingen, Germany. 
 
 
 
 
 
 
 
 
77 
   
4:10 pm Oligodendrocyte (OL) and progenitor cell (OPC) responses 
to injury—Effects of axonal damage and oxidative stress 
Michael S. Beattie, Sergio Veiga-Herrera, Karen-Amanda Irvine, 
Fang Sun, Dana McTigue, C-L Glenn Lin, Pak Chan, 
Jacqueline C. Bresnahan. 
Presenter affiliation: UCSF, San Francisco, California. 
 
 
 
 
 
78 
   
4:30 pm BREAK  
 
 
 xviii 
SATURDAY, July 24—4:30 PM 
 
 
SESSION 7 POSTER SESSION II 
 
  
A mild vascular challenge causes a rapid disruption of axon-glial 
integrity and function 
Michell M. Reimer, Barbara Zonta, Anne Desmazieres, Jessica Smith, 
Catherine Gliddon, Gillian Scullion, Philip R. Holland, Emma Wood, Peter 
Brophy, James McCulloch, Karen Horsburgh. 
Presenter affiliation: University of Edinburgh, Edinburgh, United Kingdom. 
 
 
 
 
 
79 
  
Laminin regulates oligodendrogenesis in the developing postnatal 
brain 
Jenne Relucio, Holly Colognato. 
Presenter affiliation: Stony Brook University, Stony Brook, New York. 
 
 
 
80 
  
Two-photon imaging reveals astroglial injury alongside neuronal 
damage during stroke-induced ischemic depolarizations 
Christopher Risher, Deborah Ard, Jianghe Yuan, Sergei Kirov. 
Presenter affiliation: Medical College of Georgia, Augusta, Georgia. 
 
 
 
81 
  
Expression of the vesicular glutamate transporter 1 (VGLUT1) and the 
glutamine synthetase (GS) in the control and regenerating lizard visual 
system 
Maria del Mar Romero-Alemán, Maximina Monzón-Mayor, Elena Santos, 
Carmen M. Yanes. 
Presenter affiliation: University of Las Palmas de Gran Canaria, Las Palmas 
de Gran Canaria, Spain. 
 
 
 
 
 
 
82 
  
Acetate supplementation reduces neuroglia activation and cholinergic 
cell loss while increasing brain energy reserves and lipid deposition in 
a rat model of neuroinflammation 
Dhaval P. Bhatt, Dane J. Mitteness, Heidi M. Gienger, Thad A. Rosenberger. 
Presenter affiliation: University of North Dakota School of Medicine, Grand 
Forks, North Dakota. 
 
 
 
 
 
83 
  
Myosin II is a negative regulator of oligodendrocyte morphological 
differentiation 
Tomasz Rusielewicz, Haibo Wang, Carmen Melendez-Vasquez. 
Presenter affiliation: Hunter College and , The Graduate Center, The City 
University of New York, New York. 
 
 
 
 
84 
  
 xix 
Imaging neuroinflammation in man—13C MRS study 
Napapon Sailasuta, Thao Tran, Brian D. Ross. 
Presenter affiliation: Huntington Medical Research Institutes, Pasadena, 
California. 
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PTPRZ1 regulates oligodendrocyte development and schizophrenia 
related phenotypes in mice 
Nagahide Takahashi, Takeshi Sakurai, Mihaela Gazdoiu, Nathan P. Dorr, 
Joanne Moy, Ozlem Bozdagi, Miguel Gama-Sosa, Gregory A. Elder, Lisa 
Krug, Kenneth L. Davis, Joseph D. Buxbaum. 
Presenter affiliation: Mount Sinai School of Medicine (MSSM), New York 
New York. 
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Reovirus myelitis increases glial activation and expression of 
interferon stimulated genes 
Stephanie A. Schittone, Kenneth L. Tyler. 
Presenter affiliation: University of Colorado Denver Anschutz Medical 
Campus, Aurora, Colorado; Denver Veterans Affairs Medical Center, 
Denver, Colorado. 
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Identification of new glial cell specific gene functions in Drosophila 
Imke Schmidt, Silke Thomas, Christian Klämbt. 
Presenter affiliation: University of Münster, Münster, Germany. 
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Searching for the role of Cln5 in glial cells 
Mia-Lisa Schmiedt, Tea Blom, Mervi Kuronen, Aija Kyttälä, Outi Kopra, Anu 
Jalanko. 
Presenter affiliation: National Institute for Health and Welfare (THL) and 
FiMM, Helsinki, Finland. 
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Gas6 enhances debris removal, remyelination and axonal survival 
following cuprizone toxicity 
Vladislav Tsiperson, Xiaosong Li, Gary J. Schwartz, Cedric S. Raine, Bridget 
Shafit-Zagardo. 
Presenter affiliation: Albert Einstein College of Medicine, Bronx, New York. 
 
 
 
 
90 
  
Hypoxia/reoxygenation differentially modulates astroglial-soluble 
epoxide hydrolase expression 
Sherylee J. Thompson, Shivachar C. Amruthesh. 
Presenter affiliation: Texas Southern University, Houston, Texas. 
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Proliferative behavior of cortical progenitors in the intact and injured 
adult mouse brain 
Christiane Simon, Magdalena Goetz, Leda Dimou. 
Presenter affiliation: Ludwig-Maximilians-University Munich, Munich, 
Germany. 
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Increased expression of gap junction protein Cx43 in localized brain 
injury 
Nicolas Theodoric, John. Bechberger, Christian C. Naus, Wun-Chey Sin. 
Presenter affiliation: University of British Columbia, Vancouver, Canada. 
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Glia are required for neuronal receptive ending shape in C. elegans 
Aakanksha Singhvi, Shai Shaham. 
Presenter affiliation: Rockefeller University, New York, New York. 
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Glia specific regulation of Sgk1 isoforms by drugs of abuse 
Michal Slezak, Agnieszka Gieryk, Michal Korostynski, Marcin Piechota, Eliza 
Wlazlo, Ryszard Przewlocki. 
Presenter affiliation: Institute of Pharmacology PAS, Krakow, Poland. 
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NG2+ progenitor response and lineage analysis in white matter stroke 
Elif G. Sozmen, Daniel K. Crawford, Seema Tiwari-Woodruff, Stanley T. 
Carmichael. 
Presenter affiliation: Geffen School of Medicine at UCLA, Los Angeles, 
California. 
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Profiling transcriptional coregulation of dynamically regulated gene 
loci during peripheral myelination 
Rajini Srinivasan, Erin A. Jones, Sung-Wook Jang, Guannan Sun, Sunduz 
Keles, John Svaren. 
Presenter affiliation: University of Wisconsin-Madison, Madison, Wisconsin. 
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Galectin-4, a novel regulator of myelination 
Mirjana Stancic, Davor Slijepcevic, Marta Olah, Jack van Horssen, Hans-
Joachim Gabius, Dick Hoekstra, Wia Baron. 
Presenter affiliation: University Medical Center Groningen, Groningen, The 
Netherlands. 
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Distinct roles of SoxD proteins on oligodendrocyte development 
Claus C. Stolt, Yvonne Zimmermann, Anja Schillinger, Petra Lommes, 
Elisabeth Sock, Michael Wegner. 
Presenter affiliation: University of Erlangen-Nuremberg, Erlangen, Germany. 
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MicroRNAs are key regulators of the early events of Wallerian 
degeneration 
Adilakshmi Tadepalli, Nikolaos Tapinos. 
Presenter affiliation: Geisinger Clinic, Danville, Pennsylvania. 
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 xxi 
Increase in ATP release from astrocytes results in increase in the 
excitability of the hippocampus 
Kenji Tanaka, Yoshihiko Yamazaki, Hae Ung Lee, Kishio Furuya, Hideki 
Hida, Satoshi Fujii, Kazuhiro Ikenaka. 
Presenter affiliation: National Institute for Physiological Sciences, Okazaki, 
Japan. 
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Depletion of Dicer in astrocytes causes cell non-autonomous neuronal 
degeneration 
Jifang Tao, Hao Wu, Jefferey Cantle, William Yang, Michael Sofroniew, Yi 
Sun. 
Presenter affiliation: UCLA, Los Angeles, California. 
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Microglial interactions with synapses are regulated by visual 
experience 
Marie-Ève Tremblay, Ania K. Majewska. 
Presenter affiliation: University of Rochester Medical Center, Rochester, 
New York. 
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Cytokine release by microglia and astroglia in prion disease 
pathogenesis 
Deborah Tribouillard-Tanvier, James F. Striebel, Karin E. Peterson, Bruce 
Chesebro. 
Presenter affiliation: Rocky Mountain Laboratories, NIAID, NIH, Hamilton, 
Montana. 
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CYP450s expression in human primary glial cells during brain 
development—Regulation of gene expression under inflammatory 
conditions 
Alexandra Trotier-Faurion, Georges Dorfmuller, Christine Bulteau, Olivier 
Delalande, Catherine Chiron, Anne-Cécile Guyot, Aloïse Mabondzo. 
Presenter affiliation: CEA-DSV/iBiTec-S, Gif-sur-Yvette, France. 
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The role of polyploidy in subperineurial glia in Drosophila 
Yingdee Unhavaithaya, Terry L. Orr-Weaver. 
Presenter affiliation: Whitehead Institute, Cambridge, Massachusetts. 
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Proteomic analysis of signaling processes in glioblastoma cells 
subjected to sub-lethal photodynamic treatment 
Anatoly B. Uzdensky, Asta Juzeniene, Johan Moan. 
Presenter affiliation: Southern Federal University, Rostov-on-Don, Russia; 
Institute for Cancer Research, Oslo, Norway. 
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 xxii 
Neuroglial interactions in the crayfish stretch receptor at the 
ultrastructural level 
Grigory M. Fedorenko, Anatoly B. Uzdensky. 
Presenter affiliation: Sothern Federal University, Rostov-on-Don, Russia. 
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On the mechanism of fibronectin aggregate formation in multiple 
sclerosis—Implications for remyelination 
Michel J. Vos, Dick Hoekstra, Wia Baron. 
Presenter affiliation: University Medical Center Groningen, Groningen, 
Netherlands. 
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A link between neuronophagic activity and increased expression of 
ciliary neurotrophic factor by perivascular cells in the rat 
neurohypophysis 
David Y. Lo, Kate E. Behm, John A. Watt. 
Presenter affiliation: University of North Dakota School of Medicine and 
Health Sciences, Grand Forks, North Dakota. 
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A whole cell assay for evaluating KAT II inhibition 
Kathryn A. Welch, Steve S. Gernhardt, Christine A. Strick. 
Presenter affiliation: Pfizer Global R&D, Groton, Connecticut. 
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Proteome analysis of peripheral nerve myelin and bioinformatical 
integration with mRNA abundance profiles 
Julia Patzig, Olaf Jahn, Stefan Tenzer, Sven Wichert, Wiebke Moebius, 
Patricia de Monasterio Schrader, Klaus-Armin Nave, Hauke B. Werner. 
Presenter affiliation: Max Planck Institute of Experimental Medicine, 
Goettingen, Germany. 
 
 
 
 
 
112 
  
The equilibrium between histone deacetylase 1 (HDAC1) and histone 
acetytransferase PCAF modulates chromatin compaction and nuclear 
size reduction during oligodendrocyte differentiation 
Muzhou Wu, Hugo Hanson, Greg R. Phillips, Patrizia B. Casaccia. 
Presenter affiliation: Mount Sinai School of Medicine, New York, New York. 
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Cortical radial glia mediates a homocellular network of coupling in the 
early postnatal subventricular zone 
Anna L. Xavier, Andressa S. Freitas, Carla M. Furtado, Cecilia Hedin-
Pereira, Maira M. Fróes, João R. Menezes. 
Presenter affiliation: Federal University of Rio de Janeiro, Rio de Janeiro, 
Brazil. 
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Integrin function in peripheral glia of Drosophila  
Xiaojun Xie, Vanessa Auld. 
Presenter affiliation: University of British Columbia, Vancouver, Canada. 
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 xxiii 
Sculpting circuits and cleaning up messes—Glial Crk-II/Dock-180/Elmo 
regulate axon pathfinding during development, and clearance of 
degenerating axons from the adult brain 
Jennifer S. Ziegenfuss, Johnna Doherty, Marc R. Freeman. 
Presenter affiliation: UMass Medical School/HHMI, Worcester, 
Massachusetts. 
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SATURDAY, July 24—8:00 PM 
 
 
ROUNDTABLE DISCUSSION 
 
Glia in Health & Disease—Open Questions and Future Directions 
 
Discussion Leaders: 
B. Barres, Stanford University School of Medicine 
M. Raff, University College London 
 
 
 
SUNDAY, July 25—9:00 AM 
 
 
SESSION 8 GLIOVASCULAR INTERACTIONS AND ASTROCYTE 
FUNCTION 
 
Chairpersons: R. Daneman, University of California, San Francisco 
M. Nedegaard, University of Rochester, New York 
 
   
9:00 am Cellular and molecular regulation of the blood-brain barrier 
Richard Daneman. 
Presenter affiliation: UCSF, San Francisco, California. 
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9:30 am The cAMP effector PKA mediates GPCR signaling in glial 
blood-brain barrier development 
Xiaoling Li, Ulrike Gaul. 
Presenter affiliation: University of Munich, Munich, Germany. 
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 xxiv 
9:50 am VEGFR3 signaling in subventricular zone astrocytes is 
required for postnatal neurogenesis 
Jean-Léon Thomas, Charles-Félix Calvo, Romain Fontaine, 
Jihane Soueid, Tuomas Tamella, Kari Alitalo, Anne Eichmann. 
Presenter affiliation: INSERM, Paris, France. 
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10:10 am BREAK  
   
10:30 am Twenty years of gliotransmission—Experimental artifact or 
reality? 
Maiken Nedergaard. 
Presenter affiliation: University of Rochester, New York. 
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11:00 am Cx32 and Cx47 have distinct roles in oligodendrocyte—
Astrocyte gap junction coupling 
Sam Wasseff, Steven S. Scherer. 
Presenter affiliation: University of Pennsylvania, Philadelphia, 
Pennsylvania. 
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11:20 am Anti-depressive effects of sleep deprivation require the 
astrocyte-dependent sleep-homeostat 
Dustin J. Hines, Luke I. Schmitt, Rochelle M. Hines, Philip G. 
Haydon. 
Presenter affiliation: Tufts University School of Medicine, 
Boston, Massachusetts. 
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11:40 am Astrocyte stimulation can trigger cortical UP states 
Kira E. Poskanzer, Rafael M. Yuste. 
Presenter affiliation: Columbia University/HHMI, New York, New 
York. 
 
 
 
123 
   
12:00 pm Development of a novel method to purify and culture 
mature rat brain astrocytes 
Lynette C. Foo, Nicola J. Allen, John D. Cahoy, Ben A. Barres. 
Presenter affiliation: Stanford University School of Medicine, 
Stanford, California. 
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12:20 pm LUNCH  
 
 
 xxv 
SUNDAY, July 25—1:30 PM 
 
 
SESSION 9 CNS INJURY AND DISEASE 
 
Chairpersons: M. Sofroniew, UCLA School of Medicine, Los Angeles,  
  California 
H. Zong, University of Oregon, Eugene 
 
   
1:30 pm Molecular dissection of reactive astrogliosis and glial scar 
formation 
Michael V. Sofroniew. 
Presenter affiliation: UCLA, Los Angeles, California. 
 
 
 
125 
   
2:00 pm Deciphering the damaging and protective roles of glia in 
glaucoma 
Gareth R. Howell, Ileana Soto, Xianjun Zhu, Simon W. John. 
Presenter affiliation: The Jackson Laboratory, Bar Harbor, 
Maine. 
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2:20 pm Using embryonic stem cells to study motor neuron/glia 
interactions in ALS 
Hemali P. Phatnani, Brad A. Friedman, Monica A. Carrasco, 
Flo Pauli, Tim Reddy, Michael Muratet, Richard M. Myers, 
Tom Maniatis. 
Presenter affiliation: Columbia University Medical Center, New 
York, New York. 
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2:40 pm BREAK  
   
3:00 pm The application of MADM, a mouse genetic mosaic 
system, for glioma modeling 
Hui Zong. 
Presenter affiliation: University of Oregon, Eugene, Oregon. 
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3:30 pm The lineage-restricted transcription factor Olig2 opposes 
p53 responses to genotoxic damage in neural progenitors 
Shwetal Mehta, Emmanuelle Huillard, Santosh Kesari, Cecile 
L. Maire, Diane Duby, Emily Harington, John A. Alberta, 
Michael Kane, Matthew Theisen, Keith L. Ligon, David H. 
Rowitch, Charles D. Stiles. 
Presenter affiliation: Dana-Farber Cancer Institute, Boston, 
Massachusetts. 
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 xxvi 
3:50 pm Glial progenitor cells as the origin and essence of 
glioblastoma 
Lei Liang, Adam Sonabend, Thomas Ludwig, Steven 
Rosenfeld Steven, Jeffrey Bruce, Peter Canoll. 
Presenter affiliation: Columbia University, New York, New 
York. 
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4:10 pm The NG2 protein expressed by oligodendrocyte 
progenitor cells binds to the mitochondrial serine 
protease Omi/HtrA2—A role for NG2 in stress-protection? 
Frank Maus, Khalad Karram, Judith Stegmüller, Hauke 
Werner, Klaus-Armin Nave, Rejko Krüger, Jacqueline Trotter. 
Presenter affiliation: University of Mainz, Mainz, Germany. 
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4:30 pm The glial regenerative response to central nervous system 
injury is enabled by Pros-Notch and Pros-NFκB feedback 
Kentaro Kato, Manuel G. Forero, Stephanie Fannell, Janine C. 
Fenton, Alicia Hidalgo. 
Presenter affiliation: University of Birmingham School of 
Biosciences, Birmingham, United Kingdom. 
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4:50 pm BREAK  
 
 
 
SUNDAY, July 25 
 
BANQUET 
 
Cocktails  6:00 PM Dinner  6:45 PM 
 
 xxvii 
MONDAY, July 26—9:00 AM 
 
 
SESSION 10 GLIAL DEVELOPMENT AND EPIGENETIC 
MECHANISMS 
 
Chairpersons: D. Rowitch, University of California, San Francisco 
P. Casaccia, Mount Sinai School of Medicine, New York,  
New York 
 
   
9:00 am Region-restricted origins and distribution of astrocytes in 
the mammalian spinal cord 
David H. Rowitch, Hui-hsin Tsai, Raquel Taveira-Marques, 
William D. Richardson. 
Presenter affiliation: UCSF and HHMI, San Francisco, 
California. 
 
 
 
 
 
133 
   
9:30 am Identification and characterization of a functional Schwann 
cell enhancer regulating Oct6 gene expression 
Noorjahan Jagalur, Mehrnaz Ghazvini, Martine Jaegle, Siska 
Driegen, John Kong a San, Frank Grosveld, Dies Meijer. 
Presenter affiliation: Erasmus Medical Center, Rotterdam, The 
Netherlands. 
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9:50 am Neural crest origin of olfactory ensheathing glia 
Perrine Barraud, Anastasia A. Seferiadis, Luke D. Tyson, 
Maarten F. Zwart, Heather L. Szabo-Rogers, Christiana 
Ruhrberg, Karen J. Liu, Clare V. Baker. 
Presenter affiliation: University of Cambridge, Cambridge, 
United Kingdom. 
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10:10 am Helping to start and stop myelination—Csk has dual 
regulatory functions during oligodendrocyte development 
Iva D. Tzvetanova, Freyja K. McClenahan, Holly Colognato. 
Presenter affiliation: Stony Brook University, Stony Brook, New 
York. 
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10:30 am BREAK  
   
10:50 am Histone deacetylases between damage and repair 
Patrizia Casaccia. 
Presenter affiliation: Mount Sinai School of Medicine, New York, 
New York. 
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 xxviii 
11:20 am Schwann cell survival and myelination are critically 
dependent on HDAC1 and HDAC2 function 
Claire Jacob, Carlos N. Christen, Jorge Pereira, Christian 
Somandin, Arianna Baggiolini, Pirmin Loetscher, Murat 
Oezçelik, Nicolas Tricaud, Dies Meijer, Teppei Yamaguchi, 
Patrick Matthias, Ueli Suter. 
Presenter affiliation: ETH Zurich, Zurich, Switzerland. 
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11:40 am CHD4 is required for efficient myelination of the peripheral 
nervous system 
Holly A. Hung, John P. Svaren. 
Presenter affiliation: University of Wisconsin, Madison, 
Wisconsin. 
 
 
 
 
139 
   
12:00 pm Glial cell differentiation and neural stem reprogramming in 
Drosophila melanogaster 
Hakima Flici, Berra Erkosar, Orban Komonyi, Omer F. Karatas, 
Angela Giangrande. 
Presenter affiliation: IGBMC, Illkirch, Strasbourg, France. 
 
 
 
 
140 
   
12:20 pm MEETING END  
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ZFP191 IS REQUIRED FOR CNS MYELINATION 
 
Brian Popko  
 
The University of Chicago, Neurology, Chicago, IL, 60637 
 
We have used a forward genetics approach in mice to uncover factors 
critical to the myelination process. This effort has identified a mouse strain 
that is severely hypomyelinated in the CNS due to a mutation in the gene 
that encodes the zinc finger protein191 (Zfp191). ZFP191 is a widely 
expressed, nuclear localized protein that belongs to a family whose 
members contain protein-protein interacting SCAN domains in addition to 
the DNA-binding zinc finger domains. Despite the absence of CNS myelin 
Zfp191 mutants contain normal numbers of oligodendrocyte progenitor 
cells, as well as mature, process-extending oligodendrocytes, suggesting 
that the mutation blocks late stage oligodendrocyte maturation. Our data 
also indicates that ZFP191 acts in a cell autonomous fashion to promote the 
myelinating function of oligodendrocytes. Interestingly, global gene 
expression studies reveal that a limited number of genes are expressed at 
significantly reduced levels in the Zfp191 mutant CNS, and that many of the 
differentially expressed genes have been previously identified as 
participants in the myelination process. Thus, the Zfp191 mutants provide a 
novel model system that should provide insight into the molecular control 
of the final stages of oligodendrocyte maturation and function. 
 2 
GPR126 REGULATES SCHWANN CELL DEVELOPMENT AND 
MYELINATION IN MAMMALS 
 
Kelly R Monk, William S Talbot  
 
Stanford University School of Medicine, Developmental Biology, Stanford, 
CA, 94305 
 
During the development of myelinated axons, promyelinating Schwann 
cells associate with one segment of an axon, and later become mature 
Schwann cells that repeatedly wrap their membranes around axons to form 
the myelin sheath. Incompletely understood signals between axons and 
Schwann cells initiate and control myelination. Using mutational analysis in 
zebrafish, we previously reported that gpr126, which encodes a member of 
the G protein-coupled receptor superfamily, is required for Schwann cell 
myelination in zebrafish. We now show that loss of Gpr126 in mouse 
causes a severe congenital hypomyelinating peripheral neuropathy. Gpr126-
/- mice possess abnormal limb posture and die before weaning. Schwann 
cells in Gpr126-/- mice fail to express several developmental markers, 
axonal sorting is delayed, and Schwann cells are ultimately arrested at the 
promyelinating stage of development. Additionally, invasive perineurial 
fibroblasts form aberrant fasicles throughout the endoneurium of the sciatic 
nerve. This work shows that Gpr126 is required for Schwann cell 
myelination in mammals. 
 3 
SYNAPTIC ACTIVITY CONTROLLING LOCOMOTORY PATTERN, 
PAUSING FREQUENCY AND SPEED IS REGULATED BY C. 
ELEGANS CEPSH GLIA 
 
Menachem Katz, Shai Shaham  
 
The Rockefeller University, Developmental Genetics, New York, NY, 
10065 
 
Information processing by the nervous system, leading to precise animal 
behavior, is complex. Recent studies suggest the possibility that glial cells 
participate in controlling synaptic activities, and may thus contribute to 
behavior. However, the precise role of synaptic glia in control of animal 
behavior is poorly understood. C. elegans glia share morphological, 
functional and genetic features with their vertebrate counterparts. However, 
in contrast to vertebrate glia, C. elegans glia are not essential for neuronal 
survival, offering a unique arena for exploring the involvement of glia in 
neuronal functions in a live animal. The CEP sheath glia (CEPsh) of C. 
elegans envelope the nerve ring (the animal’s brain), and, reminiscent of 
mammalian astrocytes, extend processes that abut synapses within the nerve 
ring. Here we demonstrate that animals in which the CEPsh glia are 
genetically ablated during the first larval stage display behavioral defects 
including reduced locomotion speed and extended locomotory pausing. 
Ablated animals also display exaggerated small-angle turns and frequent 
reversals that limit their dispersal. To understand how these locomotory 
behaviors are regulated by CEPsh glia, we focused on a synapse between 
the ALA and AVE neurons, which is ensheathed by these glia (White et al., 
1986). In line with the previously described role of ALA in behavioral 
quiescence and locomotory pausing (Van Buskirk and Sternberg, 2008), we 
found that inactivation of the ALA neuron reduces the pausing frequencies 
of glia-ablated animals. Inactivation of the AVE neurons in wild-type 
animals, induced extended pausing periods similar to those seen in glia 
ablated animals. Our results suggest that AVE is a key regulator of speed 
and pausing frequency in the C. elegans nervous system, and that ALA 
functions to inhibit the activity of AVE. Moreover, our results indicate that 
the CEPsh glia provide important negative regulation on the activity of this 
tripartite synapse. 
To understand the molecular basis of CEPsh glia function we have begun to 
identify genes expressed in these cells using an mRNA-tagging method, 
with the aim of examining the roles of enriched genes in C. elegans 
locomotory behavior. 
 4 
ASTROCYTE HETEROGENEITY REVEALED BY COMPREHENSIVE 
GENETIC ANALYSIS OF IN VIVO ASTROCYTE IN ASTROGLIAL 
REPORTER MICE 
 
Yongjie Yang, Svetlana Vidensky, Lin Jin, Jeffrey Rothstein  
 
Johns Hopkins University, Neurology, Baltimore, MD, 21205 
 
Astrocytes are the most abundant cells in the CNS, not only provide 
essential metabolic support to neurons, but also participate in the 
information processing by active modulation of neuronal/synaptic activity 
in the CNS. In pathophysiological conditions, astrocytes undergo dramatic 
morphological and molecular changes that can cause potentially both 
beneficial and detrimental effects. Although astrocytes are essential in 
normal CNS function and are involved in many neuropathological 
conditions, astrocyte heterogeneity remains largely unknown in the CNS, 
partially due to the lack of the specific astroglial makers. In this study, 
molecular identity of in vivo astrocytes was compared in BAC ALDH1L1 
eGFP and BAC GLT1 eGFP transgenic mice by astroglial RNA 
transcriptome analysis. ALDH1L1 promoter is selectively activated in adult 
cortical and spinal cord astrocytes, indicated by the overlap of eGFP 
expression with ALDH1L1 and GFAP, but not with NeuN, APC, Oligo2, 
IbaI, PDGFR immunoreactivity in BAC ALDH1L1 eGFP reporter mice. 
Interestingly, ALDH1L1 expression levels (protein, mRNA, and promoter 
activity) in spinal cord were selectively decreased during postnatal 
maturation. In contrast, its expression was up-regulated in reactive 
astrocytes in both acute neural injury and chronic neurodegenerative (G93A 
mutant SOD1) conditions, similar to GFAP, but opposite of GLT1. 
ALDH1L1+ and GLT1+ cells isolated through fluorescence activated cell 
sorting (FACS) from BAC ALDH1L1 and BAC GLT1 eGFP mice share a 
highly similar gene expression profile, suggesting ALDH1L1 and GLT1 are 
co-expressed in the same population of astrocytes. This observation was 
further supported by overlap of the eGFP driven by the ALDH1L1 genomic 
promoter and the tdTomato driven by a 8.3kb EAAT2 promoter fragment in 
astrocytes of BAC ALDH1L1 eGFP X EAAT2-tdTomato mice. In contrast, 
astrocytes isolated from brain or spinal cord show highly differential 
expression pattern, providing potential clues for their differential functions 
and astrogliogenesis in the CNS. These studies compared the molecular 
identity of in vivo astrocytes, as the first attempt to investigate the 
molecular differences of heterogeneous astrocytes in the CNS.  
 5 
CELLULAR AND MOLECULAR BIOLOGY OF ASTROCYTE 
MORPHOGENESIS  
 
Tobias Stork, Marc R Freeman  
 
UMASS Medical School, Neurobiology/ HHMI, Worcester, MA, 01605 
 
Astrocytes fulfill diverse roles in the development, function, and 
maintenance of the nervous system. However, the molecular mechanisms 
which govern the establishment and maintenance of their intricate 
morphology and intimate association with neurons remain largely unknown. 
We have identified a novel subtype of glial cells in Drosophila which 
shows a striking morphological, molecular, and functional similarity to 
vertebrate astrocytes. For example, fly astrocytes have a highly tufted 
morphology, associate closely with synapses, and express neurotransmitter 
clearing proteins (e.g. glutamate and GABA transporters). We are using this 
cell type as model system to elucidate basic principles of astrocyte 
morphogenesis, dynamics, and function.  
Drosophila astrocytes infiltrate the synaptic neuropil at the end of 
embryogenesis. By the time the larva hatches from the egg shell, a dense 
meshwork of glial ramifications, showing close apposition to synapses, has 
been established throughout the neuropil. Similar to mammalian astrocytes, 
individual Drosophila astrocytes occupy discrete spatial domains with little 
overlap of their processes with neighboring cells. Although astrocyte-like 
glial cell bodies tend to occupy fairly stereotyped positions in the CNS, the 
tufted morphology of their cellular processes can vary substantially from 
cell to cell, suggesting dynamic cell-cell communication and cell 
competition pathways. Strikingly, we find that ablation of adjacent 
astrocytes lead to tremendous overgrowth of individual astrocytes, 
suggesting that astrocyte-astrocyte communication limits cell growth.  
How do astrocytes invade the neuropil and elaborate membrane processes? 
We utilized forward genetics to identify molecular signals governing the 
coordinated infiltration of astrocyte-like glial cell projections into synaptic 
regions. In mutant animals for the FGF receptor heartless, or its ligands 
pyramus and thisbe, astrocytes are specified normally but fail to infiltrate 
the neuropil. Heartless is expressed on the astrocytes while Pyramus and 
Thisbe appear to be secreted from neurons. We are currently testing whether 
FGFs act as trophic signals which promote general glial outgrowth or if 
they directionally attract glial processes to dendrites and synapses.  
Together our initial work indicates that Drosophila astrocytes show 
remarkable morphological, molecular, and functional conservation with 
their vertebrate counterparts and will serve as an excellent model to study 
fundamental aspects of astroglial development and function.  
 6 
GLIA DELIMIT SHAPE CHANGES OF SENSORY NEURON 
RECEPTIVE ENDINGS IN C. ELEGANS 
 
Carl Procko, Yun Lu, Shai Shaham  
 
The Rockefeller University, Laboratory of Developmental Genetics, New 
York, NY, 10065 
 
Neuronal receptive endings such as dendritic spines and sensory protrusions 
are remodeled by experience, and these morphological changes can alter 
downstream neuronal responses. The mechanism of receptive-ending 
remodeling is not well understood. In response to environmental stressors, 
the nematode Caenorhabditis elegans enters a diapause state, termed dauer, 
which is accompanied by sensory organ remodeling. We have found that 
proper remodeling of the sensory receptive endings of the AWC neurons in 
dauers is dependent on concomitant remodeling of the AMsh glial cell that 
envelops these endings. Remodeling of AMsh glia requires the Otd/Otx 
transcription factor TTX-1, the fusogen AFF-1, and the VEGFR-related 
protein VER-1, all acting within the glial cell. ver-1 expression requires 
direct binding of TTX-1 to ver-1 regulatory sequences, and is induced in 
dauers and at high temperatures. Our results raise the possibility that glia 
may function as general regulators of neuronal receptive ending shape. 
 7 
MANIPULATING DROSOPHILA GLIA TO MODEL HUMAN GLIOMA 
 
Renee D Read1, Webster K Cavenee2, Frank B Furnari2, John B Thomas1  
 
1The Salk Institute for Biological Studies, Molecular Neurobiology 
Laboratory, La Jolla, CA, 92037, 2University of California at San Diego, 
Ludwig Institute for Cancer Research, La Jolla, CA, 92093 
 
Glioma formation is a complex process involving accumulation of 
mutations in many genes, some of which normally regulate proliferation 
and differentiation of neuro-glial progenitor cells, such as EGFR. 
Constitutive activation of the EGFR-Ras and PI-3 kinase (PI3K) signaling 
pathways is common in gliomas and is sufficient to cause glioma in mouse 
models, although how these pathways specifically regulate glial 
pathogenesis is unclear. To investigate the genetic basis of this disease, we 
developed a glioma model in Drosophila. This builds on observations that 
the Drosophila brain contains multiple glial cell types that are strikingly 
similar to their mammalian counterparts in terms of function, development, 
and gene expression. We found that constitutive co-activation of EGFR-Ras 
and PI3K signaling in Drosophila glia gives rise to highly proliferative, 
neoplastic, and invasive glial cells that create transplantable tumor-like 
growths. Genetic analyses demonstrate that EGFR-Ras and PI3K initiates 
neoplastic transformation via a combinatorial genetic network composed of 
pathways activated in human glioma, which act synergistically to 
coordinately stimulate cell cycle entry and progression, protein translation, 
and inappropriate cellular growth and migration. We have used our 
Drosophila model in forward genetic screens to identify new genes that 
drive gliomagenesis and to characterize the cell types that give rise to glial 
neoplasia. These functional screens have identified over 40 genes, including 
novel kinases and cell-type specific transcription factors, that govern 
normal and/or neoplastic glial proliferation. Using lineage analysis and cell-
type specific markers, we have found that neoplastic glial cells originate 
from lineage-restricted glial progenitor cells, rather than from differentiated 
glia or multipotent neuroblasts. Genes that are required for normal 
development and function of these glia are required for their transformation 
by EGFR and PI3K signaling. Mammalian orthologs of genes uncovered by 
these screens are now being examined in mammalian glioma model 
systems. These studies may bring new insights into the genetic and cellular 
origins of human glioma. 
 8 
SCHWANN CELL C-JUN CONTROLS THE GENERATION OF THE 
DENERVATED SCHWANN CELL AND NERVE REPAIR.  
 
Kristjan R Jessen, Rhona Mirsky  
 
University College London, CDB, London, WC1E6BT, United Kingdom 
 
Following nervous system injury, the glial response is a key determinant of 
repair. In the CNS, this response prevents recovery, but in the PNS 
Schwann cells foster repair. This is because injury prompts myelinating and 
non-myelinating Schwann cells to generate the denervated Schwann cell. 
This cell, which has a distinct phenotype related to that of immature 
Schwann cells in developing nerves, provides essential support for axon 
growth and later myelinates the regenerated fibres. Therefore injury 
generates the repair cell needed for healing and functional recovery. Given 
their importance, remarkably little is known about the transcriptional 
programmes that control the generation of the denervated cell. In recent 
studies, we have implicated c-Jun and Notch in this process and have 
defined the concept of negative transcriptional regulation of myelination 
(Jessen and Mirsky, Glia 56: 1552-1565, 2008; Woodhoo et al. Nat 
Neurosci 12: 839-847, 2009). We find that c-Jun, in particular, is an 
essential regulator of the distinct molecular and morphological phenotype of 
the denervated cell. It is also necessary for the key function of these cells, 
since after injury, neuronal survival, axon regrowth and functional recovery 
are severely and permanently compromised in mice with genetic 
inactivation of c-Jun specifically in Schwann cells. (In contrast, 
development and myelination are unaffected.) Because Schwann cell c-Jun 
also directly and indirectly controls the rate of injury-related myelin 
breakdown, c-Jun appears to act as a global regulator of the regenerative 
response in injured nerves. 
 9 
EPHB SIGNALLING DIRECTS PERIPHERAL NERVE 
REGENERATION THROUGH SOX2-DEPENDENT SCHWANN CELL 
SORTING 
 
Simona Parrinello1, Ilaria Napoli1, Patrick Wingfield Digby1, Sara Ribeiro1, 
David Parkinson2, Alison C Lloyd1  
 
1University College London, MRC Laboratory for Molecular Cell Biology, 
LONDON, WC1E 6BT, United Kingdom, 2University of Plymouth, 
Peninsula College of Medicine and Dentistry, Plymouth, PL6 8BU, United 
Kingdom 
 
The peripheral nervous system has astonishing regenerative capabilities in 
that cut nerves are able to reconnect and re-establish their function. 
Schwann cells are important players in this process, during which they 
dedifferentiate to a progenitor/stem cell and promote axonal regrowth. Here 
we report that fibroblasts also play a key role. Upon nerve cut, 
ephrinB/EphB2 signalling between fibroblasts and Schwann cells results in 
cell-sorting, followed by directional collective-cell migration of Schwann 
cells out of the nerve stumps to guide regrowing axons across the wound. 
Mechanistically, we show that cell-sorting downstream of EphB2 is 
mediated by the stemness factor Sox2 through N-cadherin relocalisation to 
Schwann cell-cell contacts. In vivo, inhibition of EphB2 impaired organised 
migration of Schwann cells, resulting in misdirected axonal regrowth. Our 
results identify a new link between Ephs and Sox proteins, providing a 
mechanism by which progenitor cells can translate environmental cues to 
orchestrate the formation of new tissue. 
 
 10 
CLAW PAW MEETS THE ADAMS FAMILY: THE ROLE OF LGI4 
AND ADAM22 IN PERIPHERAL NERVE DEVELOPMENT 
 
Ekim Ozkaynak1, Gina Abello1, Siska Driegen1, Linde Kegel1, Martine 
Jaegle1, Koji Sagane2, John R Bermingham3, Dies Meijer1  
 
1ErasmusMC, Cell Biology and Genetics, Rotterdam, 3015GE, Netherlands, 
2Eisai Co. Ltd, Tsukuba Research Laboratories, Tsukuba, 300-2635, Japan, 
3McLaughlin Research Institute, Genetics, Great Falls, MT, 59405 
 
The development, homeostasis and function of the nervous system depend 
on intimate cellular interactions between neurons and glia cells. 
Disturbances of these interactions result in neurological disease. We are 
interested in defining the molecular interactions between Schwann cells and 
neurons in the peripheral nervous system that govern cellular differentiation 
and myelin formation. Analysis of the natural mouse mutant Claw Paw 
(Clp) has revealed a novel signalling pathway operating in nerve 
development. Claw paw mice are characterized by congenital 
hypomyelination and limb posture abnormalities. We have demonstrated 
that a mutation in the Leucine rich Glioma Inactivated (Lgi) gene 4, 
underlies the claw paw phenotype (1). Lgi4 is a member of the Lgi family 
of secreted proteins and is expressed by Schwann cells and neurons.  
Recently, it has been shown that Lgi1 and Lgi4 can bind to ADAM22, a 
member of the type I transmembrane A Disintegrin And Metalloproteinase 
family of cell surface receptors (2). It is likely that this interaction is 
functionally significant as ADAM22 mutant mice exhibit a peripheral nerve 
phenotype similar to that observed in clp mice(3). Adam22 is expressed in 
Schwann cells and neurons. To determine whether Lgi4-Adam22 function 
involves a paracrine and/or an autocrine mechanism of action we performed 
heterotypic Schwann cell sensory neuron cultures and cell-type-specific 
ablation of Lgi4 and Adam22 in mice. We have shown that Schwann cells 
are the principal cellular source of Lgi4 in the developing nerve and that 
Adam22 is required on axons (4). Our results revealed a novel paracrine 
signalling axis in peripheral nerve myelination in which Schwann cell 
secreted Lgi4 functions through binding of axonal Adam22 to drive the 
differentiation of Schwann cells.  
 
References  
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FORMATION OF AXONAL DOMAINS IN MYELINATED NERVES 
OF THE CNS 
 
Peter J Brophy  
 
University of Edinburgh, Centre for Neuroregeneration, Edinburgh, EH16 
4SB, United Kingdom 
 
The paranodal axoglial junction, an adhesion zone whose structural 
integrity is vital for the propagation of the action potential, is the major site 
of axon-glia contact in myelinated nerves. The adhesion complex is 
composed of the axonal proteins Caspr/Paranodin and Contactin and the 
glial receptor Nfasc155, an isoform of the cell adhesion molecule 
Neurofascin. This was the first glial cell adhesion molecule shown to 
mediate axon-glia interaction in the myelinated vertebrate nerve. We have 
generated mice lacking a functional Neurofascin gene which revealed that 
Nfasc155 is indeed a glial component of the junctional complex. 
Furthermore, these mutants also lack Nfasc186, the neuronal Neurofascin 
isoform, which is a major component of the node of Ranvier. In this mutant 
nodes of Ranvier are disrupted and rescue experiments have shown that 
Nfasc186 is required for their assembly in the CNS. More recently, we have 
shown in the CNS that clustering of sodium channels at the node of Ranvier 
can be promoted either by an intact axoglial junction or by the expression of 
Nfasc186. 
 12 
DICER1 AND MIR-219 ARE REQUIRED FOR NORMAL 
OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION 
 
Jason C Dugas1, Trinna L Cuellar2, Anja Scholze1, Brandon Ason2, Adiljan 
Ibrahim1, Ben Emery1, Jennifer L Zamanian1, Lynette C Foo1, Michael T 
McManus2, Ben A Barres1  
 
1Stanford University School of Medicine, Neurobiology, Stanford, CA, 
94305, 2University of California, San Francisco, Diabetes Center, San 
Francisco, CA, 94143 
 
To investigate the role of microRNAs in regulating oligodendrocyte (OL) 
differentiation and myelination, we utilized transgenic mice in which 
microRNA processing was disrupted in OL precursor cells (OPCs) and OLs 
by targeted deletion of Dicer1. We found that inhibition of OPC-OL 
miRNA processing disrupts normal CNS myelination, and that OPCs 
lacking mature miRNAs fail to differentiate normally in vitro. We identified 
three miRNAs, miR-219, miR-138, and miR-338, that are induced 10-100x 
during OL differentiation; the most strongly induced of these, miR-219, is 
necessary and sufficient to promote OL differentiation, and partially rescues 
OL differentiation defects caused by total miRNA loss. miR-219 directly 
represses the expression of PDGFRα, Sox6, FoxJ3, and ZFP238 proteins, 
all of which normally help to promote OPC proliferation. Together, these 
findings show that miR-219 plays a critical role in coupling differentiation 
to proliferation arrest in the OL lineage, enabling the rapid transition from 
proliferating OPCs to myelinating OLs. 
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Mechanisms that regulate the migration and differentiation of 
oligodendrocyte precursors are of great importance in understanding normal 
development and demyelinating/remyelinating conditions. In a microarray 
analysis comparing adult and neonatal O4+ cells, we found that Kai1/CD82 
is far more highly expressed in the adult than in the neonatal cells. CD82 is 
a transmembrane tetraspanin that suppresses tumor metastasis and its 
expression is often down-regulated or lost in the advanced stages of 
metastatic cancer. We hypothesized that CD82 could be a factor that 
restricts migration and promotes differentiation of maturing 
oligodendrocytes.  
+, olig2+ or NG2+, or became CC1+ non-myelinating oligodendrocytes or 
GFAP+ astrocytes.We have previously shown that in the adult rat white 
matter CD82 is co-expressed with CC1 and olig2 but not with NG2 or 
GFAP. CD82 is also expressed in isolated adult O4+ cells and continues to 
be expressed as these become O1+ in vitro. When we forced constitutive 
expression of CD82 in immature cells of the neonatal SVZ in vivo, the cells 
did not remain immature but differentiated either into CC1+ and MBP+ 
myelinating oligodendrocytes in the white matter or zebrinII+ astrocytes in 
the cortex. Their migration from the SVZ was severely restricted. In 
contrast, downregulation of CD82 in SVZ cells in vivo using retroviral-
expressed shRNAs, prevents their differentiation into myelinating 
oligodendrocytes. shRNA-expressing cells remained PDGFR  
Our new data confirm that preventing CD82 expression in either adult or 
neonatal O4+ cells in vitro prevented the cells from accumulating MBP, an 
observation that correlates with the inability of CD82 shRNA-expressing 
cells to myelinate in vivo. CD82 has been physically linked to c-Met, the 
hepatocyte growth factor receptor, in tumor cell membranes and this 
interaction decreases signalling through c-Met. Accordingly, we performed 
immunoprecipitation and found that c-Met and CD82 bind each other 
directly in acutely isolated adult O4+ cells. Since c-Met is a positive 
regulator of oligodendrocyte precursor migration and is expressed in both 
neonatal and adult O4+ cells, the expression of CD82 may help to restrict 
migration. CD82 interaction with integrins, as occurs in other cell types, 
may also play a role in restricting precursor migration.  
 
 
This work is supported by a Postdoctoral Fellowship from the National 
Multiple Sclerosis Society  
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Neuregulin expressed by axons can regulate myelination by signalling to ErbB 
receptors on myelinating cells. Furthermore, in CNS grey matter, neuregulin 
increases the expression of NMDA receptors. Oligodendrocytes at all 
developmental stages in the white matter exhibit NMDA evoked currents, 
mediated by receptors which show very weak magnesium block and are 
expressed in the myelin (Káradóttir et al., 2005, 2008), indicating that they 
might play a role in myelination. 
 
We now use an assay in which cortical oligodendrocytes ensheath dorsal root 
ganglion cells (Wang et. al., 2006) to show that neuregulin and NMDA 
receptors interact to regulate myelination. Without neuregulin, blocking NMDA 
receptors had no effect on myelination. Adding neuregulin (in the form of the 
extracellular domain of NRG1-β1, 10ng/ml) increased myelination by 60%, and 
led to the majority of myelination becoming dependent on activation of NMDA 
receptors: NMDA receptor block decreased myelination by 80%. Blocking 
action potentials with TTX also had no effect in the absence of neuregulin, but 
greatly reduced myelination in the presence of neuregulin. Neuregulin’s effect 
was associated with a 4-fold increase in NMDA receptor current and an increase 
in phosphorylation of Creb in oligodendrocyte lineage cells. Thus, neuregulin 
apparently switches myelination from a default programme, that is independent 
of neuronal activity, to a mechanism that is regulated by glutamate released 
from active axons. 
 
These data reveal a function for oligodendrocyte NMDA receptors, and could 
provide a novel white matter explanation for how the linkage of neuregulin to 
schizophrenia can be reconciled with schizophrenia involving a malfunction of 
NMDA receptors. The absence of neuregulin in multiple sclerosis lesions, and 
enhanced remyelination by added neuregulin, suggest a role for 
neuregulin/NMDA receptor dependent remyelination after pathology. 
 
Káradóttir R, Cavelier P, Bergersen L & Attwell D (2005) Nature 438, 1162-1166. 
Káradóttir R, Hamilton N, Bakiri Y & Attwell D (2008) Nature Neuroscience 11, 
450-456 
Wang Z, Colognato H & ffrench-Constant C (2006) Glia 55, 537-45 
Supported by the Wellcome Trust, MRC, FP7 Marie Curie Training Network, 
Action Medical Research, and the Royal Society. 
 15 
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The neuronal ceroid lipofuscinoses (NCLs) represent the most common 
group of severe neurodegenerative diseases in children. NCLs are inherited, 
autosomal recessive lysosomal storage diseases (LSD), which are 
characterized clinically by epileptic seizures, progressive psychomotoric 
decline, visual failure, variable age of onset, and premature death. 
We have previously generated the Cln1 and Cln5 deficient mouse models 
[1, 2]. These mice suffer from several neuronal defects, such as retinal 
atrophy leading to blindness, motor dysfunction, weight loss, and 
difficulties in movement. The brain analyses show localized astrocytosis 
and neuronal loss in the thalamocortical system.  
In this study we have developed a novel Cln1 and Cln5 deficient double 
knock-out (KO) mouse model, The Cln1/Cln5 double KO offspring is 
viable, and the first phenotypical defects (myoclonic jerks, balance 
problems, spontaneous seizures) are observed at 3 months, which is earlier 
than in Cln1 or Cln5 deficient mouse, which show the first symptoms 
around the age of 5 months. The double KO mice revealed a massive 
accumulation of autofluorescence storage material in the brain, especially in 
cortex and thalamus. The histopathological analysis showed the loss of 
Purkinje cells in the cerebellum, and the presence of glial cells (astrocytes 
and microglia) in the cortex indicates astrocytosis in the Cln1/Cln5 double 
KO mouse brain. However, the loss of myelin, which is commonly seen in 
Cln1 and Cln5 deficient mouse brain, was not observed in double KO 
mouse brains. These results will be confirmed by immunohistochemical 
straining and stereological analysis of the brain sections. 
Together the results suggest that loss of both Cln1 and Cln5 genes leads to a 
more severe phenotype that the loss of only one of these genes. The basic 
disease phenotype of the novel mouse model will be characterized in more 
detail, and the gene expression profiles will be analyzed and compared to 
the existing data of Cln1 and Cln5 deficient mouse models. Since Cln1 KO 
mouse has disturbances in cholesterol synthesis, the lipid metabolism in the 
double KO mouse will be also analyzed. In addition, the possible defects in 
oligodendrocyte biology and mitochondrial function will be investigated. 
The data obtained from this study will provide a comprehensive view of 
NCL diseases and should lead to further understanding of 
neurodegenerative mechanisms involved in the development of brain 
disorders. 
 
1. Jalanko et al., Neurobiol Dis (2005), 18:226-241. 
2. Kopra et al., Hum Mol Gen (2004), 13:2893-2906. 
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Complete transection of the thoracic spinal cord and implantation of a 
Schwann cell (SC) bridge is a rigorous model to assess the regeneration of 
CNS axons. Previous work with this model found that implantation of a pre-
gelled bridge of SCs and Matrigel results in the regeneration of intra-spinal 
but not supra-spinal axons into the bridge. We now report that, in contrast to 
pre-gelled bridges, an initially fluid bridge of SCs and Matrigel is sufficient 
for up to ten percent of AAV-GFP labeled brainstem axons to regenerate 
into the bridge. The host spinal cord/SC bridge interfaces varied from sharp 
boundaries to irregular ones where long GFAP positive astrocyte processes 
were found to enter and cross the bridge for at least 2.5 mm. The processes 
were finger-like, with more robust ones found close to the interface and 
very fine ones found farther into the bridge. At the rostral interface, the 
astrocyte processes were also in close association with brainstem axons as 
well as SCs, and together formed a triumvirate. The brainstem axons were 
often found to regenerate beyond the astrocyte processes. The percentage of 
brainstem axon regeneration into the bridge correlated positively with the 
number of GFAP positive processes 0.25 mm past the rostral interface 
(p<0.005; r2=0.65). In addition, the number of GFAP positive processes 
found at all measured distances across the SC bridge was greater in the 
initially fluid bridges compared to those that were pre-gelled (p<0.0001; 
two-way ANOVA). At 0.25 mm past the rostral interface, there was an 
average of 182 GFAP positive processes/mm2 in the initially fluid bridges 
compared to only 16 GFAP positive processes/mm2 in the pre-gelled 
(p<0.01; Bonferroni posttest). After six weeks, scores for an open-field hind 
limb locomotion test, the BBB, also correlated with the total number of 
GFAP positive processes found at both the caudal and rostral interfaces 
(p<0.05; r2=0.31). Thus, the presence of GFAP processes crossing both 
interfaces defines an environment that may lead to improvements in hind 
limb locomotion after complete transection and implantation of a SC bridge. 
In this way, a host spinal cord/SC bridge interface may or may not be 
permissive for brainstem axon regeneration and functional recovery, and 
this appears to be dependent upon the nature and morphology of the GFAP 
positive astrocytes at the interface. 
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Charcot-Marie-Tooth (CMT) peripheral neuropathy is the most common 
inherited disorder of the peripheral nervous system. Approximately, 1 in 
2500 people exhibit CMT defects. The high prevalence of the CMT disease 
brings enormous burdens onto our health-care system and severely affects 
the economy of the United States. Formulating new therapeutic approaches 
are critical for improving the quality of life of CMT patients.  
 
CMT1C is a subclass of the CMT family. Mutations in protein SIMPLE 
(small integral membrane protein of the lysosome/late endosome) account 
for the etiology found in CMT1C patients. Molecular basis of SIMPLE 
mutations in causing demyelination in CMT1C, however, remain elusive. 
The lack of knowledge on the role of SIMPLE further complicates our 
understanding of SIMPLE in CMT1C demyelination.  
 
We have recently discovered that SIMPLE participates in vesicular 
trafficking to extracellular milieu. Indeed, secreted SIMPLE is found in 
exosomes, extracellular fractions that contain 50-90 nm nano-vesicles. 
Exosomes are arisen from membrane invagination of late endosomes. 
Exosomal trafficking, therefore, is an extracellular continuum of the 
complex endosomal pathway.  
 
To provide the molecular foundation for subsequent examination of 
SIMPLE in CMT1C neuropathy, we investigated the role of SIMPLE in 
exosomes per se. We found that a composite signal is required for exosomal 
targeting of SIMPLE. Exosomal SIMPLE contributes to the making of these 
nano-vesicles. SIMPLE is also evolutionarily conserved and SIMPLE 
ortholog in C. elegans is expressed along the worm intestinal tract, located 
at the apical/basal membranes and exhibited vesicular punctate localization. 
Notably, we found that all mutations identified in CMT1C patients impair 
targeting of SIMPLE to exosomes. Together, our data demonstrate that 
defective exosomal localization is a new disease-causing mechanism and 
could account for CMT1C neuropathy. To further unravel the 
pathomechanisms of CMT1C neuropathy, we will discuss molecular studies 
of CMT1C mice, Simple-/- null mice and genetic mutagenesis in C. elegans.  
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To achieve precise neural connectivity and form mature neural circuits, pre-
formed axons and synapses need to be remodeled extensively. These 
remodeling processes include elimination of excess axons, dendrites, 
synapses and their debris. Growing evidence suggests that elimination 
processes are essential in shaping neural circuits during development as 
well as in regulating synaptic plasticity in response to experience and 
memory in adulthood. Moreover, certain neurodegenerative diseases, such 
as Alzheimer’s disease (AD), are associated with a profound loss of 
synapses early in the disease process, underscoring the importance of 
understanding the mechanism for this synapse loss. Studies in mammals, 
flies and worms have previously demonstrated that glial cells play central 
roles in clearing apoptotic neurons and degenerating axons through an 
engulfment process called phagocytosis. However, the cellular and 
molecular mechanisms that drive these phenomena are largely unknown, 
particularly in the mammalian CNS. Recently by gene profiling, we have 
found that several phagocytic pathways--the MEGF10/draper/ced1 pathway 
that mediates axon pruning in flies and the MERTK pathway that mediates 
outer segment clearance by retinal pigment epithelial cells--are specifically 
and highly expressed by mouse astrocytes in both the developing and adult 
CNS. Although it has been assumed that microglia in the mammalian CNS 
are largely responsible for clearing neural debris, our findings suggest that 
mammalian astrocytes may actively participate in eliminating excess axons, 
dendrites, synapses and their debris. In our studies, we have found that 
astrocytes in fact have high phagocytic activity in clearing axonal debris in 
vitro. Currently, we are investigating the hypothesis that astrocytes 
phagocytose neural debris and synapses through the MEGF10 and/or 
MERTK phagocytic receptor pathways expressed by astrocytes. 
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Maternal cocaine abuse is correlated with decreased mother-infant 
attachment, increased neglect and altered infant behavioral development. 
Increased neglect may derive from effects prenatal cocaine has on infant 
cues that promote maternal response. Perhaps most salient among these 
cues is the cry of the newborn and young infant. In both human and rodent 
infants auditory stimuli (cries and ultrasonic vocalizations) elicit maternal 
care. This study examined human and rodent infant vocalizations to 
determine if prenatal cocaine alters vocalizations which might influence 
maternal care and if vocalizations might be a sensitive tool in predicting 
infant glial and neuronal integrity. Limbic regions of the neonatal brain are 
plastic and mature during the postnatal period correlating with altered social 
behavior in human infants. Prenatal cocaine has been found to delay 
astrocyte maturation but the impact this has on neuronal development or 
behavior has not been explored. Healthy control mothers, mothers who 
abused cocaine, and mothers who abused drugs but not cocaine during 
pregnancy brought in their infants at 4 weeks + 4 days. Infants were placed 
on a chilled scale and 35 seconds of crying was obtained and subsequently 
analyzed. In our animal model Sprague-Dawley rats, upon conception, were 
divided into three groups: untreated, chronic-cocaine treated (30mg/kg/day 
from gestation days (GDs) 1-20), or chronic-saline treated (2mg/kg/day 
from GDs 1-20). On GDs 13-15 pregnant rats were injected with 
Bromodeoxyuridine (10mg/kg) to label proliferating cells in the 
periaqueductal gray, amygdala, and nucleus accumbens. On postnatal day 
14 pups were tested for vocalizing behavior by placement on a metal scale 
mirroring our human cry elicitation protocol. Vocalizations were altered in 
both species following cocaine-exposure, including alterations in pitch, 
duration, and amplitude. Rodent brains are now being assessed for astrocyte 
and neuronal maturation rates with fluorescent immunohistochemistry to 
explore if prenatal cocaine exposure delays neural-glial development and if 
this developmental delay correlates with altered vocalizing behavior. 
Vocalizations may serve as a behavioral and biological marker for infants 
with developmental vulnerability to maternal neglect. 
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Homeoprotein (HP) transcription factors play fundamental roles in 
development, ranging from embryonic polarity to cell differentiation and 
migration. Their cell autonomous activity has been extensively documented. 
Less importance has been granted to their other properties, notably their ability 
to undergo intercellular transfer. Recent years, have underscored functions of 
HP transfer in eye field development (Lesaffre 2007), axon guidance (Brunet 
2005), retino-tectal patterning (Wizenmann 2009) and visual cortex plasticity 
(Sugiyama 2008). 
More recently, we investigated a possible role of HP transfer in cell migration. 
We started by looking at the role of certain HPs, notably Pax6 and Nkx2.2, in 
migration in the embryonic spinal cord, using the chick neural tube as a model.  
In the developing spinal cord, Nkx2.2 and Pax6 are involved in the regulation of 
specification and/or differentiation of oligodendrocytes. The oligodendrocyte 
precursors (OPCs) arise in the Olig2-positive ventral domain of the ventricular 
zone and disperse in successive ventral and latero-dorsal waves. In analogy with 
the work on axon guidance (Brunet et al., 2005), the presence of extracellular 
Pax6 and Nkx2.2 in the neural tube at E6 suggested a possible non-cell 
autonomous role of these factors in OPC migration. 
This hypothesis was tested by loss and gain of function experiments to 
neutralize or enhance extracellular Pax6 activity, respectively. Loss of function 
was achieved through the expression by electroporation of secreted antibodies 
designed to antagonize Pax6 HP transfer. Secreted Pax6 antibody expression at 
E3 resulted in a reduction in the number of migrating Olig2+OPCs at E6. In 
contrast, electroporation of the protein Pax6 with a signal peptide increased the 
number of migrating OPCs. Identical conclusions were reached by culturing 
open book neural tubes in the presence of Pax6 neutralizing antibodies or 
purified Pax6 protein. 
All in all, these findings suggest a paracrine effect of Pax6 on OPCs, 
specifically promoting their migration, which provides a new example of non-
cell autonomous HP activity.  
 
References 
Brunet et al. Engrailed-2 guides retinal axons. Nature, 438: 94-98, 2005. 
Lesaffre et al. Direct non-cell autonomous Pax6 activity regulates eye development 
in the zebrafish. Neural Development, 2, 2, 2007. 
Sugiyama et al. Experience-dependent transport of Otx2 HP in the visual pathway 
activates postnatal cortical plasticity. Cell: 134, 508-520, 2008. 
Wizenmann et al. Extracellular Engrailed participates in the topographic guidance of 
retinal axons in vivo. Neuron, 64: 355-366, 2009. 
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We are investigating the signaling pathways that regulate myelination. 
Previous studies have shown that the amount of Neuregulin1 (NRG1) type 
III on the axon surface triggers myelination by Schwann cells and regulates 
myelin sheath thickness (Michailov et al, 2004; Tavveggia et al, 2005). 
Type III NRG1 binds to the erbB2/3 heterodimer on Schwann cells, 
activating downstream signaling pathways including PI 3-kinase, which is 
critical for myelination (Maurel and Salzer, 2000). In this study, we have 
examined the role of the serine/threonine kinase, Akt, a key downstream 
effector of PI 3-kinase. We have generated and are characterizing transgenic 
mice in which constitutively active (CA) Akt constructs (DD-Akt and myr-
Akt) are expressed in Schwann cells and oligodendrocytes under the control 
of the 2', 3'-cyclic nucleotide phosphodiesterase (CNPase) promotor. These 
mice exhibit hypermyelination, i.e. increased myelin sheath thickness in 
both the CNS and PNS. Some myelinated fibers in the PNS show 
outfoldings similar to that observed in CMT4 patients. In unmyelinated 
fiber tracts, CA Akt expression does not convert Remak Schwann cells to a 
myelinating phenotype but does drive dramatic membrane expansion and 
axon wrapping by these cells. Conversely, inhibiting Akt activity with 
perifosine blocks Schwann cell myelination in cocultures in a Krox20 
independent manner. Taken together, these results suggest that Akt is a key 
signal downstream of NRG1 that drives wrapping of axons by Remak 
Schwann cells and the sheath thickness of myelinating Schwann cells, 
independent of effects on transcription.  
 
This research was supported by a grant from the NIH (NS26001); ED was a 
recipient of a Ministerio de Educación y Ciencia - Fulbright Fellowship. 
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In the past decade much progress has been made in elucidating the 
transcriptional control of oligodendrocyte differentiation and myelination, 
with factors such as Sox10, the Oligs and Nkx family members shown to 
have pivotal roles in aspects of oligodendrocyte development. In addition, 
we have recently identified a novel transcriptional regulator, Myelin Gene 
Regulatory Factor (MRF) that is essential for the transition of a pre-
myelinating oligodendrocyte into a myelinating oligodendrocyte expressing 
the full complement of myelin genes. Less is known, however, about 
whether maintenance of myelin in the adult CNS requires ongoing 
expression and activity by the same set of transcription factors that are 
required during oligodendrocyte development. Here, we make use of PLP-
CreERT2 transgenic mice to conditionally inactive the MRF gene within 
mature oligodendrocytes in adult mice. This results in a severe CNS-
specific demyelination that occurs over an eight-week period, accompanied 
by significant microglial activation and functional impairment. These 
results indicate that in addition to being required for the final stages of 
oligodendrocyte differentiation, MRF expression in oligodendrocytes is 
required on an ongoing basis to maintain the integrity of CNS myelin. 
These observations will form the basis for ongoing work identifying the 
immediate target genes of MRF, and may also provide a reliable non-
immune mediated model of CNS demyelination/remyelination. 
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The cleavage of amyloid precursor protein (APP) by gamma-secretase, 
plays an important role in the pathogenesis of Alzheimer’s disease (AD). 
Thus, gamma-secretase is a target for the development of AD therapeutics 
and specific inhibitors are currently in clinical trials. Nevertheless, gamma-
secretase also cleaves other receptors such as notch receptors, which control 
cell development and homeostasis. Our aim was to investigate whether 
gamma-secretase can also mediate microglial phagocytosis of Alzheimer’s 
disease beta amyloid. We have demonstrated that gamma-secretase 
inhibitors impair microglial activity, as seen in gene expression, protein 
expression, migration ability and which resulted in a reduction of soluble 
beta amyloid phagocytosis. We further showed that dysfunction gamma 
secretase catalytic site lead to microglia impairment in clearing insoluble 
beta amyloid from brain sections taken from an Alzheimer’s disease mouse 
model, as compared to microglia from wild-type mice. In this work, we 
suggest for the first time, a dual role of gamma-secretase in Alzheimer’s 
disease. One role is the cleavage of amyloid precursor protein towards beta 
amyloid production and the other is to regulate microglia activity that is 
important for clearing amyloid deposits. 
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Spinocerebellar ataxia type 7 (SCA7) is a dominantly inherited disease 
resulting in the progressive degeneration of specific neuronal populations 
including cerebellar Purkinje cells (PCs). SCA7 is caused by the expansion 
of a CAG/polyglutamine(polyQ) repeat in the ataxin-7 gene. We have 
previously reported that directing expression of polyQ-expanded ataxin-7 to 
Bergmann glia (BG) in transgenic mice leads to ataxia and non cell-
autonomous PC degeneration. We set out to further examine the BG 
pathology and its contribution to the behavioral and histological phenotype 
of SCA7 mice. We generated a novel SCA7 mouse model in which polyQ-
expanded ataxin-7 flanked by loxP sites is ubiquitously expressed by the 
mouse prion protein transgene promoter in a bacterial artificial 
chromosome. This floxed-SCA7-92Q line demonstrated progressive ataxia 
and PC degeneration on a time course similar to previously published SCA7 
transgenic mouse models with wide spread expression of the mutant 
protein. Additionally, our model exhibited a measurable reduction in the 
number of BG processes within the cerebellar molecular layer. To 
conditionally inactivate polyQ-expanded ataxin-7 expression in BG, we 
generated mice expressing our floxed mutant ataxin-7 transgene and a 
transgene in which Cre recombinase is controlled by the human glial 
fibrillary acidic protein (GFA2) cassette, a promoter known to direct 
expression to murine BG. In floxed-SCA7-92Q;GFA2-Cre bigenic mice, 
the mutant transgene was excised in approximately 70% of BG. Using a 
composite phenotype score and accelerating rotarod analysis, we 
determined the removal of polyQ-expanded ataxin-7 from BG partially 
ameliorates the SCA7 behavioral phenotype. Concurrently, we generated 
mice bigenic for the floxed-SCA7-92Q transgene and a Cre transgene with 
PC-specific expression. Excision of the mutant SCA7 transgene from the 
majority of PCs also partially reversed the SCA7 behavioral phenotype. 
Analysis of BG morphology in both bigenic lines is ongoing. In summary, 
polyQ-expanded ataxin-7 expression is required in both PCs and BG to 
recapitulate SCA7 pathogenesis in mice, suggesting that neurodegeneration 
in SCA7 results from dysfunction that develops in both neurons and glia. 
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Myelination provides an insulating myelin sheath, regularly interrupted at 
nodes of Ranvier (NR) where voltage-gated Na+ channels are concentrated. 
The Na+ channels are localized in the axonal membrane of the nodes where 
they are part of multimolecular complexes which present striking 
similarities with those identified in the axonal initial segment of neurons 
(AIS) where action potentials are generated. 
SCHIP-1 is a protein highly enriched at NRs and AISs. To shed light on the 
possible role of SCHIP-1 in vivo we generated mice deficient for its 
expression. Adult mutant mice appeared normal, but suffered from a mild 
growth delay. Analysis of PNS myelinated fibers revealed morphological 
anomalies of NR and a progressive decrease in their number within the 
nerve. Additionally, nodal accumulation of some of the NR proteins was 
progressivly perturbed with age. Electron microscopy of semi-thin sections 
of phrenic nerve of old mice revealed a slight decrease in axonal diameter, 
g-ratio, and fibers number, as compared to wild type mice, suggesting also 
axonal alterations in mutant mice. Sciatic nerve conduction was not 
significantly different between mutant and wild type littermates. However, 
CAPs duration was increased in mutant mice, suggesting a mild conduction 
defect in small caliber fibers. Therefore our results show that SCHIP-1 has a 
minimal importance in the formation and function of the NRs in young 
mice, but support the hypothesis that it plays a critical role in their 
maintenance. Analysis of the clinical phenotype of the mutant mice 
revealed subtle walking problems, including abnormal hind limb spreading. 
Tests of motor coordination also revealed impairments. However, the 
muscular strength of mice did not show any deficit. We also showed that 
mutant mice displayed slightly reduced pain sensitivity. Thus, SCHIP-1 
mutant mice presented some degree of ataxia which could correspond to 
sensory defects of the PNS nerves. However, since histological and 
physiological alterations of peripheral nerves appeared to be minor, these 
symptoms may also involve defects of the CNS. 
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Neuroinflammation, a process in which reactive glial cells are involved, is 
suggested to play a role in the development of neurodegenerative diseases. 
The CCAAT/enhancer binding protein (C/EBP) family of transcription 
factors is involved in glial activation by regulating the expression of pro-
inflammatory genes. Our objective in this study was to investigate the role 
of C/EBPs in neuroinflammation and neurotoxicity induced by reactive glial 
cells.  
As a model of neuroinflammation, we induced neuronal death in neuronal-
microglial co-cultures using LPS/IFNγ to activate microglia. Specific 
pharmacological inhibitors of C/EBPs are not available, making it difficult 
to study their role in neuroinflammation. As an alternative, we studied the 
neuroprotective role of an anti-inflammatory agent, the flavonoid chrysin, 
and the involvement of C/EBPs in its mechanism of action. Chrysin pre-
treatment inhibited the pro-inflammatory phenotype in LPS/IFNγ-treated 
microglia (NO and TNF-α release, and iNOS expression) and the resulting 
neurotoxicity. These effects occurred in the presence of a decrease in 
C/EBPδ mRNA and protein expression induced by LPS/IFNγ, while no 
effect on C/EBPβ and p65 nuclear expression or DNA binding was 
observed.  
We also studied glial activation in C/EBPβ KO mice using mixed glial 
cultures treated with LPS or LPS/IFNγ. We observed an inhibition of the 
inflammatory response in C/EBPβ KO cultures (COX-2, IL1β, and iNOS 
mRNA expression, iNOS and COX-2 protein expression and NO release).  
Our results show that the inhibition of C/EBPs expression results in a 
decreased glial activation. In addition, we show for the first time that 
C/EBPδ inhibition protects from the neurotoxicity induced by reactive 
microglial cells. We suggest C/EBPs as possible therapeutic targets against 
neurodegenerative processes occurring in the presence of 
neuroinflammation.  
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Neuroinflammation, in which reactive glial cells (mainly microglia) are 
involved, is suggested to play a role in the development of 
neurodegenerative diseases. Microglia are the principal immune cells of the 
CNS. In the control brain, these cells are continually surveying their 
microenvironment, ready to detect changes that could compromise neuronal 
function. In response to brain tissue injury, they develop morphological and 
functional changes, among them the production of pro-inflammatory 
mediators with potentially neurotoxic consequences. This reactive/pro-
inflammatory phenotype is inhibited in the normal brain through a strict 
control through a series of “off-on” signals. CD200 (neuronal) and 
CD200R1 (microglial) constitute an “off-signal”. It is present in control 
conditions and its absence determines the onset of pro-inflammatory 
microglial activation. TREM-2 (microglial) activation is an “on-signal”. It 
is inducible and its activation determines the onset of an anti-inflammatory 
microglial response. The mechanism of action of these signals is still 
unknown.  
The objective of the present work is to study the role of CD200-CD200R1 
and TREM-2 in the modulation of the inflammatory response in reactive 
microglial cells and the resulting neurotoxicity. As a first approach we 
determined the response of CD200R1 and TREM-2 to pro-inflammatory 
and anti-inflammatory stimuli using microglial cell cultures. We also 
studied the modulation of CD200 (CD200R1 ligand expressed in neurons) 
in neuronal cultures in the presence of apoptotic or necrotic neuronal death, 
which are associated to anti-inflammatory or pro-inflammatory microglial 
activation respectively.  
We believe that the modulation of the signal induced by these molecules 
may constitute a target to act against neurodegenerative processes occurring 
in the presence of neuroinflammation.  
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Multiple Sclerosis (MS) is a chronic immune mediated demyelinating 
disease of unknown etiology. Only recently has research begun to discover 
some of the molecular abnormalities that occur in the MS. We have 
previously shown that the protein tyrosine phosphatase SHP-1 is reduced in 
PBMC’s and macrophages of multiple sclerosis patients. Studies in mice 
have demonstrated that SHP-1 is a crucial negative regulator of pro-
inflammatory cytokine signaling, Toll-like receptor signaling, and 
inflammatory gene expression involved in demyelination. Furthermore, we 
have shown that mice lacking functional SHP-1 display myelin 
abnormalities and an extreme susceptibility to inflammatory demyelination 
relative to wild-type mice. We hypothesize that the increased vulnerability 
to demyelination may be accounted for in part by the loss of SHP-1 in 
oligodendrocytes. In order to determine if SHP-1 may also play a role in 
oligodendrocytes of MS subjects we examined oligodendrocytes in normal 
appearing white matter (NAWM) of MS and normal brains. We found that 
SHP-1 is particularly enriched in oligodendrocytes and that SHP-1 
expression is reduced in NAWM relative to WM of controls. We and others 
have also found inflammatory cytokines to be increased in NAWM. SHP-1 
has been demonstrated to be critical in terms of modulation the immune 
response and proper development of oligodendrocytes; therefore a reduction 
in SHP-1 may represent a crucial factor in the pathophysiology of MS. 
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Alexander Disease (AxD) is a leukodystrophy caused by heterozygous 
mutations in GFAP. Infantile AD patients suffer from seizures, extensive 
de/dysmyelination, neuronal death, and hydroencephaly. Astrocytes in 
white matter and at the pial surface contain Rosenthal fibers (RFs), dense 
inclusions containing GFAP, small heat shock proteins, and other proteins. 
Mutant GFAP produces cell stress, including upregulation of MAPK 
pathways, autophagy, and proteasome inhibition. In this study we examined 
AxD CNS for iron, an important cofactor in oligodendrocytes, essential for 
myelination. Previously, mice with a knock-in mutation equivalent to that 
found in patients with a common GFAP mutation were found to have 
accumulated Fe 3+ iron in astrocytes (Hagemann et al., 2006). We stained 
AxD CNS tissues for Fe3+ by the enhanced Perl’s method and by 
immunocytochemistry for ferritin and found both associated with RFs. 
Additionally we found ferroportin, putatively the sole protein allowing iron 
exit from astrocytes, accumulated in the cell bodies of astrocytes. In 
primary astrocyte cultures obtained from mice expressing both transgenic 
human GFAP and a knock-in mouse GFAP mutation, we found that 
ferroportin accumulated in large, perinuclear inclusions that also contained 
GFAP. In these cultures all astrocytes contained ferritin, while in cultures 
from wild type mice, ferritin was not detectable in all astrocytes. 
Sequestration of iron in AxD astrocytes may increase the levels and 
consequences of cellular oxidative stress and make astrocytes more toxic to 
oligodendrocytes and neurons. 
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Demyelination is a significant source of morbidity in nerve injuries and 
neuropathies, however, the mechanisms involved have remained elusive. 
Demyelination is frequently associated with, and may result from 
dedifferentiation of Schwann cells and the consequent breakdown of their 
myelin sheaths. Our lab has developed an experimental model of 
demyelination that involves addition of the Neuregulin-1 (NRG1) growth 
factor to myelinating cocultures. This results in the activation of the erbB 
receptors and their downstream signaling pathways followed by Schwann 
cell dedifferentiation and demyelination. Among the pathways activated by 
NRG1 is the mammalian target of rapamycin (mTOR), a serine/threonine 
kinase that regulates the translational apparatus and integrates a number of 
upstream signals. We have found that inhibiting mTOR with rapamycin 
effectively prevents NRG1-induced demyelination. Recent results suggest 
that mTOR is also aberrantly activated in the PMP22 overexpressing 
transgenic rat, a murine model of the demyelinating human neuropathy 
Charcot-Marie-Tooth 1A (CMT1A). This activation leads to Schwann cell 
dedifferentiation as inhibition of mTOR with rapamycin rescues 
myelination in a tissue culture model of CMT1A. Current studies seek to 
elucidate further the role of mTOR in Schwann cell dedifferentiation, and 
the mechanism by which alterations in gene dosage of PMP22 lead to its 
activation. 
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Astrocytes in the CNS are putative mediators of synaptogenesis and neural 
plasticity. The outgrowth and retraction of astrocytic processes represent a 
mechanism by which these cells could influence the surrounding neural 
milieu. Specific subclasses of astrocytes have been identified on the basis of 
expression of cytoskeletal Type III intermediate filament (IF) genes such as 
glial fibrillary acidic protein (GFAP) and vimentin. These IFs are important 
in determining process length; the expression of IF genes is tightly 
regulated throughout the development of the CNS when neural connections 
are first established. We investigated whether astrocyte-specific IF genes 
were affected by loss of vision caused by retinal degeneration, a 
neurodegenerative disorder that causes aberrant connections within the 
visual pathway. We utilized two lines of mice: Pde6b- mice with 
progressive retinal degeneration due to a mutation in the gene that codes for 
phosphodiesterase 6 beta subunit, and Pde6b+ mice which served as 
congenic controls. In an earlier phase of this study, we found that Pde6b- 
mice began showing significant visual impairments between postnatal day 
(PND) 28 and PND 35. Using this timepoint as a guideline, we evaluated 
whether IF gene expression was altered in the visual cortex by quantifying 
GFAP and vimentin gene expression using real time PCR (N = 40). We 
found that expression of GFAP was reduced, and vimentin expression was 
altered transiently, between PND 28 and PND 49 in the visual cortex of 
Pde6b- mice. We are currently evaluating IF protein expression and process 
length in subclasses of astrocytes in the visual cortex with Western blotting 
and immunohistochemistry. Our findings tentatively support the conclusion 
that loss of sensory inputs to the visual cortex, caused by retinal 
degeneration, ultimately leads to transient alterations in the expression of 
GFAP and vimentin. Notably, this is associated with the onset of visual 
impairments. It remains to be determined whether transient alterations in IF 
gene expression enhance brain plasticity, and present a unique opportunity 
to optimize retinal implant interventions. 
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Generally, in injured brain, microglia have been known to produce 
inflammatory mediators and cause delayed neuronal death. However, the 
results in this study showed that in acutely injured brain, blood 
inflammatory cells as well as microglia participate in brain inflammation 
but that the inflammatory responses were not neurotoxic. When ATP was 
injected into the substantia nigra pars compacta (SNpc) and cortex, Iba-1+ 
microglia as well as neurons died in the injection core within 3 h, and 
morphologically activated thick process-bearing microglia were arranged 
around the injury sites. Round Iba-1+ cells highly expressing CD45 (a 
marker of monocytes) appeared in the penumbra at 1- 2 d, filled the core at 
7 d, and then rapidly disappeared at 14 d. Interestingly, in ATP-injected 
brain, iNOS was barely detectable at all times. Although IL-1β was 
detectable from 3 h to 1 d, PBS also induced IL-1β as much as ATP did. 
CD68 that represents phagocytic activity was detectable in the area where 
CD45+ cells existed. Importantly, the total numbers of TH+ neurons at 3 h 
(about 80% of those in the contralateral sides) did not decrease further at 7 
d. In the cortex, similar results were obtained: ATP induced acute death of 
neurons and microglia within 3 h but neuron-damage area did not increase 
for up to 7 d. These results suggest that microglia appear to isolate injury 
sites and blood monocytes appear to phagocyte damaged cells and debris, 
but their inflammatory responses are not sufficient to cause delayed 
neuronal death. 
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Traumatic spinal cord injury (SCI) causes acute neuronal death followed by 
delayed secondary neuronal damage. As a candidate to cause secondary 
damage, changes in microenvironment of the spinal cord could be 
condidered. Since microglia and astrocytes respond to the traumatic damage 
and blood cells infiltrate the injured tissue, we examined how these cells 
behave and affect secondary neuronal damage. We designated the sites of 
the injured spinal cord as epicenter (the damage site), C1 (0.9 mm caudal 
from the epicenter where delayed neuronal death occurred), and C2 (1.8 
mm caudal from the epicenter where delay neuronal death did not occur). 
Major findings in this study is that first, neurons in the ventral region were 
much more vulnerable than neurons in the dorsal regions: at the epicenter 
and C1 region, neurons in the ventral region died within 3 h and at 14-18 h, 
respectively, but neurons in the dorsal region survived up to 3 d. Second, 
microglia and blood monocytes appeared not to be related to delayed 
neuronal death: microglia underwent death earlier than neurons in C1 
ventral region, and activated in C2 region where neurons did not die. 
Monocyte infiltration occurred after neurons died, and monocytes showed 
alternatively activated phenotypes rather than classically activated ones. 
Third, astrocytes were different in the morphology and function in dorsal 
and ventral regions: dorsal astrocytes have highly branched and interacting 
processes while ventral astrocytes have long and thin processes. 
Furthermore, dorsal astrocytes had higher capacity to uptake potassium and 
glutamate in normal and injury-mimic state although mRNA levels of 
potassium and glutamate uptake system, GLT-1/GLAST and Kir4.1, 
respectively, were lower in the dorsal regions compared to the ventral 
regions. Accordingly, in the dorsal areas at the epicenter and C1 region, and 
dorsal and ventral areas of C2 region, neuron survival was correlated with 
astrocytes existence. Taken together, these results suggest that 
microenvironment maintained by astrocytes could be more important for 
neuronal survival than those regulated by microglia and monocytes. 
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NG2+ cells constitute a fourth major glial population in CNS. Although they 
serve as progenitors for myelinating oligodendrocytes in early development, 
their roles in the mature CNS are less clear, as many do not undergo 
differentiation. To determine the functions of NG2+ cells in the normal and 
diseased CNS, we generated NG2-floxed EGFP-STOP-DTa BAC 
transgenic mice, in which diphtheria toxin is expressed under the control of 
NG2 promoter only after tamoxifen-induced activation of Cre. After these 
mice were crossed to Olig2-CreER mice, we were able to ablate both 
cycling and non-cycling NG2+ glial cells in the adult brain by administering 
4-hydroxytamoxifen (4HT). In mice aged P70 or older, 80-95% of cortical 
NG2+ cells disappeared within 3-4 days after exposure to 4HT (7mg in 4 
days). The ablation of NG2+ cells was not accompanied by changes in the 
number of astrocytes, oligodendrocytes, microglia, vascular cells (NG2-
expressing pericytes) or neurons, indicating that these mice allow selective 
deletion of NG2+ glial cells in the adult brain. Moreover, this ablation did 
not induce overt reactive changes in microglia or astrocytes, and did not 
result in obvious alterations in the behavior of the mice. In response to 
incomplete ablation, remaining NG2+ cells rapidly began to proliferate, and 
eventually repopulated the entire cortex in 1-3 weeks, with the rate of 
repopulation varying with the extent of cell loss. Almost all NG2+ cells 
incorporated BrdU during repopulation, suggesting that few, if any, NG2+ 
cells are postmitotic in the adult brain. After crossing these mice with NG2-
Lck-EGFP BAC transgenic mice, we monitored the behavior of NG2+ cells 
in vivo using time-lapse, two-photon imaging for days to weeks after 4HT 
administration. These studies confirmed that administration of 4HT to these 
mice triggered the death of cortical NG2+ cells, and revealed the behavior of 
newly generated NG2+ cells during repopulation. These studies indicate that 
NG2+ cells are capable of rapid cellular homeostasis in the absence of brain 
injury, demyelination or damage to oligodendrocytes, suggesting that each 
NG2+ cell continually monitors the status of other neighboring NG2+ cells. 
The ability to selectively remove NG2+ cells in vivo may help define the 
mechanisms that regulate the growth and development of these progenitors, 
as well as reveal other roles of these ubiquitous glial cells. Supported by the 
NIH (NS051509, NS050274). 
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Chemokines play critical roles in inflammation by recruiting inflammatory 
cells to injury sites. In this study, we found that UDP induced expression of 
chemokines, CCL2 and CCL3, in microglia, astrocytes, and slice cultures, 
by activation of P2Y6. Interestingly, CCL2 was more highly expressed than 
CCL3. However, CCL2 synthesis kinetics in response to UDP differed in 
microglia and astrocytes; microglia rapidly produced small amounts of 
CCL2 whereas astrocytes slowly and continuously synthesized CCL2, 
resulting in a high ultimate level of the chemokine. UDP-induced 
chemokine expression was reduced in the presence of a specific antagonist 
of P2Y6 (MRS2578), or siRNA directed against the P2Y6 gene. Inhibition 
of phospholipase C (PLC) and calcium increase, downstream signaling 
pathways of Gq-coupled P2Y6, reduced UDP-induced chemokine 
expression. UDP activated two calcium-activated transcription factors, 
NFATc1 and c2. Furthermore, inhibitors of calcineurin (a phosphatase 
activating NFAT) and NFAT reduced UDP-induced chemokine synthesis. 
We also found, using a transmigration assay, that UDP-treated astrocytes 
recruited monocytes. These results suggest that UDP induces chemokine 
expression in microglia and astrocytes of the injured brain by activation of 
P2Y6 receptors. 
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Unverricht-Lundborg disease type 1 (EPM1, OMIM 254800) is an 
autosomal recessively inherited neurodegenerative disorder with 
progressive course and the most common progressive myoclonic epilepsy. 
Onset lies between 6 and 16 years and the symptoms include tonic-clonic 
seizures, stimulus-sensitive progressive myoclonus, ataxia and a 
characteristic EEG. It is caused by loss-of-function mutations in the cystatin 
B gene (CSTB, OMIM 601145), which encodes an inhibitor of lysosomal 
cysteine proteases. However, the exact function of CSTB remains to be 
elucidated.  
A mouse model for EPM1, Cystatin B-deficient (Cstb -/-) mouse, has been 
generated by targeted disruption of the mouse Cstb gene. Cstb-/- mice 
develop myoclonic seizures and progressive ataxia recapitulating the 
clinical features of the human disease. Mice also show severe loss of 
cerebellar granule cells by apoptosis and wide-spread gliosis.  
Microglial activation is a common hallmark of neurodegenerative diseases. 
Activated microglia produce a variety of inflammatory mediators, such as 
cytokines, chemokines, reactive free radicals and proteases, which can be 
detrimental for neurons and brain homeostasis, if their release is not tightly 
regulated. Interestingly, in Cstb-/- mice, activated microglia showing 
atypical morphology is evident in selected brain areas already in 
presymptomatic mice.  
 
In this study, we elucidate the microglial contribution to the neuronal 
dysfunction and selective neuronal death of cerebellar granule cells in 
EPM1. We aim to characterize the functional properties of Cstb-/- microglia 
and their effects on the survival of Cstb-/- neurons. Our results show that 
the Cstb mRNA level in cultured wild type mouse microglia shown by real 
time quantitative PCR is high in relation to astrocytes or neurons, 
suggesting that CSTB has a pivotal role in microglia. Moreover, LPS 
stimulation induces increased release of chemokines from Cstb-/- microglia 
into the media indicating altered inflammatory response due to the CSTB 
deficiency. Also, neurons cultured with Cstb-/- microglia display neuritic 
fragmentation and cell death.  
Our data give insight into the role of microglia in EPM1 and provide a basis 
for further detailed studies on the pathophysiology of this devastating 
disease.  
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Proper migration and layering of the dentate granule cells are fundamental 
to the establishment of functional neural networks in the hippocampus. 
However, the mechanisms that regulate the incorporation of migrating 
granule cells to the cell layer remain unclear. Because the granule cells 
perform radial migration tightly attaching onto GFAP-positive glial 
scaffold, we hypothesized that astrocyte-derived factors modulate the cell 
migration. In this study, we show that astrocyte-secreted factors modulate 
granule cell migration by decreasing the expression of polysialic acid 
(PSA). PSA is a long linear homopolymer of alpha-2,8-linked sialic acid, 
which is added to the fifth Ig-like domain of the neural cell adhesion 
molecule (NCAM). The expression of PSA on the cell surface is known to 
reduce cell interactions and promote neuronal migration. We prepared 
hippocampal slices from postnatal day (P)14 rats and cultured them in the 
presence of NeuAc2en, an inhibitor of neuraminidases/sialidases. Although 
newborn granule cells terminated their migration in the inner granule cell 
layer in control cultures, a number of them were found in the outer granule 
cell layer in NeuAc2en-treated cultures. Next, we examined whether 
astrocytes regulate PSA expression of the granule cells. For this purpose, 
we prepared astrocyte-conditioned medium (ACM) from the postnatal rat 
dentate gyrus and applied it to explant cultures of the dentate hilus. We 
found that ACM increased the expression of neuraminidase and reduced 
PSA expression in the granule cells, inhibiting their emanation from the 
explants. Importantly, these phenomena were blocked by NeuAc2en, which 
suggests that astrocyte-secreted factors modulate the migration of granule 
cells via activating neuraminidases. These results indicate that astrocyte-
secreted factors induce PSA degradation which is required for the proper 
incorporation of granule cells to the cell layer.  
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The neuronal ceroid lipofuscinoses (NCLs; CLN1-CLN10), a group of 
inherited lysosomal storage disorders, are the most common cause for 
pediatric neurodegeneration. Their clinical course includes progressive 
mental and psychomotor retardation, epilepsy, blindness and premature 
death. Mutations in the CLN8 gene account for two types of NCL: Northern 
epilepsy in Finland and the late infantile form enriched in the 
Mediterranean. The motor neuron degeneration mouse, mnd, harbors a 
mutation in the Cln8 gene and is used as a model to study CLN8 disease 
mechanisms. 
 
Mechanisms of neuronal dysfunction in the CLN8-related NCLs are largely 
unknown. Based on sequence homology, CLN8 is linked to a TLC (TRAM, 
LAG1, CLN8) superfamily of proteins, which have been proposed to have a 
role in lipid biosynthesis, metabolism and sensing. Supporting this in silico 
finding, we have shown perturbed sphingolipid metabolism in Northern 
Epilepsy patient brains. In addition, we have shown a decrease in myelin-
specific galactolipids in mnd mouse brains as well as delayed myelination. 
This was explained by the reduced activity and mRNA level of galactolipid-
synthesizing enzyme UDP-galactose:ceramide galactosyltransferase 
(Ugt8A). 
 
Oligodendrocytes are the main Cln8 expressing cells in the CNS and 
responsible for synthesis of galactolipids as well as myelin formation. In 
this study, we have used neural progenitor cells from mnd to investigate 
whether the reduced levels of galactolipids have consequences on 
oligodendrocyte development and maturation. Our results show enhanced 
neural progenitor proliferation. Neural progenitors exit the cell cycle 
normally, and produce neurons, astrocytes and oligodendrocytes of different 
developmental stages. In vivo, by real-time PCR, we have observed 
decreased oligodendrocyte/myelin marker expression in mnd brains. 
 
In conclusion, our study indicates oligodendrocytes as the key cell type in 
the CLN8 disease. These findings are critical for understaning the 
pathomechanisms of CLN8 disease as well as the physiological function of 
the CLN8 protein. 
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The HMG-domain transcription factor Sox10 is expressed throughout 
oligodendroglial development and is an important component of the 
transcriptional regulatory network in this glial cell type of the central 
nervous system. Of the Sox10 regulatory regions identified so far, only one 
exhibits activity in oligodendroglia. To better understand oligodendroglial 
Sox10 expression the activity and regulation of this evolutionary conserved 
U2 enhancer located in the 5’ flanking region of the Sox10 gene was 
analyzed both in vitro and in transgenic mice. We found that U2 was active 
in oligodendrocyte precursors, but not in differentiating oligodendrocytes. 
U2 activity also failed to account for initial Sox10 induction in 
oligodendrocyte precursors immediately after their specification pointing to 
the existence of additional regulatory regions which extend Sox10 
expression in oligodendroglia beyond U2 activity. In oligodendrocyte 
precursors, U2 activity was strictly dependent on the bHLH transcription 
factor Olig2. In fact, Olig2 bound U2 through a highly conserved site in the 
part of its sequence that displayed the highest sequence conservation, and 
activated the enhancer directly. The closely related bHLH transcription 
factor Olig1 by contrast showed little binding and was a much less efficient 
activator of the U2 enhancer. Additionally, U2 activity was repressed by the 
homeodomain transcription factor Nkx6.2 in a manner that did not require 
site-specific binding of Nkx6.2 to U2 and probably involved sequestration 
of U2 activators including Olig2. Considering the altered ratio of Olig1 
versus Olig2 and the onset of Nkx6.2 expression in differentiating 
oligodendrocytes, both factors likely contribute to the downregulation of U2 
activity during terminal differentiation in this glial cell type. 
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Spinocerebellar ataxia type 1 (SCA1) is a debilitating neurodegenerative 
disorder caused by an expanded CAG trinucleotide repeats within the coding 
sequence of the ataxin-1 protein. There are many evidences of inflammatory 
mechanisms of such disease. In order to prove this theory we the levels of 
different types of antibodies directed against neuronal and glial structures 
within SCA1 mice CNS. These mice considered as a most close models of SCA 
in humans. Autoantibodies (AAB) against Purkinje cells (PC), AAB against 
GAD, which is glutamic acid decarboxylase, an enzyme that catalyzes the 
decarboxylation of glutamate to GABA and CO2 , and , finally, proper anti-
GABA (gamma aminobutiric axid) B receptor have been studied in the serum 
and cerebrospinal fluid (CSF) of 24 SCA1 mice. Control group consisted of 56 
intact mice without any signs of ataxia or any other movement deficiency. We 
used Western blot analysis and ELISA and immunohistochemical studies, 
which revealed on mouse 2 μm brain sections of cerebellum, brain stem, 
hypothalamus and thalamic areas binding of high titer (up to 1:5.000) IgG AAB 
to the cerebellar molecular layer and white matter. Highly specific antibodies 
for PC were found binding for axons, dendrites and both sides of PC cell’s 
membrane. These AAB have been produced by B-cell clones within the CNS, 
which we found by staining these brain slices with immunofluorscent 
antibodies. It was discovered significant neuronal (mostly PC) loss in the 
cerebellar cortex with infiltratinf C8+ B cells. Reactive astrogliosis and 
microglial activation have been detected in terms of increasing of Bergmann 
glia and considerable microglial proliferation. Markedly increased levels of 
anti-GAD and anti-GABA B receptor AAB were obtained both in the serum 
and CSF in experimental animals in comparison with the control mice. Our 
findings suggest the presence of inflammation in PC revealing by astroglial and 
microglial activation. Western blotting of SCA mice1 cerebellum extract 
showed binding of CSF and serum IgG to a 76-84 kDa protein that presented 
exactly in the PC. On the other hand we couldn’t rule out a possible role of 
neoplastic cells in producing GAD AAB, which could be considered as a 
paraneoplastic marker in an experimental SCA1. Another approach emerged 
when anti-GABA B receptor AAB were revealed in the serum and CSF of 
SCA1 mice. Since this mice biology has been associated with signs of 
neuroinflammation with an active role of glial elements, the next step would 
include injection of anti- GABA B receptor AAB intratecally into cistern magna 
of SCA1 and intact mice for comparison of movement activity and 
neuroimmunological properties in brain morphology and future 
immunochemical studies. 
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Chronic manganese (Mn) exposure causes manganism, a neurological 
disease resembling idiopathic Parkinson’s disease. While the mechanism of 
Mn-induced neurotoxicity has not been completely established, glial cells 
play a crucial role in mediating its neurotoxicity as Mn induces impairment 
of astrocytic glutamate transporters. Two astrocyte-encoded glutamate 
transporters, GLAST and GLT-1, are primarily responsible for the removal 
of excess glutamate from the extracellular space and thus play a central role 
in preventing excitotoxic neuronal death. Numerous studies have reported 
that 17β-Estradiol (E2) and tamoxifen (TX), a selective estrogen receptor 
modulator (SERM) exert neuroprotective effects in various animal and cell 
models. Interestingly, many experimental results illustrate that astrocytes 
are the main target of E2/TX action. Therefore, we hypothesized that E2 
and TX protect against Mn-induced neurotoxicity by enhancing astrocytic 
glutamate transporter function via the transforming growth factor-α (TGF-
α) pathway. Studies in rat neonatal primary astrocyte cultures revealed that 
Mn decreased GLT-1 levels (mRNA and protein), while E2 and TX 
treatment increased its expression and reversed the Mn-induced reduction in 
GLT-1 expression and glutamate uptake. The effects of Mn and E2/TX on 
GLT-1 were parallel to those with TGF-α; namely, Mn decreased, whereas 
E2/TX increased and reversed TGF-α expression. TGF-α increased GLT-1 
expression as well as glutamate uptake and reversed the astrocytic Mn-
induced glutamate uptake inhibition. Moreover, blockade of the epidermal 
growth factor receptor (EGFR), the receptor for TGF-α with AG1478 
completely abolished the effect of E2 and TX on GLT-1 expression, 
providing additional evidence that TGF-α mediates E2/TX-induced GLT-1 
expression. To determine the ER subtypes responsible for these E2 and TX 
effects, the selective agonists for each ER subtype, propyl pyrazole triol 
(PPT) for the ER-α, diarylpropionitrile (DPN) for the ER-β and G1 for 
GPR30, were tested in relationship to GLT-1 expression. Among the three 
ER subtypes, GPR30 appears to play the most critical role in the 
enhancement of astrocytic glutamate transporter function, because G1 
induced the highest GLT-1 expression and glutamate uptake activity. Taken 
together, these results suggest that E2 and TX reverse Mn-induced 
impairment of GLT-1 expression and glutamate uptake activity, at least in 
part, by the enhancement of TGF-α signaling via the GPR30 pathway in 
astrocytes. 
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The presence and activity of dendritic cells (DC) in retina is controversial, 
as their limited numbers make them difficult to identify. Transgenic mice 
(CD11c-DTR Ly5.2) that express green fluorescent protein (GFP) on the 
CD11c promoter to label DC allowed the visualization and quantification of 
retinal DC. Retinal whole mounts were stained for GFP+ cells and 
microglia (GFP-CD11b+ MG), and analyzed by confocal microscopy. A 
retina injury model, the optic nerve crush (ONC), was used to study their 
injury response. Many GFP+ DC were recruited to the ganglion cell 
layer/nerve fiber layer (GCL/NFL) following an ONC; many GFP+ cells 
were tightly associated with retinal ganglion cell (RGC) nerve fibers. 
Conversely, very few MG were found in close contact. All of the GFP+ DC 
were CD11b+, suggesting a myeloid origin. In addition, the GFP+ DC 
upregulated expression of MHC class II after injury, while the MG did not. 
To study the origin of retinal GFP+ DC, radiation bone marrow (BM) 
chimeras [CD11c-DTR Ly5.2 recipients of Ly5.1 BM, and vice versa] were 
used. Retinal GFP+ cells were depleted by injecting diphtheria toxin (DTx) 
into the anterior chamber. Analysis of retinas from Ly5.1 recipients of 
CD11c-DTR BM, in the absence of injury, showed a slow increase in GFP+ 
cells. This suggests minimal turnover from grafted cells up to six months, 
even though the mice were irradiated. Retinas from Ly5.1 recipients of 
CD11c-DTR BM that received an ONC prior to harvesting had many donor 
GFP+ cells in the crushed eyes around the optic disc and in the periphery. 
These GFP+ cells appeared to be derived from circulating precursors. The 
persistence of retinal GFP+ cells in CD11c-DTR recipients of Ly5.1 BM up 
to 7 months pointed to a precursor that must come from a non-circulating 
source, possibly MG or local progenitor cells. The number of MG was 
found to be unchanged after the retinas of these mice were repeatedly 
treated with DTx. Thus, MG are unlikely to be contributors of GFP+ cells. 
The injection of DTx not only led to the depletion of GFP+ cells; it also 
seemed to deplete their local progenitor cells, as no GFP+ cells were found 
after the retinas had received an additional stimulus to recruit more GFP+ 
cells. These results suggest that MG do not contribute to the GFP+ cells. 
Use of the radiation BM chimeras together with DTx treatment showed that 
GFP+ cells were recruited, in part, from local precursors, and can also be 
recruited from circulating precursors. Overall, this study showed that DC 
were found in the retina and that they rapidly responded to neural injury. 
We propose that they are a previously overlooked population, distinct from 
MG, and may be important in the injury response.  
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Pinpointing the identity of tumor propagating cells (TPCs) in gliomas is 
critical for designing targeted therapies. Previous studies have postulated 
the neural stem cell (NSC) nature of TPCs based on their abilities to self-
renew and to differntiate into mutiple cell types in cell culture. However, 
the sole dependence of end-point analysis could be misleading since late-
stage tumor cells could acquire aberrant features during malignant 
transformation. An ideal approach to fully understand TPCs would be to 
analyze mutant cells throughout the tumorigenic process, with a greater 
focus on stages piror to the malignant transformation. To overcome the 
difficulty in identifying pre-transformed mutant cells free of identifiable 
pathological features, we used a mouse genetic mosaic model termed 
MADM to generate sporadic GFP-labeled mutant cells in an otherwise 
colorless normal mouse, enabling mutant cell visualization upon their 
generation. By inducing co-LOH of p53 and NF1 from embryonic NSCs, 
MADM model effectively induced glioma formation with almost full 
penetrance within 4-6 months. Genomic fingerprinting confirmed the close 
relevance of this model to the proneural subtype of human GBMs based on 
recent TCGA classification. Taking advantage of the unambiguous GFP 
labeling of mutant cells, we analyzed the extent of cell expansion in each 
and every CNS lineages in 2-month-old mice, prior to any signs of 
maligancy. Surprisingly, although mutations were induced in NSCs, there 
was no detectable over-proliferation of mutant NSCs compared to WT ones. 
Among all neuroglial lineages, the oligodendrocyte precursor cell (OPC) 
lineage was the only one showing drastic over-expansion. Upon tumor 
formation, marker staining and microarray analysis again revealed that 
actively proliferating tumor cells share many OPC features. Interestingly, 
purified OPC-like tumor cells could self-renew in culture, differentiate into 
multiple cell types upon induction, and initiate secondary tumors by 
orthograft assay. In conclusion, MADM enabled us to study TPC identity as 
a developmental process. Our findings suggest that stem cell features of 
TPCs may not necessarily be an indication of their NSC nature, rather these 
features could be acquired by mutant OPCs during malignant 
transformation. 
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Demyelination and failure to remyelinate after demyelinating lesions 
contribute to the neuropathological changes observed in neurological 
disorders, such as multiple sclerosis. Oligodendrocytes are the myelin-
forming cells in the central nervous system. We have previously 
demonstrated that the differentiation of oligodendrocyte progenitor cells 
(OPC) requires histone deacetylation, to decrease the transcript levels of 
oligodendrocyte differentiation inhibitors and neural stem cell markers. 
However histone deacetylation is a transient modification which is followed 
by histone methylation. Therefore we studied the role of repressive histone 
3 lysine 9 methylation in OPC differentiation. We showed increasing levels 
of tri-methylated histone 3 lysine 9 (me3H3K9) as OPCs mature into 
myelinating oligodendrocytes and in the developing corpus callosum in 
mice. This was consistent with increased expression of the histone 
methyltransferases responsible for this modification, in the oligodendrocyte 
lineage. Inhibition of H3K9 methylation led to decreased expression of 
myelin genes and decreased the number of mature oligodendrocytes in 
primary cultures. Together, these data suggest a critical role of H3K9 
methylation in OPC differentiation and myelination. 
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SC1 is an anti-adhesive molecule that contributes to brain plasticity. In 
rodents, it is expressed during CNS development, and its cellular 
distribution in adults is altered following status epilepticus. Here, we 
assessed SC1 expression and cellular distribution for the first time after 
stroke. A transient focal ischemic stroke was evoked by injecting the 
vasoconstrictor peptide, endothelin-1 (Et-1), into the striatum of adult 
Sprague-Dawley rats. Changes in cellular distribution of SC1 protein were 
examined in vivo after stroke, as well as in cultured primary astrocytes after 
Et-1 treatment. Three days after the stroke, SC1 increased in the cell bodies 
of GFAP-labeled hypertrophied astrocytes that formed a glial limitans, 
which became prominent at 7 days. This up-regulation resulted from the 
stroke, because SC1 was unchanged in cultured astrocytes treated with Et-1. 
Interestingly, at one day after stroke, SC1 was detected in the cell bodies 
but also along the processes of ‘starburst’-shaped astrocytes bordering the 
lesion, which were no longer present by 7 days. These cells were positive 
for GFAP, but not vimentin, nestin, NG2 or CD11b. The subcellular 
distribution of SC1 differs among reactive astrocyte sub-types following 
ischemia, which might reflect different roles of these cells and SC1 in 
astrogliosis. The ‘starburst’ astrocyte might represent a novel subclass of 
reactive astrocyte that responds to neural insults earlier than the classical 
hypertrophied astrocyte. This work has broader implications because 
astrogliosis occurs following many forms of brain damage and neural 
injury.  
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MicroRNAs (miRNAs) regulate various biological processes, but evidence 
for miRNAs that control the differentiation program of specific neural cell 
types has been elusive. To determine the role of miRNAs in the formation 
of myelinating oligodendrocytes, we selectively deleted a miRNA-
processing enzyme, Dicer1, in oligodendrocyte lineage cells. Mice lacking 
Dicer1 display severe myelinating deficits despite an expansion of the 
oligodendrocyte progenitor pool. To search for miRNAs responsible for the 
induction of oligodendrocyte maturation, we identified miR-219 and miR-
338 as oligodendrocyte-specific miRNAs in spinal cord. Overexpression of 
these miRNAs is sufficient to promote oligodendrocyte differentiation. 
Additionally, blockage of these miRNA activities in oligodendrocyte 
precursor culture and knockdown of miR-219 in zebrafish inhibit 
oligodendrocyte maturation. miR-219 and miR-338 function in part by 
directly repressing negative regulators of oligodendrocyte differentiation, 
including transcription factors Sox6 and Hes5. These findings suggest that 
these miRNAs are important promoters for oligodendrocyte differentiation 
while inhibiting oligodendrocyte precursor proliferation, and that they are 
potential targets for myelin repair. 
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Interactions between axons and Schwann cells in the peripheral nervous 
system (PNS) induce myelination and result in the organization of axons 
into distinct domains. The largest domain by far is the internode, the portion 
of the axon located under the compact myelin sheath. The molecules that 
mediate the functional relationship between axon and myelinating glial cell 
along the internode are still incompletely characterized. We and others 
reported that DRG neurons and Schwann cells express distinct Nectin-like 
(Necl) cell adhesion proteins [Maurel et al, JCB, 2007: 178(5) and Spiegel 
et al, Nat Neurosci, 2007 Jul:10(7)]. A member of this family of proteins, 
Nectin-like 4 (Necl-4) is expressed on myelinating Schwann cells and binds 
specifically to Necl-1 expressed on axons. These proteins were localized to 
the internode and mediate heterophilic interactions. Knock down of Necl-4 
inhibits Schwann cell differentiation and subsequent myelination. These 
results demonstrate that Necl-4 is needed to initiate PNS myelination and 
implicate Necl proteins as mediators of internodal interactions.  
 
A key question is how Necl-4 promotes myelination. Its structural features 
provide important clues. Necl-4 mediates cell adhesion through its 
extracellular, N-terminal Ig-like domains and has been proposed to interact 
with PDZ-domain and cytoskeletal proteins through different segments of 
its cytoplasmic domain. Par-3, a PDZ-domain containing protein of the Par-
aPKC polarity complex, was previously reported to be required for 
Schwann cell myelination [Chan et al, Science, 2006: 314(5800)]. Our data 
indicates that Necl-4, through its PDZ-binding domain, interacts with Par-3 
directly. Necl-4 also interacts with members of the 4.1 family of 
cytoskeletal proteins via its FERM-binding domain. Together these findings 
suggest a model where Par-3 is recruited by Necl-4 to the adaxonal 
membrane of the Schwann cell upon axon-glial contact. The localization of 
Par-3 to this site in turn may target and activate aPKC/Par-6, and promote 
formation of a leading edge in the Schwann cell that drives spiral wrapping 
of the axon. This Necl-4/Par complex is then stabilized through interactions 
between Necl-4 and protein 4.1G and its association with spectrin and the 
actin cytoskeleton, thereby promoting long-term stability of the myelin 
sheath. 
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Oligodendrogenesis does not develop simultaneously nor with similar 
spatial patterns in all regions of the CNS. Very little is known about the 
control of this diversity along the rostro-caudal axis. Hox genes encode 
homeodomain transcription factors which display spatially restricted rostro-
caudal patterns of expression and control the regional patterning of neural 
progenitors in the hindbrain and spinal cord. Here, we explored the 
involvement of the Hox genes in the rostro-caudal patterning of 
oligodendrocyte precursor cells in the mouse hindbrain, which is subdivided 
in neuroepithelial compartments known as rhombomeres (r).  
Hindbrain oligodendrogenesis showed a rhombomere-specific timing, with 
a marked delay in r2-r3. Hoxa2 is the only Hox gene expressed in r2, 
whereas it is only co-expressed with its paralogue Hoxb2 in r3, suggesting 
that the paralogue group 2 Hox genes could control oligodendrogenesis at 
this level of the CNS. We examined oligodendrogenesis in the rostral 
hindbrain of homozygous Hoxa2flox/flox embryos, in which Hoxa2 deletion 
was induced at E10.5 by tamoxifen administration to the pregnant mother. 
At E13.5, oligodendrogenesis was increased two-fold in the r2-r3 derived 
territories of conditional Hoxa2 deficient embryos. Additional alterations of 
Pax6 and Nkx2.2 expression, which were down-regulated and up-regulated, 
respectively, were associated. Moreover, ventral progenitor expression of 
phosphoErk1/2, a downstream signal of FGFR activation, was increased.  
Therefore, Hoxa2 appears to act as a negative regulator of 
oligodendrogenesis in the rostral hindbrain, by local control of Pax6 and 
Nkx2.2 expression and modulation of progenitor response to the pro-
oligodendrogenic FGF signal. 
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The p75 neurotrophin receptor (p75NTR) is expressed in neurons and in a 
wide variety of glial cells. The aim of this study is to characterize the glial 
cells expressing p75NTR in the optic nerve (ON) of adult lizards and to 
analyze their response after optic nerve transection. Using 
immunohistochemical methods, we detected p75NTR+ cells co-expressing 
astrocyte markers as GFAP, glutamine synthetase and vimentin (Vim). 
After ON transection, reactive astrocytes upregulated GFAP and Vim but 
not p75NTR. Moreover, a subpopulation of reactive tomato-
lectin+/p75NTR+ microglia/macrophages were observed in the lesion site. 
These data indicate that the p75NTR is expressed in astrocytes, and in a 
subpopulation of reactive microglia/macrophages although it does not seem 
to be involved in reactive astrogliosis unlike occurs in mammals. Finally, 
p75NTR+ endothelial cells were observed in the lesioned ON suggesting a 
possible role of this receptor in the maintenance of the blood-brain barrier 
integrity. This study was supported by the Spanish Ministry of Education 
(Research Project BFU2007-67139) and the Regional Canary Island 
Government (ACIISI, Research Projects SolSubC200801000281 and 
ULPAPD-08/01-4).  
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Myelination is a crucial step in brain development and maintenance. The 
identification of novel proteins selectively expressed by developing 
oligodendrocytes should help understanding this complex process. 
Semaphorin is a family of cell-cell signaling proteins that have been 
involved in axon guidance. We found that the transmembrane semaphorin 
6A is expressed by myelinating oligodendrocytes in the postnatal mouse 
brain. We are studying the role of Sema6A in oligodendrocytes, in normal 
and pathological condition using Sema6A deficient mice. To determine if 
the number of oligodendrocytes and the time-course of myelination were 
normal in Sema6A-deficient mice, we have quantified the number of cells 
expressing specific oligodendrocyte lineage markers in major forebrain 
axonal tracts. This revealed a significant but transient reduction of the 
density of PLP and MAG expressing cells in the anterior commissure, while 
the density of Olig2 cells was comparable. We next studied the in vitro 
maturation of oligodendrocytes purified from Sema6A-/- newborn mice. We 
found that oligodendrocyte differentiation is delayed in oligodendrocytes 
lacking Sema6A and is not rescued by addition of exogenous Sema6A-Fc, 
suggesting a cell-autonomous function for Sema6A in myelination. We next 
developed myelinating co-culture of DRGs and oligodendrocytes and found 
that addition of Sema6A-Fc protein increased myelination in a dose 
dependent manner. This pro-myelinating activity appears to require plexin-
A expression on myelinated axons, with Sema6A acting as a ligand on 
oligodendrocytes. Furthermore, a role of Sema6A has been analyzed in a 
pathophysiological context, in which demyelination is induced by 
cuprizone. There is a significant increase of oligodendrocytes expressing 
Sema6A, starting 3 weeks after the administration of cuprizone, peaking at 
4 and then returning to the basal level of expression at 6. Altogether these 
results suggest that Sema6A play a role in myelination in the central 
nervous system. We are currently investigating the signalling pathways 
involved in this process. 
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Peripheral Nervous System (PNS) injury induces myelinating Schwann 
cells to dedifferentiate to progenitor-like cells. These dedifferentiated 
Schwann cells and the recruitment of inflammatory cells are essential steps 
for successful nerve regeneration. The mechanism controlling this switch in 
cell state and the role of Schwann cells in orchestrating the inflammatory 
response are poorly understood. 
We have previously shown the that Ras/Raf/Erk pathway is able to induce 
the dedifferentiation of Schwann cells in vitro (Harrisingh et al., Embo J, 
2004). To address whether ERK activation is also sufficient to drive 
Schwann cell dedifferentiation in vivo and investigate the effect of this 
specific signal on the biology of the peripheral nerve, we have generated a 
transgenic mouse model in which Raf kinase can be activated in 
myelinating Schwann cells in the adult nerve. We found that activation of 
Raf in these mice drives demyelination of peripheral nerves in vivo and 
results in severe impairment of motor function. Moreover, we show that 
ERK activation also induces the break down of the nerve blood barrier and 
is consistently accompanied by an inflammatory response and macrophage 
infiltration along the entire nerve. Importantly, the phenotype of peripheral 
nerve degeneration is reversible with the period of dedifferentiation 
determined by the period of ERK activation. We conclude that 
Raf/MEK/ERK signalling can both initiate and sustain Wallerian-like 
degeneration in the absence of axonal injury. 
This mouse model provides a powerful system to study the regulation of 
PNS degeneration and regeneration.  
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Myelination in the peripheral nervous system requires complex signaling 
events between Schwann cells, axons, and the basal lamina. The signaling 
pathways involved in the myelination in the peripheral nervous system are 
not fully understood. Lymphoid cell kinase (Lck), a non-receptor tyrosine 
kinase Src family member, regulates proliferation in M. leprae-infected 
Schwann cells through a PKCξ/Lck dependent signaling pathway (Tapinos 
and Rambukkana, 2005). Here we show that Lck is also involved in 
laminin-induced signaling in rat Schwann cells and that inhibition of Lck 
negatively affects myelination in DRG co-cultures. Phosphorylation of the 
Lck active site can be detected after 10 min of laminin treatment in rat 
Schwann cells overexpressing Lck. In non-transfected rat Schwann cells, 
small molecule inhibitors of Lck significantly inhibit radial lamellipodia 
formation on a laminin substrate, but do not affect the extension of axial 
lamellipodia. Live imaging of rat Schwann cells plated on laminin shows a 
reduction in the number and rate of radial lamellipodia formation when 
Schwann cells are treated with Lck inhibitors over the course of two hours. 
Inhibition of Lck signaling in Schwann cell/DRG co-cultures reduces the 
average length of myelin internodes, but does not affect the total number of 
myelin segments formed. Lck inhibition does not affect the alignment of 
Schwann cells with axons. Reduced internode lengths are seen if the Lck 
inhibitor is introduced at the time of Schwann cell addition to the DRG 
cultures or during ascorbate treatment only. The data suggest that Lck is a 
critical component of laminin signaling and the formation of radial 
lamellipodia during myelination in the peripheral nervous system. 
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Glia ensheath neurons to establish a niche that facilitates neuronal morphogenesis 
and function. This architecture is evident in the amphid, the main sensory organ of 
C. elegans, where glia form a tube through which the cilia of sensory dendrites gain 
access to the environment. We have been studying amphid development as a model 
system for neuron-glia interactions. 
 
We previously showed that daf-6/Patched is required within glia for the normal 
morphogenesis of the amphid channel. In daf-6 animals the channel is bloated and 
the sensory cilia become trapped within the glia. DAF-6 lines most luminal surfaces, 
and daf-6 interacts with che-14/Dispatched in regulating tubulogenesis in many 
organs, thus providing a molecular link between the processes of tubulogenesis and 
glial ensheathment. 
 
To further understand neuron-glia interactions in C. elegans, we performed a screen 
for suppressors of daf-6/Patched. One suppressor is an allele of the Nemo-like 
kinase homolog lit-1. lit-1 is part of a MAPK module that has been previously 
shown to guide cell fate decisions by regulating Wnt signaling. However, mutations 
in lit-1 do not affect glia specification. Rather, lit-1, which is expressed in many 
glial cells, acts within amphid glia to regulate amphid tubulogenesis. In contrast to 
the bloated channel seen in daf-6 mutants, lit-1 animals often have channels that are 
too small or fail to form altogether, suggesting opposing activities for daf-6 and lit-1 
in regulating the size of the amphid channel, in accordance with the genetic 
suppression of daf-6 by lit-1.  
 
A GFP::LIT-1 fusion lines the amphid channel, similar to DAF-6::GFP, with the 
carboxy-terminal domain of LIT-1 being necessary and sufficient for this 
localization. LIT-1 localization is disturbed in mutants that fail to form sensory cilia, 
hinting at neuron-glia crosstalk in establishing the glial lumen. In a Y2H screen, the 
carboxyterminal domain of LIT-1 was found to interact with actin and WASP, 
suggesting that LIT-1 could direct glial tubulogenesis through the regulation of 
cytoskeleton dynamics. In accordance with this hypothesis, GFP::ACT-4 also lines 
the amphid channel and mutation of wsp-1 suppresses daf-6. 
 
LIT-1 is part of a MAPK module that regulates Wnt signaling in C. elegans, 
Drosophila and vertebrates, but Wnt pathway mutants do not affect glial 
tubulogenesis. However, the two other components of the MAPK module, wrm-
1/beta-catenin and mom-4/MAP3K, suppress daf-6, and both WRM-1 and MOM-4 
localize to the amphid channel, suggesting a new function for this conserved 
module. 
 
Our results suggest a novel interaction between Patched, Dispatched and the LIT-
1/MAPK module in directing the ensheathment of neurons by glia in C. elegans. 
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Our research focusses on trying to understand how Merlin loss leads to the 
development of Schwannoma tumours in Neurofibromatosis type 2 (NF2). 
Schwannoma cells lacking Merlin appear undifferentiated in vivo showing 
decreased expression of the compact myelin proteins P0, Peripheral Myelin 
Protein 22 (PMP22) and Myelin Basic Protein (MBP). Our in vitro 
experiments on primary human cell cultures have also shown that 
Schwannoma cells show enhanced proliferation compared to wild-type 
Schwann cells, mediated through increased activation of both platelet-
derived growth factor (PDGF) and insulin-like growth factor (IGF) 
signalling.  
We want to understand the process that follows Merlin loss and the 
mechanisms that cause the abnormal de-differentiation and increased 
proliferation of Schwann cells in these tumours. We have previously shown 
that Krox-20 acts as a key regulator of Schwann cell behaviour, controlling 
cell differentiation, proliferation and survival. Using an in vitro model we 
have investigated both the upstream control of Krox-20 expression and the 
downstream effect of enforcing Krox-20 in Schwannoma cells. Critically 
we found that Schwannoma cells were unable to induce either Krox-20 or 
the myelin marker periaxin in response to the in vitro myelination signal 
cyclic AMP. During myelination in vivo Krox-20 expression is controlled 
from the Myelinating Schwann cell Enhancer (MSE) element through 
binding of the transcription factors Oct-6 and Sox-10. We have found that 
the induction of Oct-6 in response to cAMP is also reduced in Schwannoma 
cells. Potentially the failure to induce Krox-20 and Oct-6 may result from 
the decreased expression of Sox-10 we have observed in these cells. Despite 
these defects, enforced expression of Krox-20 can effectively drive 
Schwannoma cell differentiation through up-regulation of the myelin 
protein P0 and the myelin marker periaxin. Importantly staining for the cell 
proliferation marker Ki-67 showed that expression of Krox-20 also halts 
Schwannoma cell proliferation in response to mitogenic signals such as 
Neuregulin-1 (NRG), PDGF and IGF-1. This data suggests that the 
abnormal proliferation and dedifferentiation of Schwannoma cells may be 
due to the impaired induction and maintenance of Krox-20. Furthermore, 
the key to a future treatment of these tumours may lie in understanding the 
relationship between Merlin and Krox-20.  
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In the mammalian central nervous system (CNS), glial cells expressing 
Excitatory Amino Acid Transporters (EAATs) tightly regulate extracellular 
glutamate levels to control neurotransmission and protect neurons from 
excitotoxic damage. Dysregulated EAAT expression is associated with 
several CNS pathologies in humans, yet mechanisms of EAAT regulation 
and the importance of glutamate transport for CNS development and 
function in vivo remain incompletely understood. Drosophila is an 
advanced genetic model with only a single high-affinity glutamate 
transporter termed Eaat1. We found that Eaat1 expression in CNS glia is 
regulated by the glycosyltransferase Fringe, which promotes neuron-to-glia 
signaling through the Delta-Notch ligand-receptor pair during 
embryogenesis. We made Eaat1 loss-of-function mutations and found that 
homozygous larvae could not perform the rhythmic peristaltic contractions 
required for crawling. We found no evidence for excitotoxic cell death or 
overt defects in the development of neurons and glia, and the crawling 
defect could be induced by post-embryonic inactivation of Eaat1. Eaat1 
fully rescued locomotor activity when expressed in only a limited 
subpopulation of glial cells situated near potential glutamatergic synapses 
within the CNS neuropil. Eaat1 mutants had deficits in the frequency, 
amplitude and kinetics of synaptic currents in motor neurons whose 
rhythmic patterns of activity may be regulated by glutamatergic 
neurotransmission among pre-motor interneurons; similar results were seen 
with pharmacological manipulations of glutamate transport. Our findings 
indicate that Eaat1 expression is promoted by Fringe-mediated neuron-glial 
communication during development, and suggest that Eaat1 plays an 
essential role to regulate CNS neural circuits controlling locomotion in 
Drosophila. 
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Recent pre-clinical experiments in mouse leukodystrophy models have utilized 
exogenous cell-based transplantation approaches in an effort to restore myelin 
and improve functional outcome. The aim of our study was to determine 
whether cultured and expanded embryonic oligodendroglial precursor cells are 
as effective at engrafting and myelinating as acutely harvested and transplanted 
embryonic progenitors. The medial ganglionic eminence (MGE) and anterior 
entopeduncular area (AEP) is a source of embryonic oligodendrocyte precursor 
cells. We harvested cells from the E15.5 MGE/AEP progenitor zones, and 
acutely transplanted them into hypomyelinated newborn shiverer mice. In a 
parallel set of experiments, we purified and expanded proliferating PDGFRα-
expressing oligodendrocyte precursor cells (OPCs) from E15.5 ventral 
embryonic forebrain before transplantation into newborn shiverer mice. We 
found that acutely transplanted progenitors resulted in robust engraftment in 
shiverer recipient forebrains and led to production of numerous oligodendroglia 
within white matter tracts, as well as some cortical interneurons and few 
astrocytes. In contrast, oligodendrocyte production and myelination was less 
extensive in shiverer mice transplanted with equivalent number of purified and 
expanded OPCs. These results suggest that cultured OPCs are less capable then 
progenitors of engraftment and myelination upon transplantation. Next, we 
investigated whether OPCs that have been genetically modified might display 
an improved ability to engraft and myelinate. We have shown previously that 
~7 fold more OPCs are generated in the MGE/AEP of Dlx1&2 mutant mice 
compared to controls, and that these OPCs precociously express markers of 
maturing oligodendrocytes. We transplanted either acutely dissociated 
progenitors from the MGE/AEP of Dlx1&2-mutants or purified and expanded 
embryonic OPCs from Dlx1&2 mutant forebrain. Transplantation of Dlx1&2-
mutant progenitors resulted in greater engraftment and myelination within white 
matter tracts with no neurons and only rare astrocytes generated compared to 
wildtype progenitors. In contrast, we did not observe obvious differences in 
engraftment and myelination between purified Dlx1&2 mutant and wildtype 
OPCs. Thus, we conclude that acutely-grafted, uncommitted progenitors from 
ventral telencephalic regions that give rise to oligodendrocytes during normal 
embryonic development are superior at incorporating and myelinating white 
matter in the hypomyelinated brain than cultured, purified oligodendroglial 
precursors. Our results suggest that cultured cells, which are under clinical 
investigation for leukodystrophies, may be significantly less capable than 
freshly harvested progenitors at engraftment and myelination. 
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A requisite component of nervous system development is the achievement 
of cellular recognition and spatial segregation through competition-based 
refinement mechanisms. Competition for available axon space by 
myelinating oligodendrocytes ensures that all relevant CNS axons are 
myelinated properly. To ascertain the nature of this competition, we 
generated a transgenic mouse with sparsely labeled oligodendrocytes and 
establish that individual oligodendrocytes occupying similar axon tracts can 
greatly vary the number and lengths of their myelin internodes. Here we 
show that intercellular interactions between competing oligodendroglia 
influence the number and length of myelin internodes and identify the 
amino-terminal region of Nogo-A, expressed by oligodendroglia, as 
necessary and sufficient to inhibit this myelinogenic potential. Additionally, 
the formation of exuberant myelin in the absence of Nogo suggests that 
spatial segregation and the extent of myelination is a consequence of the 
microenvironmental inhibition of myelinogenic potential. We demonstrate a 
novel physiological role for Nogo-A in the precise myelination of the 
developing CNS. Maximizing the myelinogenic potential of 
oligodendrocytes may offer an effective strategy for repair in future 
therapies for demyelination. 
 58 
SCHWANN CELL MITOCHONDRIAL DYSFUNCTION DISRUPTS 
AXO-GLIAL INTERACTIONS WITHOUT INTERFERING WITH 
SCHWANN CELL SURVIVAL 
 
Andreu Viader1, Judith P Golden2, Robert H Baloh3, Jeffrey Milbrandt1  
 
1Washington University in St. Louis, Genetics, St Louis, MO, 63110, 
2Washington University in St. Louis, Pain Center, St Louis, MO, 63110, 
3Washington University in St. Louis, Neurology, St Louis, MO, 63110 
 
Schwann cells (SCs) are the primary glial cell type in the peripheral nervous 
system and play a central role in axonal integrity and peripheral nerve 
function. Mitochondrial dysfunction is a common cause of peripheral 
neuropathy; however, whether SC mitochondrial dysfunction contributes to 
axonal degeneration or demyelination is unknown.  
With the goal of understanding how SC mitochondrial abnormalities affect 
SCs and their ability to support axonal integrity, we generated a mouse with 
impaired mitochondrial function exclusively in SCs. These Tfam-SCKO 
mice were generated through the tissue-specific deletion (via MPZ-Cre) of 
the mitochondrial transcription factor A gene (Tfam), an essential regulator 
of mitochondrial DNA transcription and replication. Tfam-SCKOs were 
viable and developed normally for the first few weeks of life. As they aged, 
however, Tfam-SCKOs developed a progressive peripheral neuropathy 
characterized by nerve conduction abnormalities as well as extensive 
muscle denervation. Morphological examination of Tfam-SCKO nerves 
revealed that pathological changes due to SC mitochondrial dysfunction 
first appeared in small unmyelinated fibers. Consistent with the 
degeneration of these small fibers, Tfam-SCKOs displayed early skin 
denervation and sensory deficits. By 3 months, pathology was also observed 
in large myelinated axons. Extensive axonal loss as well as demyelination 
became prominent by 4-6 months, with accompanying motor deficits and 
muscle weakness. Remarkably, the severe mitochondrial DNA depletion 
and respiratory chain abnormalities in Tfam-SCKO mice did not affect SC 
survival. 
Normal mitochondrial function in SCs is, therefore, essential for 
maintenance of SC-axonal interactions and axonal survival, suggesting that 
SC mitochondrial dysfunction contributes to human peripheral 
neuropathies.  
 59 
SCHWANN CELLS REMODEL BASEMENT MEMBRANES TO 
LOCALIZE PERIPHERAL NERVES 
 
Alya R Raphael, Julie R Perlin, William S Talbot  
 
Stanford University, Developomental Biology, Stanford, CA, 94305 
 
Schwann cells play well known roles in myelinating and supporting axons. 
Recently, new roles for Schwann cells have emerged, including regulating 
the differentiation of sensory organs and preventing oligodendrocytes from 
exiting the spinal cord. We describe a new role for Schwann cells in 
relocating peripheral nerves across basement membranes. We find that the 
posterior lateral line nerve of the zebrafish initially grows in the epidermis 
and then rapidly transitions across the epidermal basement membrane into 
the subepidermal space. In mutants lacking Schwann cells, the nerve is 
improperly localized within the epidermis. Transplantation of wildtype 
Schwann cells into these mutants rescues the position of the nerve, such that 
it is correctly located below the epidermal basement membrane. We 
postulate that relocating the posterior lateral line nerve into the 
subepidermal space serves a protective function, since the mislocalization 
of the nerve in mutants lacking Schwann cells results in significant 
disorganization of the nerve. These results define a new role for Schwann 
cells and a new mechanism for axon localization that is distinct from 
growth cone pathfinding. 
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Although myelin is an excellent insulator that allows axons to conduct at 
faster speed than achievable without it, action potentials would decay over a 
few millimeters and thus must be regenerated at regular intervals. Nodes of 
Ranvier are gaps in the myelin that are exquisitely designed for just this 
purpose, equipped with high density of voltage-gated sodium channels. The 
nodal region is organized into several distinct domains, each of which 
contains a unique set of ion channels, cell adhesion molecules and 
cytoplasmic adaptor proteins. This local differentiation of myelinated axons 
is tightly regulated by myelinating Schwann cells. Two cell recognition 
molecules, Caspr and Caspr2 mediate axoglial interactions around the nodes 
and play an important role in the organization of the nodal environs by two 
different mechanisms: Caspr participate in the generation of a barrier-like 
structure at the paranodal junction formed at both sides of the nodes, 
whereas Caspr2 serves as a scaffold that maintains potassium channels at 
the nearby juxtaparanodal region. Initial clustering of sodium channels in 
heminodes that border each myelin segment requires gliomedin, NrCAM 
and neurofascin 186 (NF186), three cell adhesion molecules (CAMs) that 
mediate the interaction between Schwann cells and the axon. We further 
identify NrCAM as a glial component of PNS nodes, which cooperates with 
gliomedin in the capturing of Na+ channels at heminodes by binding to 
NF186. Heminodal clustering coincides with a second, paranodal junction 
(PNJ)-dependent mechanism that allows Na+ channels to accumulate in 
mature nodes by restricting their distribution between two growing myelin 
segments. We propose that Schwann cells govern the assembly of nodes in 
the PNS by two independent adhesion systems that provide reciprocal 
backup capacities. 
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Axons reorganize into distinct domains during myelination, centered around 
nodes of Ranvier; the mechanisms which underlie this reorganization are 
poorly understood. We now show that nodes assemble sequentially from 
distinct sources of proteins: existing pools of adhesion molecules on the 
axon surface redistribute to initiate node, and paranode formation whereas 
ion channels and cytoskeletal proteins are recruited to the node from 
transport-dependent, internal stores. NF186, a key adhesion molecule, is 
targeted to nascent nodes via extracellular interactions. In contrast, NF186 
is targeted to mature nodes, where it turns over slowly, via intracellular 
interactions with ankyrin G, aided by paranodal interactions. These results 
support a model in which domain formation is initiated by redistribution of 
axon adhesion molecules which concentrate at the node via diffusion 
trapping with cognate Schwann cell receptors whereas ion channels, 
cytoskeletal proteins and replenished domain components are recruited 
from internal stores transported to these sites. 
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The Drosophila midline glia (MG) perform a variety of functions in 
controlling and supporting neural development and function. MG-derived 
factors guide and provide trophic support for commissural axons and 
neurons. There are 2 distinct types of MG, anterior (AMG) and posterior 
(PMG). AMG contact, migrate around and ensheath bundles of 
commissural axons. The function of PMG is currently unknown and all 
undergo apoptosis during embryogenesis. We are interested in 
understanding the molecular mechanisms that govern the formation of MG 
types and the regulation of MG migration and MG-axon interactions. To 
date, we have identified 56 genes (15 transcription factors) expressed in 
MG including genes differentially expressed in AMG and PMG. These 
include the transcription factors runt and engrailed (en) that are expressed 
throughout development in AMG and PMG, respectively. Early in 
development, Notch signaling mediates the decision of bipotential MG-
neuronal precursors to activate MG gene expression, but does not control 
AMG or PMG-specific gene expression. In contrast, the Hedgehog 
morphogen directs en expression as hh mutants showed loss of En and hh 
overexpression showed excess En. In addition, runt expression was 
expanded to all MG in hh mutants and was absent in hh overexpression 
suggesting that hh repressed runt expression possibly via En repression. 
Misexpression of runt showed that Runt activated AMG gene expression 
and repressed en and other PMG gene expression in AMG. In en 
misexpression PMG gene expression was activated and runt and AMG gene 
expression was repressed. The mutual repression between Runt and En 
reinforced the distinction between MG types leading to different expression 
profiles and functions. The membrane protein Wrapper is found at high-
levels in AMG and low-levels in PMG, its expression is regulated by hh-
runt-en, and it is required for AMG migration and commissural 
ensheathment through its interaction with Neurexin IV on axons. Thus, one 
functional consequence of hh-runt-en regulation is restricting MG:neuron 
interactions only to AMG. Current work uses live imaging and genetic 
analyses to uncover additional regulatory proteins 
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One critical and conserved feature of glial cells is their ability to sense and 
respond to neuronal injury. During injury responses, glia exhibit robust 
changes in gene expression, migrate to sites of trauma, and phagocytose 
degenerating neuronal debris. Glial responses to neurodegeneration are 
thought to help minimize brain damage however the molecules and 
signaling pathways mediating neuron-glia communication after injury 
remain poorly defined. We use the adult Drosophila olfactory system as a 
powerful in vivo genetic model to explore the molecular mechanisms that 
govern glial recognition and clearance of degenerating axons. Previously, 
we showed that glia respond robustly to axotomy of olfactory receptor 
neurons (ORNs) by upregulating the phagocytic receptor Draper, extending 
membranes to severed axons, and clearing degenerating axons from the 
CNS. We recently performed a large-scale, in vivo, RNAi screen in an effort 
to identify novel genes required for glial responses to axon injury. The 
STAT (Signal Transducer and Activator of Transcription) pathway is a 
highly conserved signaling cascade which results in STAT-dependent 
transcriptional activation of target genes in response to cytokine signaling. 
Here we describe a novel role for STAT signaling in establishing glial 
competence to respond to injury and modulating injury-induced 
upregulation of engulfment genes in phagocytic glial cell types.  
 
We found that RNAi knockdown of STAT in glia completely suppressed 
the recruitment of glial membranes to severed axons, and the glial 
engulfment of axonal debris. Loss of STAT function in glia (by RNAi 
knockdown, or in mutant clones) eliminates basal levels of glial Draper 
expression, as well as the injury-induced increases in Draper expression 
observed in control animals. Using GFP reporters that reflect STAT 
activity, we detect a basal level of glial STAT activity in uninjured animals 
as well as a transient burst in glial STAT activation following injury. These 
data raise the intriguing possibility that STAT directly regulates Draper 
expression, and thereby competence of glia to respond to injury. The 
Drosophila genome contains only one STAT (stat92E), a single JAK kinase 
(hopscotch), and a single STAT-activating receptor (domeless). 
Surprisingly, genetic perturbation of these STAT signaling effectors had no 
effect on glial clearance of degenerating axons or Draper expression levels. 
Our data suggest that STAT92E signals through a non-canonical signaling 
cascade to regulate constitutive as well as injury-induced transcription of 
the draper gene and may reveal a novel STAT-activating signaling pathway 
activated within glia in response to neurodegeneration.  
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Developing sensory systems rely on intrinsically-generated electrical 
activity to guide the maturation of pathways required for processing sensory 
information. In all sensory modalities that have been examined, this 
spontaneous activity occurs in the form of discrete bursts of action 
potentials (APs) separated by long periods of quiescence. In the developing 
auditory system, bursts of action potentials occur in primary afferent 
neurons prior to the onset of hearing, yet little is known about how these 
patterns are generated or how they influence the formation of developing 
circuits. We found that a group of glial-like “supporting” cells in the 
cochlea spontaneously release adenosine 5’-triphosphate (ATP) during this 
period. ATP then activates purinergic autoreceptors, induces a rise in 
intracellular Ca2+ and depolarization, and eventually forces crenation of 
these progenitors. In parallel, this paracrine release of ATP activates 
purinergic receptors on adjacent inner hair cells, triggering Ca2+ spikes, and 
inducing release of glutamate onto primary afferent dendrites, ultimately 
leading to bursts of action potentials in primary auditory neurons. In vivo 
recordings from principal neurons in two auditory nuclei in prehearing rats 
revealed that the firing patterns initiated by ATP in the developing cochlea 
propagate to auditory centers of the brain. Spontaneous purinergic signaling 
in the cochlea rapidly subsides after the onset of hearing, and is sufficient to 
initiate synchronous activity in hair cells that will eventually exhibit similar 
characteristic frequencies. These results suggest that glial cells in the 
cochlea play a crucial role in the maturation of this peripheral sensory organ 
as well as auditory circuits within the brain. Preliminary studies suggest that 
ATP is released from these supporting cells through connexin 
hemichannels. As many congenital forms of deafness arise from mutations 
in connexins (e.g Cx26) that are expressed exclusively by supporting cells, 
it is possible that these forms of hearing loss arise from alterations in 
purinergic signaling during this crucial period of development. Supported 
by NIH (DC009464, DC008860). 
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Synapses are specialized cell adhesions that are the fundamental functional 
units of the nervous system, but the extracellular signals that induce CNS 
synapse formation and function are poorly understood. We have been 
investigating the role of astrocytes in the formation and function of 
excitatory synapses in vitro and in vivo. Using retinal ganglion cells (RGCs) 
as a model CNS neuron, we previously found that astrocytes release several 
factors that strongly enhance the formation and function of excitatory 
synapses onto RGCs. Biotinylation and Western blotting experiments 
showed that astrocytes increase the surface levels of all 4 AMPA glutamate 
receptor subunits in RGCs by 3-fold, and immunostaining for surface 
GluR1 subunits demonstrated that astrocytes induce a clustering of AMPA 
receptors in synaptic sites. We identified thrombospondins as astrocyte-
derived proteins that normally promote CNS synaptogenesis in vivo and are 
sufficient to induce ultrastructurally normal synapses in vitro, however 
thrombospondin-induced synapses are post-synaptically silent due to the 
absence of AMPA glutamate receptors. We therefore took a biochemical 
approach to identity the astrocyte-secreted signal that increases the number 
of synaptic AMPA receptors. We used a combination of chromatography 
columns to fractionate the hundreds of proteins present in astrocyte 
conditioned medium (ACM), and obtained a fraction that contained 1% of 
the starting proteins and was 5-fold enriched for functional activity, as 
assayed by adding this fraction to RGCs and subsequent 
electrophysiological recording of synaptic activity. Analysis of this fraction 
by mass spectrometry identified approximately 20 proteins as being present, 
and using an over-expression system we identified one of these proteins as 
being sufficient to induce an increase in synaptic activity in RGCs. This 
protein was sufficient to significantly increase mEPSC amplitude and 
frequency in RGCs in vitro to the same level as astrocytes, and also 
increased surface levels of GluR1 subunits and clustering of GluR1 at 
synaptic sites. Expression profiling of acutely isolated astrocytes and 
neurons showed that the mRNA for this protein is enriched in astrocytes in 
vivo and present during synaptogenic periods. We are currently 
characterizing mice deficient in this protein to determine its role in synapse 
formation and function in vivo. 
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Glia can regulate the development and function of the nervous system. We 
have previously demonstrated the the glial release of the pro-inflammatory 
cytokine tumor necrosis factor alpha (TNFα) is an important modulator of 
synaptic function. Through activation of neuronal TNF-R1 receptors, TNFα 
causes the exocytosis of GluR2-lacking AMPA receptors and results in an 
increase of excitatory synaptic strength. Concurrently, TNFα application 
leads to an endocytosis of GABA-A receptors, and a decrease in inhibitory 
synaptic strength. The release of TNFα is increased when neural activity is 
reduced and mediates homeostatic synaptic plasticity, where the nervous 
system compensates for a long-term reduction in neural activity levels by 
increasing the excitation and reducing the inhibition in the neural circuit. 
These compensatory changes are usually assumed to occur proportionally 
across all the synapses on a given neuron. Here we present data that the 
local application of TNFα results in a local up-regulation of AMPA 
receptors, suggesting that homeostatic plasticity does not necessarily in the 
multiplicative scaling of all synapses. It is possible that glia regulate 
synapses in a very local manner. Further, we have evidence that TNFα-
mediated synaptic plasticity is occurring in vivo, and contributes to the slow 
modification of neuronal circuit function. These changes can be adaptive, 
such as during the development of dykinesia, or mal-adaptive, such as the 
increase in excitotoxicity following neuronal insults. 
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Supporting cells of the vestibular epithelium, non–neuronal cells with many 
similarities to glia, are closely associated with hair cells and afferent nerve 
terminals, making them potential contributors to vestibular development 
and function. Vestibular supporting cells express erbB receptors and 
vestibular sensory neurons express the erbB ligand neuregulin 1. We tested 
the potential roles of this pathway in the vestibular system using a 
transgenic mouse line in which erbB receptor signaling in vestibular 
supporting cells is blocked by expression of a dominant-negative erbB 
receptor (DN-erbB4).  
 
Adult DN-erbB4 mice display behaviors consistent with vestibular 
dysfunction (ataxia, spinning behavior, inability to swim). Evoked potential 
recordings showed that vestibular function is severely affected by P21, even 
though macular epithelia are normal in size and general structure and 
afferent nerve terminal appear unaffected. FM1-43 dye uptake and 
neurofilament staining are normal in mutant mice, indicating that hair cell 
mechano-transduction is unaffected as well. In contrast, synaptic site 
numbers (defined as the colocalization of RIBEYE and GluR2/3 staining) 
are dramatically reduced, suggesting a synaptic defect. Analysis of synapse 
numbers at different postnatal ages showed that the number of synaptic 
puncta increases by 5 fold between birth and P21 in wild types, but this 
does not occur in the mutants. The phenotype produced by loss of erbB 
signaling correlates with reduced BDNF expression in supporting cells and 
is rescued by re-expression of BDNF in these glia. Furthermore, knock-
down of BDNF expression in supporting cells postnatally phenocopies the 
loss of erbB signaling. Together these results indicate that vestibular 
supporting cells contribute to the formation/maturation of synapses in the 
postnatal vestibular maculae and that this is mediated by NRG1-erbB and 
BDNF-TrkB signaling. 
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The mammalian CNS contains an abundant, widely distributed population 
of glial cells that serve as oligodendrocyte progenitors. It has been reported 
that these NG2-immunoreactive cells (NG2+ cells) form synapses and 
generate action potentials, suggesting that neural-evoked excitation of these 
progenitors may regulate oligodendrogenesis. However, recent studies also 
suggest that NG2+ cells may be comprised of functionally distinct groups 
that differ in their ability to respond to neuronal activity, undergo 
differentiation, and experience injury following ischemia. To better define 
the physiological properties of NG2+ cells, we used transgenic mice that 
allowed an unbiased sampling of this population and unambiguous 
identification of cells in discrete states of differentiation. Using acute brain 
slices prepared from developing (P5-8, P12-15, P22-26) and mature (P40-
45) mice, we defined the physiological properties of NG2+ cells in two 
white matter regions (corpus callosum and cerebellar white matter) and two 
grey matter regions (CA1 hippocampus and cerebellar molecular layer). 
NG2+ cells in these diverse brain regions shared a core set of physiological 
properties, including expression of voltage-gated Na+ (NaV) channels and 
ionotropic glutamate receptors, and formation of synapses with 
glutamatergic neurons. Although small amplitude Na+ spikes could be 
elicited in some NG2+ cells (4/18 cells) during the first postnatal week, 
these cells were not capable of generating action potentials nor did they 
exhibit spontaneous spiking. Na+ spikes were not observed at any later 
developmental time points (0/76 cells P12-45), indicating that this 
rudimentary form of excitability is not a prominent or lasting feature of 
these cells. Transition of NG2+ progenitors to the pre-myelinating stage was 
accompanied by the rapid removal of synaptic input, as well as down 
regulation of AMPA and NMDA receptors and NaV channels. Thus, prior 
reports of physiological heterogeneity among NG2+ cells may reflect 
analysis of cells in later stages of maturation. These results suggest that 
NG2+ cells are uniquely positioned within the oligodendrocyte lineage to 
monitor the firing patterns of surrounding neurons. 
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Metabotropic glutamate receptor 5 (mGluR5) is receiving attention as a 
therapeutic target in schizophrenia since positive allosteric modulators 
(PAMs) of this receptor augment synaptic plasticity and learning. Because 
synaptic stimuli activate astrocytic Ca2+ signals which can in turn lead to the 
release of glutamate, we have developed a line of mice in which we 
attenuated astrocytic IP3/Ca2+ signaling and asked the role of this glial 
pathway in contributing to effects of mGluR5 PAMs at hippocampal CA1 
synapses and learning. We have identified three distinct stimulus-dependent 
conditions in which astrocytes play differing roles in induction of long-term 
potentiation (LTP) of synaptic transmission: with weak neuronal 
stimulation astrocytes are not sufficiently activated to  
contribute to LTP. However, under this condition the extrinsic activation of 
astrocytic Gq/Ca2+ signaling can cause an mGluR5-dependent enhancement 
of LTP induction. Under intermediate stimulus conditions the activity of 
neuronal afferents substantially recruits astrocytic IP3/Ca2+ signaling which 
contributes significantly to the modulation of the magnitude of LTP. Under 
this stimulus condition LTP is sensitive to mGluR5 inhibition. Finally, 
under intense neuronal stimulus conditions astrocytic IP3/Ca2+ signaling 
does not significantly contribute to LTP induction, demonstrating that glial 
IP3/Ca2+ signals modulate synaptic plasticity by causing an mGluR5-
dependent enhancement of LTP. Furthermore, we show that the ability of 
mGluR5 PAMs to enhance LTP and learning requires astrocytic Ca2+ 
signals, raising the potential for novel astrocytic targets for cognitive 
enhancement in disorders such as schizophrenia. 
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The concept that astrocytes release neuroactive molecules (gliotransmitters) 
to affect synaptic transmission is one of the most important paradigm shifts 
in neuroscience over the past decade. This concept suggests that astrocytes 
together with pre- and postsynaptic neuronal elements comprise a functional 
synapse. Astrocyte release of gliotransmitters (e.g., glutamate, ATP, D-
serine) is generally accepted to be a Gq GPCR Ca2+ dependent process. We 
used two mouse lines to either selectively increase or obliterate astrocytic 
Gq GPCR Ca2+ signaling to further test the hypothesis that astrocytes 
release gliotransmitters in a Ca2+-dependent manner to affect synaptic 
transmission. Neither increasing nor obliterating astrocytic Ca2+ fluxes 
affects spontaneous and evoked excitatory synaptic transmission or synaptic 
plasticity. Our findings suggest that, at least in the hippocampus, the 
mechanisms of gliotransmission need to be reconsidered. 
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Glia exhibit large fluctuations in intracellular calcium both spontaneously 
and in response to neuronal activity, although the influence of glial calcium 
transients on neuronal signaling is not well understood. By screening for 
temperature-sensitive seizure mutations in Drosophila we identified the 
zydeco mutation, which disrupts a glial-specific K+-dependent, Na+/Ca2+ 
exchanger (NCKX) that utilizes Na+ and K+ gradients to export intracellular 
calcium. Zydeco mutant seizures can be rescued by expression of a zydeco 
transgene in cortex glia and astrocyte-like glia, which are cell types closely 
associated with neuronal cell bodies and neuropil, respectively. Knockdown 
of zydeco by RNAi in cortex glia and astrocyte-like glia also causes 
temperature-sensitive seizures in adults, indicating that zydeco expression in 
glia is both necessary and sufficient to regulate neuronal excitability. To 
determine the temporal requirement for NCKX function in glia, we 
conditionally expressed a zydeco transgene using a heat-shock inducible 
Gal4 driver. We find that adult specific expression of zydeco is sufficient to 
rescue the neuronal seizure phenotype, supporting an acute rather than 
developmental role for zydeco in the nervous system. We next investigated 
the contribution of zydeco to glial calcium signaling by imaging glial 
calcium waves in vivo using a genetically encoded calcium sensitive GFP 
(GCamp3). Zydeco mutant and RNAi knockdown animals exhibit glial 
calcium waves of reduced frequency compared to wild-type. We verified 
the importance of glial calcium signaling in the Drosophila nervous system 
by expressing a heat sensitive UAS-Trp channel in glia, which at elevated 
temperature allows influx of cations, including calcium. Activation of UAS-
Trp in cortex glia and astrocyte-like glia causes rapid paralysis in adult flies, 
indicating glial calcium signaling is acutely required for nervous system 
function. Our results indicate that a NCKX regulates glial calcium waves 
and that acute disruption of glial calcium signaling alters neuronal 
excitability and leads to seizures. 
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Fine control of neuronal activity is crucial to rapidly adjust to subtle 
changes of the environment. This fine-tuning was thought to be purely 
neuronal until the finding that glial cells could also modulate neuronal 
activity. Yet, the regulation of synaptic and neuronal activity by astrocytes 
is well documented but the contribution of microglia has to be explored. 
Microglial cells display several features of putative functional partners of 
synapses. They are present at high density in the brain, they rapidly activate 
upon stimulation by releasing various neuro-active factors. Finally, 
pathological activation of microglia, which is the primary stage of 
inflammation, and synaptic alterations are common early features of most 
neuropathies. We have now established a functional link between microglial 
activation and synaptic function. We have shown that activation of 
microglia induced a rapid increase of spontaneous AMPAergic synaptic 
events frequency. We further demonstrated that upon activation, microglia 
rapidly releases ATP, which recruits astrocytes through purinergic 
receptors. ATP stimulation of astrocytes induces a neuronal mGluR 
response leading to the modulation of AMPAergic transmission. These 
results depict microglia as a novel actor in the regulation of 
neurotransmission and provide a basis to understand synaptic dysfunctions 
in neuronal diseases. 
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During development, neural circuitry undergoes a remodeling process in 
which excess synapses are eliminated or pruned and the remaining synapses 
are strengthened. While it is clear that this is an activity-dependent process, 
the precise molecular mechanisms have not been elucidated. Stevens et al. 
(Cell, 2007) discovered that components of the classical complement 
cascade (C1q and C3), traditionally associated with innate immune system 
function, are necessary for synapse elimination in the normal, developing 
CNS. Furthermore, complement proteins were found to localize to synapses 
in the developing brain and during early stages of neurodegenerative 
disease. One of the major questions arising from these findings and main 
objective of the current study is to determine by what mechanism 
complement is mediating synapse removal. In the innate immune system, 
complement proteins coat or opsonize debris for removal. A common 
pathway for complement-opsonized debris removal is through phagocytosis 
by macrophages. Because microglia are the resident phagocytic cell of the 
CNS, we suggest that this cannonical immune system mechanism may be 
involved in the normal, developing CNS. We hypothesize that weak or 
inappropriate synapses may be tagged by activated C3 and subsequently 
phagocytosed by microglia. Using high resolution imaging and assesment 
of mice deficient in complement-related proteins, we provide evidence that 
microglia actively participate in synaptic pruning by phagocytosing 
neuronal processes. Furthermore, our data suggest that this is a 
complement-dependent process. Taken together, our data demonstrate new 
roles for microglia in the developing CNS and provide a mechanism 
underlying complement-dependent synaptic pruning. 
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In the adult hippocampus, neuroprogenitor cells in the subgranular zone 
(SGZ) of the dentate gyrus give rise to newborn neuroblasts. However, only 
a small subset these cells integrate into the hippocampal circuitry as mature 
neurons at the end of a four-week period. Here, we show that the majority 
of the newborn cells undergo death by apoptosis in the first one to four days 
of life, during the transition from amplifying neuroprogenitors to 
neuroblasts. These apoptotic newborn cells are rapidly cleared out through 
phagocytosis by unchallenged microglia present in the adult SGZ niche. 
Phagocytosis by the microglia is efficient and undeterred by aging or 
inflammatory challenge. Our results suggest that the critical period of 
newborn cell survival occurs within a few days of birth and reveal a new 
role for microglia in maintaining the homeostasis of the baseline neurogenic 
cascade. 
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Neuroinflammation triggered by systemic inflammation and occurring 
during critical periods of CNS development is hypothesized to contribute to 
the development and/or pathogenesis of many neurodevelopmental 
disorders including cerebral palsy, schizophrenia and autism. In the adult 
CNS, the type and magnitude of microglial activation and macrophage 
influx triggered by systemic inflammation are well characterized. As yet, 
little is known about if and how microglial phenotype changes during 
critical periods of CNS development associated with synaptogenesis and 
oligodendrocyte development. Here, using flow cytometry and dual in situ 
hybridization/immunohistochemistry we show that in the early postnatal 
murine brain, microglia display an activated phenotype that is not polarized 
toward either “classic” proinflammatory or “alternative” anti-inflammatory 
activation states. Furthermore, we find that at all ages examined, systemic 
inflammation induced by an intraperitoneal injection of LPS leads to 
widespread activation of microglia and a transient influx of peripheral 
macrophages into the murine CNS. However, the magnitude of macrophage 
influx into the CNS is developmentally modulated. Systemic inflammation 
triggers the highest level of macrophage influx into the CNS between days 
7 and 14. In addition, CNS-infiltrating macrophages display a highly 
polarized pro-inflammatory phenotype. During this same developmental 
period, microglial activation is associated with high level expression of 
multiple alternative activation markers and induction of TREM2. We 
speculate that these microglial-specific forms of activation in part serve to 
compensate for the higher levels of pro-inflammatory macrophages that 
infiltrate the CNS during early development. Altogether our data contribute 
to the growing literature demonstrating that the brain may have age-specific 
susceptibilities to insults associated with the development and treatment of 
neurodevelopmental disorders.  
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In the neuro-degenerative disease Amyotrophic Lateral Sclerosis (ALS), 
death of motor neurons is accompanied by robust glial cell activation. In the 
mutant superoxide dismutase 1 (SOD1) transgenic model of ALS, non-
neuronal cells including microglia and astrocytes have been found to 
contribute significantly to disease progression. However, the molecular 
mechanisms governing neuron-glia interactions in ALS are not well 
characterized. The humoral complement system mediates synapse 
elimination during CNS development and glia express receptors for 
complement. In mSOD1 transgenic mice, we found that several components 
of complement were up-regulated in spinal cord and peripheral nerves 
during disease progression. In the degenerating spinal cord, white and gray 
matter GFAP+ astrocytes expressed C3, while motor neurons stained for 
C1q. We bred the mSOD1 transgene onto a complement C4-/- background 
to ablate classical and lectin pathways of complement. In mSOD1C4-/- 
mice, astrocyte and microglia activation were significantly decreased 
compared to mSOD1C4+/+ mice. FACS analysis of acutely isolated 
microglia from mSOD1C4-/- spinal cord showed stunted up-regulation of 
dendritic cell markers CD86 and CD11c. However, C3 deposition in ventral 
horns remained elevated in the absence of C4, indicating activation of the 
alternative complement pathway. Thus, complement plays a role in 
modulating the glial response in ALS. Further investigation of complement 
induction and deposition may produce insights into spinal cord gliosis and 
potential therapeutic avenues for motor neuron disease. 
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The transfer of antigens from oligodendrocytes to immune cells has been 
implicated in the pathogenesis of autoimmune diseases. Here, we show that 
oligodendrocytes secrete small membrane vesicles, exosomes, containing 
encephalitogenic antigens to the extracellular space. These exosomes are 
specifically and efficiently taken up by microglia both in vitro and in vivo. 
Internalization of exosomes occurs by a macropinocytotic mechanism 
without inducing a concomitant inflammatory response. After stimulation of 
microglia with interferon-γ, we observe an upregulation of MHC II in a 
subpopulation of microglia. However, exosomes are preferentially 
internalized in microglia that do not seem to have antigen-presenting 
capacity. We propose that the constitutive macropinocytotic clearance of 
exosomes by a subset of microglia represents an important mechanism 
through which microglia participate in the degradation of oligodendroglial 
membrane in an immunologically “silent” manner. By designating the 
capacity for macropinocytosis and antigen presentation to distinct cells, 
degradation and immune function might be assigned to different subtypes of 
microglia. 
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The role of myelin loss and repair in demyelinating diseases (e.g. MS) is well 
established although axon loss complicates the picture. The role of 
demyelination after spinal cord injury (SCI) is less clear. Numerous studies 
have shown that oligodendrocytes (OL) undergo secondary apoptosis after SCI, 
and this loss has been correlated with the presence of axonal degeneration and 
microglial activation (reviewed in Beattie, 2004). However, even if substantial 
demyelination occurs in long tracts or at the site of injury, spared axons may be 
re-myelinated by resident OPCs. Thus, the myelination status of spared axons 
after SCI depends upon both cell loss and the reparative response of OPCs.  
 
Thoracic contusion SCI in rats produced delayed OL apoptosis and cell loss in 
the dorsal columns (DC) rostral to the lesion associated with both axonal 
degeneration and morphological features of microglial activation. OL apoptosis 
peaked at 8 days after injury, and was preceded by evidence of early 
intracellular oxidation of RNA beginning before 24 hrs post injury (Sun et al, in 
press). In contrast, massive axonal degeneration induced by dorsal root section 
outside of the CNS produced similar evidence for microglial activation, but 
failed to induce either OL RNA oxidation or apoptosis. Both types of injury, 
however, stimulated OPC (NG2+) proliferation and differentiation in the DC, 
and neither resulted in demyelination of intact axons adjacent to degenerating 
tracts. Parallel studies of OPCs isolated from neonatal rat cortex confirmed that 
oxidative stress induced by activated microglia (Miller et al, 2007) or t-buOOH 
accelerated OPC apoptosis. OPCs from transgenic rats over-expressing SOD-1 
were protected. Further, OPCs from SOD-1 over-expressers proliferated and 
differentiated more rapidly than wild type OPCs in vitro. In vivo, SOD-1 over-
expressing rats have more OLs in the white matter after SCI. Together, these 
studies suggest that axonal injury and microglial activation are associated with 
both OL death and repair, and that their effects may be modulated by oxidative 
stress.  
 
Beattie MS (2004) Trends in Molecular Medicine, 10: 580-583.  
Miller B et al (2007) J. Neuroinflammation, 4:28.  
Sun F et al (2010) Glia, in press  
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Ageing of the brain can lead to cognitive decline which causes severe 
personal and social problems. Studies have shown that with advancing age 
there is a decline in white matter integrity and changes in myelin structure 
and function are suggested to contribute to cognitive decline. The 
occurrence of changes in white matter are often linked with chronic cerebral 
hypoperfusion (modest reductions in cerebral blood flow). In humans 
investigating the causes of these changes is strictly limited to brain imaging 
and in some cases post-mortem tissue analysis. Thus the underlying 
morphological changes and cellular mechanisms in white matter remain 
largely unclear in the ageing brain. 
A mouse model of chronic cerebral hypoperfusion has been developed, 
whereby hypoperfusion is induced by application of microcoils to both 
common carotid arteries (BCAS). In this BCAS model, incredibly modest 
reductions in blood flow results in selective damage to the white matter and 
mimics aspects of cerebrovascular white matter lesions. This model permits 
insight to mechanisms that occur early in response to hypoperfusion that are 
prohibited in human brain.  
Here we investigated the effects of chronic cerebral hypoperfusion on the 
integrity of the white matter at the cellular level using detailed confocal 
imaging. Key proteins were analysed at the axon-glial junction after chronic 
cerebral hypoperfusion. We found that the axon-glial connection is 
disrupted early in response to BCAS (within 3 days) in the absence of major 
changes to the myelin and axon. Furthermore, at later times after BCAS (1 
month) these white matter changes were associated with a cognitive 
impairment, specifically working memory. Together the results highlight 
the vulnerability of key components of white matter to modest reductions in 
blood flow which is sufficient to impair cognitive abilities.  
 
This work was conducted as part of the Disconnected Mind program, 
supported by Age Concern. 
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Brain size, organization, and function are abnormal in children with genetic 
deficiencies in the extracellular matrix protein laminin. During mouse 
embryogenesis, laminin loss-of-function leads to detachment and 
misplacement of radial glia, which in turn causes disturbances in neuronal 
progeny and cerebral cortical development. Members of the laminin family 
are found throughout the cortical plate during corticogenesis and are also 
highly enriched at the ventricular and pial surfaces, i.e. sites of radial glial 
attachment; later, laminins adopt a more restricted distribution in the adult 
brain where laminin-containing fractone structures are found in the neural 
stem cell niche of the subventricular zones. It is not known, however, if 
laminins regulate the wave of gliogenesis that originates from the 
subventricular zones in the neonatal and postnatal brain. Here we report that 
laminin alpha 2 (LAMA2) regulates postnatal oligodendrogenesis. During 
early postnatal development, LAMA2-/- mice possess significantly fewer 
oligodendrocyte progenitor cells in a future white matter tract, the corpus 
callosum. Preliminary evidence suggests that during this early 
oligodendrogenesis, the subventricular zones of LAMA2 -/- mice have 
disturbed cellular organization in conjunction with higher numbers of 
Olig2+ and Sox2+ progenitor cell populations. Later, the development of the 
LAMA2 null corpus callosum continues to lag behind, developing fewer 
mature oligodendrocytes in conjunction with what are now elevated levels 
of oligodendrocyte progenitors relative to those in wildtype littermates. 
These deficits lead to delayed myelination in the developing cerebral cortex 
by postnatal day 21. And, while fewer mature oligodendrocytes were 
observed in the developing corpus callosum of LAMA2-/- mice, these cells 
did not exhibit increased cell death. Together these data suggest that 
laminin-cell interactions in the developing postnatal brain regulate the 
timing or ability of oligodendrogenesis to occur appropriately. 
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Two-photon laser scanning microscopy (2PLSM) enables real-time 
visualization of functioning cells expressing Green Fluorescent Protein 
(GFP) deep within living neocortex in vivo. Using 2PLSM we have 
previously shown that cardiac arrest-induced global ischemia elicits 
astroglial soma and process swelling, indicating acute damage. We also 
have evidence that spreading depolarizations (SDs) cause acute damage to 
neuronal dendrites and spines in the ischemic penumbra. Here we used 
2PLSM to monitor changes in astroglial volume concurrently with signs of 
neuronal injury in two different models of ischemic stroke. The first method 
was transient bilateral common carotid artery occlusion (CCAO), which 
allowed for the induction of global ischemia and subsequent reperfusion. 
The second method was modified photothrombotic microcirculatory 
occlusion, in which a square-shaped ischemic lesion was made to surround 
a penumbra-like “area at risk” with SDs recurring for minutes to hours 
following photothrombosis. With both methods, dendrites showed a 
relatively high rate of recovery for several hours after insult. However, 
astroglial recovery was much more variable, with many somata and 
processes remaining swollen well after the induction of ischemia. Thus the 
fate of astrocytes may be a more critical determinant of the final outcome of 
ischemic stroke than was previously thought. 
 
Supported by NIH 1F31 NS064753-01A2 (WCR) and NIH RO1 NS057113 
(SAK). 
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Our purpose is to study the distribution of the VGLUT1 and GS in the 
retina and optic nerve of the adult lizard Gallotia galloti. In the retina, 
VGLUT1+ ganglion and amacrine cells were identified. The latter also 
displayed dendrite-like processes into the inner plexiform layer (IPL). 
Punctate staining of VGLUT1 was confined to a main horizontal sublamina 
in the IPL. Strong GS staining was detected in the Müller glia processes and 
endfeet. Interestingly, VGLUT1+/GS+ and VGLUT1-/GS+ glial cells were 
abundantly distributed in the optic nerve. After unilateral optic nerve 
transection, no relevant changes in VGLUT1 and GS staining were detected 
in the experimental retina. In the lesioned optic nerve, VGLUT1 labeling 
was apparently unmodified whereas down-regulation of GS was exclusively 
observed at the lesion site at the different postlesion time points studied. We 
conclude that the GS is expressed in a glutamatergic glial network in the 
lizard ON and may contribute to homeostasis under control and 
regeneration conditions. This work was supported by the Spanish Ministry 
of Education (Research Project BFU2007-67139) and the Regional Canary 
Island Government (ACIISI, Research Projects SolSubC200801000281 and 
ULPAPD-08/01-4). 
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ACTIVATION AND CHOLINERGIC CELL LOSS WHILE 
INCREASING BRAIN ENERGY RESERVES AND LIPID DEPOSITION 
IN A RAT MODEL OF NEUROINFLAMMATION 
 
Dhaval P Bhatt, Dane J Mitteness, Heidi M Gienger, Thad A Rosenberger  
 
University of North Dakota School of Medicine, Pharmacology, Physiology 
and Therapeutics, Grand Forks, ND, 58203 
 
Glyceryl triacetate (GTA) a compound effective in reducing myelin loss in 
a mouse model of Canavan disease was used to treat rats subjected to 
chronic neuroinflammation. To induce neuroinflammation, rats were 
infused directly into the 4th ventricle for 28 days with either artificial 
cerebral spinal fluid (aCSF) or bacterial lipopolysaccharide (LPS) dissolved 
in aCSF (5.0 ng/hour). During this period rats were given a daily treatment 
of either water or GTA at doses of 6g/kg by oral gavage. Brain neuroglia 
activation was measured by quantifying morphologic changes in CD11b-
positive microglia and GFAP-positive astrocytes. Cholinergic cell loss was 
measure by counting choline acetyltransferase (ChAT)-positive cells in the 
basal forebrain. Immunohistochemical analysis demonstrated that treatment 
significantly reduced the percentage of activated astrocytes and microglia 
by 40-50% compared to controls. Further, treatment significantly increased 
the number of choline acetyltransferase positive cells by 40% in the basal 
forebrain. To begin to determine the mechanism(s) involved in the anti-
inflammatory and neuroprotective effect of acetate supplementation we 
measured changes in lipid content, acetyl-CoA, nucleotide, 
phosphocreatine, and creatine levels in treated rats subjected to head-
focused microwave irradiation to stop metabolism. These studies show that 
acetate supplementation significantly increased plasma acetate levels by 15 
min and remained elevated for up to 4 hr resulting in a 4-fold increase in 
brain acetyl-CoA by 30 min which also remained elevated up to 4 hr. 
Treatment did not alter brain energy supplies; individual brain nucleotide 
levels or the energy charge ratio [ECR, 
(ATP+0.5ADP)/(ATP+ADP+AMP)] when compared to controls. However, 
treatment did significantly increase by 0.4-fold (p < 0.001) the 
phosphocreatine to creatine ratio (PCr/Cr) and by 0.9-fold (p < 0.01) the 
energy potential ratio [EPR, (PCr/Cr) x (ATP/ADP)] by 4 hr. Further, 
treatment significantly increased the levels of ethanolamine and choline 
plasmalogen by 2- and 4-fold respectively without altering the 
concentrations of other brain phospholipid. These data suggests that acetate 
supplementation alters brain energy reserves and lipid metabolism and 
provides insight into the anti-inflammatory and neuroprotective 
mechanism(s) of acetate supplementation. 
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The myelinating cell of the central nervous system, the oligodendrocyte 
(OL), undergoes a dramatic change in the organization of its cytoskeleton as 
it differentiates from an oligodendrocyte precursor cell (OPC) to a myelin 
forming OL. This change involves an increase in branching, which is 
required for the OL’s ability to myelinate multiple axons.  
We have shown that levels of non-muscle myosin II (MII), a regulator of 
cytoskeletal contractility, decrease as a function of differentiation and that 
inhibition of MII activity increases branching and myelination of OL in co-
culture with neurons. Although several pathways have been implicated in 
OL morphogenesis, their specific contribution to regulation of myosin II 
activity and expression in OL has not being directly examined.  
Previous work has shown that Fyn kinase a member of the src family kinase 
is upregulated during OL differentiation, and that overexpression of fyn or 
its downstream target p190RhoGAP decreases levels of active RhoA and 
induces branching in the OPC. We have tested the hypothesis that the 
activity of MII in OPC is negatively regulated by fyn through RhoA-ROCK 
and the phosphorylation status of its regulatory light chain (MLC). In 
support of this hyphotesis, we have found that pharmacological inhibition of 
fyn prevents the decrease in phospho-MLC levels normally observed during 
the differentiation of OPC in vitro. Furthermore, the inhibition of OPC 
branching induced by over-expression of a constitutively active form of 
RhoA can be reversed by pharmacological inhibition of MII. 
To test the relevance of our findings to OL differentiation in vivo, we have 
started to characterize myelin formation by OPC isolated from MII KO 
mice. In agreement with our previous studies, we have found that OL 
maturation is accelerated in MII KO mice compared to wild type, as shown 
by a significant increase in the number of mature MBP+ in OL derived from 
KO cultures. Taken together our results confirm that downregulation of 
myosin II promotes OL branching and maturation and suggest that upstream 
activation of Fyn kinase acts as a negative regulator of myosin II activity in 
OL promoting active actin-remodeling and maturation. 
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Introduction: Despite the critical role played by glia in neurological 
disorders, very little is known concerning glial function in the intact human 
brain. Using carbon-13 magnetic resonance spectroscopy (13C MRS) we 
demonstrate metabolic adaptation of neurons and glia when independently 
assayed in multiple regions of human brain. Specificity is provided by the 
selective use of a glial fuel, acetate in place of a neuronal fuel, glucose 
while regional selectivity is based upon MRI guided MRS voxel placement.  
 
Methods: Technological improvements allow for human 13C MRS with 
safe examination of frontal brain structures, a brain region previously 
inaccessible to 13C MRS on grounds of RF safety. Using a routine clinical 
MR scanner (GE 1.5 Tesla) more than 150 human subjects have been 
examined during intra-venous infusions of 1 or 2-labelled 13C glucose or 1-
labelled 13C acetate. Metabolic rates of neuronal or glial TCA cycle, 
glutamate-glutamine cycle and final oxidation product 13CO2 (as 
bicarbonate, H13CO3-) products identified within the brain as a function of 
time, provide rates of glutamate neurotransmission and substrate turnover.  
 
Results: Cerebral uptake of 1-13C glucose and 2-13C glucose were 
comparable. Using 2-13C glucose, neuronal metabolic rate for 13C glucose 
was comparable in frontal and posterior regions of normal human brain. 
Cerebral uptake of 1-13C acetate and its conversion to C5 labeled glutamate 
and glutamine was confirmed, providing evidence of significant glial 
metabolism. Using the maximum rate of appearance of 13C bicarbonate, 
glial TCA cycle rate in the intact human brain was 0.5 μmoles/min/g, 
approximately 30% of the maximum rate of neuronal metabolism in the 
same brain region(s) determined with 13C glucose.  
Metabolic adjustments of neuronal metabolism occur in patients with 
Alzheimer’s disease (Lin et al. MAGMA,2003;(16):29-42) and ornithine 
transcarbamylase deficiency (Gropman et al. Radiology, 2009; 252(3): 833-
41). 50% modification in glial metabolic rate was observed in subjects 
abstinent from prolonged abuse of methamphetamine (Sailasuta et al: 
Cerebral Blood Flow and Metabolism, 2010; 30: 950-960)  
 
Conclusions: In vivo glial metabolic rate is modified significantly in 
response to a pathological state. We postulate that glial metabolic rate assay 
may be reflective of adaptation in microglia and therefore could provide a 
reliable non-invasive assay for the phenomenon of neuroinflammation. 
Future studies with 13C MRS after 1-13C acetate infusion could directly 
establish a role for neuroinflammation in the many human brain disorders in 
which this process has been implicated.  
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Schizophrenia is a serious neurodevelopmental psychiatric disorder in 
which oligodendrocyte/myelin abnormalities have been implicated. The 
neuregulin (NRG) signaling system has been implicated in the etiology of 
schizophrenia by genetic studies and by animal models. PTPRZ1, receptor 
type protein tyrosine phosphatase Z, also been implicated in schizophrenia, 
can inhibit NRG/erbB4 signaling. In cultured rat oligodendrocyte precursor 
cells (OPCs), the expressions of Ptprz1 receptor isoforms (long and short) 
are downregulated during differentiation of OPCs in vitro. Inhibition of 
PTPRZ1 activity in OPCs by its ligands or shRNA treatment leads to 
acceleration of oligodendrocyte differentiation, whereas overexpression of 
PTPRZ1 leads to a delay of oligodendrocyte differentiation, supporting a 
role in oligodendrocyte development. In schizophrenia postmortem brains, 
PTPRZ1 is upregulated. To test PTPRZ1 involvement in schizophrenia, we 
have developed BAC transgenic mice that contain one extra copy of 
PTPRZ1 (PTPRZ1- BAC).  
Quantitative polymerase chain reaction (QPCR) studies demonstrated a 
downregulation of the expression of oligodendrocyte/myelin genes in the 
young PTPRZ1-BAC mice. Immunohistochemical analyses showed an 
increased ratio of oligodendrocyte precursor cells to mature 
oligodendrocytes in PTPRZ1-BAC, indicating delayed oligodendrocyte 
differentiation. In addition, we found increased levels of dopamine and of 
the Drd2 dopamine receptor in the striatum of PTPRZ1-BAC, indicating 
elevated dopamine signaling in these mice. Furthermore, glutamate related 
genes are downregulated in the hippocampus. Behavioral analysis showed 
increased spontaneous and drug-induced activity in the open field test and 
reduced prepulse inhibition, all considered to be behavioral changes 
relevant to schizophrenia in mice. These results are consistent with 
developmental hypothesis of schizophrenia, in which altered developmental 
processes can induce sustained effects on brain circuitry and behavior, 
leading to schizophrenia. 
We propose a model in which increased expression of PTPRZ1 leads to 
deficits in oligodendrocyte development, which can in turn contribute to 
aspects of the schizophrenia phenotype.  
Supported by the Silvio O. Conte Center for the Neuroscience of Mental 
Disorders (NIMH) and the Stanley Medical Research Institute. 
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A better understanding of the pathogenesis of virus-induced spinal cord 
injury (SCI) is essential for identification of novel targets for therapy. We 
have recently developed an experimental model of viral induced SCI. 
Neonatal mice are infected with 106 plaque forming units of a neurotropic 
reovirus (Type 3 Dearing) in the right hind limb. This leads to a progressive 
paralysis first of the ipsilateral hind limb and then of both hind limbs 
(paraparesis/paraplegia) by nine days post infection. Tissue was collected 
from paralyzed animals for use in western blot analysis, immuno-
fluorescence analysis (IFA) with confocal microscopy, or RNA isolation for 
gene expression analysis using reverse transcriptase PCR – evaluating 
levels either on agarose gel or quantitatively by SYBR Green based real 
time PCR. Viral infection is associated with an increase in astrocytes (glial 
fibrillary acidic protein (GFAP) + cells) in proximity to infected neurons in 
the anterior horn of the lumbar spinal cord, as well as activation associated 
cell hypertrophy. Microglial activation is also evident as determined using 
IFA with antibodies against ionized calcium-binding adaptor molecule 1 
(Iba1). Microglia show altered morphology consistent with activation with 
quantitative cell counts showing an 18 fold (p<0.0001) increase in activated 
microglia in SC from paralyzed as compared to control mice. Activated 
microglia are found throughout the lumbar spinal cord and in close 
association with infected neurons. Since both astrocytes and microglial 
contribute to host innate immune responses in the CNS through activation 
of cytokine and chemokine signaling pathways, we examined expression of 
genes encoding these molecules. We found that virus infection of the spinal 
cord resulted in increased expression of interferon (IFN) stimulated genes 
(ISG) encoding; (i) antiviral proteins, including 2’-5’oligoadenylate 
synthetase (OAS) and signal transducer and activator of transcription 1 
(STAT1); (ii) inflammatory cytokines and chemokines, including tumor 
necrosis factor alpha (TNFα) and chemokine (C-C motif) ligand (CCL) 5; 
(iii) proteins which can sensitize cells to apoptotic death, including caspase 
1 and interferon regulatory factor 1 (IRF1) and; (iv) pattern recognition 
receptors, including retinoic acid inducible gene-I (Rig-I) and toll like 
receptor 2 (TLR2). Activated glia may contribute to the increased 
expression of inflammatory mediators found in reovirus infected spinal 
cords, including inducible nitric oxide synthase and TNFα which are 
neurotoxic. Current studies are evaluating these responses to viral infection 
in IFN(α/β)R1 knockout mice, which show enhanced viral replication and 
accelerated mortality after reovirus infection. 
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The main functional features of the nervous system have been conserved 
during evolution. Likewise the biology of neurons and glial cells is 
remarkable similar in different animal species. In all cases, glial cells exert a 
number of important supporting functions for the neuronal circuitry. These 
functions include the insulation and support of neurons, the facilitation and 
modulation of electrical conductance and synaptic transmission. To 
decipher these functions, the simple structured nervous system of 
Drosophila offers a number of advantages. In the embryo and the larval 
nervous system every segmental unit of the ventral nerve cord comprises 
only 65 glial cells. All of these cells are known and markers exist to label 
the different cell types in wild type and mutant backgrounds. Moreover, the 
Drosophila glia can be specifically manipulated by a set of cell type specific 
Gal4 drivers.  
To get further insights into Drosophila glial cell biology we performed a 
glial cell specific RNAi Screen. So far we screened about 5,000 different 
genes for a cell autonomous requirement in all glia using the panglial driver 
line repoGal4. The knock down of about 14% of the tested genes leads to 
lethality. In about 1% of the cases we noted flies with reduced viability and 
with locomotion defects. To determine whether the function of these 800 
candidate genes can be attributed to a specific glial cell class we silenced 
their expression using Gal4 driver lines specific to individual glial cell types 
(perineurial glia, subperineurial glia, wrapping glia and astrocytic glia). 
Here we focus on genes required in the wrapping glia.  
The knock down of kinesin heavy chain (Khc) or tubulin severely affects 
viability and renders the flies hyperactive. Khc is a well known protein and 
has been thoroughly analyzed for its role in anterograde axonal transport. In 
glial cells a function of Khc has been recently described (Lyons et al., 
2009). In Drosophila loss of Khc in glial cells disrupts transport of 
mitochondria and leads to a cell-autonomous differentiation defect during 
early larval stages. A model describing Khc function in Drosophila glia will 
be discussed.  
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Neuronal Ceroid Lipofuscinoses (NCLs) comprise a group of children’s 
inherited neurodegenerative disorders caused by mutations in at least 8 
different genes. NCLs share many clinical and pathological features like 
visual loss, brain atrophy and ultimately lead to premature death. Mutations 
in the CLN5 gene result in the Finnish variant late infantile form of NCL 
(vLINCLFin) and 27 disease-causing mutations have been reported 
(http://www.ucl.ac.uk/ncl). CLN5 shows no homology to other known 
proteins and the function of the protein is unknown.  
The aim of our current research project is to analyze the impact of Cln5 
deficiency in glial cells. Loss of myelin has been reported to be associated 
with the vLINCLFIN disease pathology [1, 2] and gene expression profiling 
of Cln5 deficient mouse brains implicate myelination related changes [3, 4] 
. We have used qPCR as an approach to study developmental expression of 
Cln5 in wt mice and to detect possible defects in the 
oligodendrocyte/myelin maturation in Cln5 deficient mice. Our results show 
that Cln5 gene expression is linearly rising in mouse brain during 
development (P3, P10, P20, P30, 3mo, 5mo) and that it is markedly higher 
in glial cells than in neurons. Preliminary analyses of the developmental 
expression of oligodendrocyte specific genes indicate that Cnp1 (2',3'-cyclic 
nucleotide phosphodiesterase) gene expression is reduced in Cln5 ko mouse 
brains. CNP1 protein plays an essential role in maintaining axonal survival 
[5] and we are currently investigating the CNP1 protein in Cln5 deficient 
mouse brains and neuronal cultures. These findings suggest an important 
role of CLN5 in glial cells. 
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Growth arrest-specific protein 6 (Gas6) activities are mediated through the 
Tyro3, Axl, and Mer (TAM) family of receptor tyrosine kinases. Gas6 is 
expressed and secreted by a wide variety of cell types, including cells in the 
central nervous system (CNS). Gas6 affects cell proliferation, 
differentiation, phagocytosis, cell survival and apoptosis. Previous studies 
showed that mice with deletion of Gas6 and Axl have delayed CNS 
recovery following cuprizone intoxication. In this study, we tested the 
hypothesis that administration of recombinant human Gas6 protein (rhGas6) 
directly into the CNS would improve recovery following cuprizone 
withdrawal. After a 4-week cuprizone diet (0.2 % w/w), cuprizone was 
removed, and PBS and rhGas6 (400 ng/ml, 4 µg/ml and 40 µg/ml) were 
delivered into the corpus callosum of C57Bl6 mice for 14 days. Analysis of 
the lipid-associated debris in the corpus callosum of 9 out of 11 (82 %) 
PBS-treated mice showed extensive Oil-Red-O positive deposits while mice 
treated independently with three rhGas6 doses, only 4 out of 19 (21 %) 
mice had low to moderate Oil-Red-O staining. In the corpus callosum of 
rhGas6-treated mice, SMI32 positive axonal spheroids and APP positive 
deposits were reduced in number relative to PBS-treated mice. Compared to 
PBS, rhGas6 enhanced remyelination detected by MBP immunostaining 
and by electron microscopy. The rhGas6-treated mice had more 
oligodendrocytes with Olig1-positive cytoplasmic localization, indicative of 
oligodendrocyte progenitor cell maturation. The number of Iba1-positive 
cells did not differ between the rhGas6- and PBS-treated groups. The data 
show that compared to PBS, rhGas6 treatment resulted in more efficient 
repair evidenced by clearance of cellular and myelin debris, greater 
maintenance of axonal integrity, enhanced oligodendrocyte progenitor cell 
maturation, all contributing to the observed enhanced remyelination. 
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More than 100,000 Americans are suffering from stroke or ischemic-brain 
injury annually and the rate of incidents is on the rise. Stroke, commonly 
called as 'brain attack' is the third leading cause of death in adults as well as 
in older people. Emerging evidence suggests that astroglial cells, a major 
glial cell population in brain, may play a role in hypoxia-ischemic brain 
injury. Our previous studies demonstrate that astroglial cells metabolize 
arachidonic acid by a cytochrome P450 epoxygenase pathway into four 
regioisomers of epoxides in addition to cyclooxygenase, lipoxygenase 
pathways. We have shown that these epoxides play a neuroprotective role 
causing vasodilation in the pial arterioles and their action is transient due to 
rapid hydrolysis by an epoxide hydrolase activity. Our recent studies show 
that normal rat brain astroglial cells express both microsomal (mEH) and 
soluble (sEH) epoxide hydrolases, and the latter is responsible for the 
inactivation of vasoactive epoxides. In this study, using an in vitro model, 
we investigated the signaling mechanisms mediating hypoxic responses of 
the astroglial cells in relation to the cell viability and expression of sEH. In 
cultures of rat brain astroglial cells, oxygen glucose deprivation (OGD) for 
20h followed by reoxygenation (3, 6 and 24h) affected astroglial cell 
viability as assessed by dual immunocytochemical staining of cells with 
fluorescent dyes Hoechst/Propidium iodide. The OGD-induced astroglial 
cell death increased during post-hypoxia oxygen reperfusion: maximum cell 
death occurred at 6hr returning to that of normoxic controls in 24 hr. 
Immunocytochemical and quantitative western blot analyses revealed that 
OGD down-regulated sEH expression and reoxygenation reversed the 
expression of sEH to their normoxic controls in 24hr in a time-dependent 
manner suggesting a role for sEH against OGD-induced glial cell death and 
survival. These results suggest that a differential expression of sEH may be 
linked to pathophysiology of hypoxia-induced cerebral blood flow and brain 
damage after cerebral ischemia and stroke. 
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Dividing progenitor cells in the adult brain may serve as a reservoir for cell 
replacement. Besides the highly proliferative zones of neurogenesis in the 
adult mouse brain, a large number of actively cycling progenitor cells 
resides in the brain parenchyma. The majority of these dividing cells are 
oligodendrocyte precursor cells (OPCs) that can be identified by the 
expression of NG2, PDGFRa, Olig2 or Sox10. Recent fate mapping 
experiments (Olig2::CreERTM, PDGFRa-CreERT2) showed that these cells 
indeed generate progeny of the oligodendrocyte lineage, with noteable 
differences between the gray and white matter (Dimou et al. 2008; Rivers et 
al. 2008). However, the overall proliferation characteristics of this major 
population of progenitors in the adult brain are still not fully understood. 
This includes key questions of stem cell biology, such as if these 
progenitors are able to self-renew and how they react to injury.  
 
To analyze the cell cycle characteristics of cortical progenitors, adult mice 
received the thymidine analog BrdU for different time periods (4 hours – 8 
weeks). BrdU detection was then combined with Ki67-immunoreactivity to 
label the dividing progenitor pool. These data showed that the majority of 
OPCs proliferate and that they have a long cell cycle of about a month. 
When we performed BrdU-label retaining experiments, we could follow the 
progeny of these cortical progenitors and could show that these proliferating 
NG2+ generate mature oligodendrocytes. In parallel, these BrdU-retaining 
experiments revealed for the first time direct evidence of the self-renewal of 
NG2+ progenitors in the intact cortical gray matter. 
 
OPCs are also well-known to react to brain injury by increasing in number 
and changing their morphology. Here we examined the entire pool of 
proliferating cells (including astrocytes, microglia and NG2+ cells) after 
stab wound injury by cumulative BrdU labeling and Ki67 staining. Our 
results demonstrate that NG2+ cells are one of the first cells that react to the 
injury with enhanced proliferation and shortening of the cell cycle. In 
addition to OPCs, also microglia and later astrocytes start to divide in 
response to the lesion. Interestingly, the only cells that keep on proliferating 
within the glial scar at longer time points after injury are the NG2+ cells, 
being a potential target for approaches in brain repair. 
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Intracranial cerebral laceration is a common traumatic brain injury that 
results in neuronal death and brain damage. It is therefore conceivable that 
signaling molecules important in neuroprotection will also be essential for 
wound repair. The gap junction protein connexin43 (Cx43) is one such 
protein. By allowing passage of small molecules between two adjacent 
cells, the up-regulation of Cx43 in reactive astrocytes has been proposed to 
facilitate removal of harmful substances from the injury site and therefore 
provide benefits for neuronal survival. However, there are also instances 
where increased intercellular communication appears to have a detrimental 
effect on the brain. In addition to reactive astrocytes, activated microglial 
cells have substantial presence in the injury sites. However, their relative 
contribution to wound healing is unclear, as is the interaction of microglia 
with astrocytes. Gap junctions consist of a family of channel proteins with 
cell type-specific expression in the brain. To examine key players in the 
wound healing process following brain injury, we determined the up-
regulation of gap junction proteins in astrocytes and microglia following a 
single needle wound to the mouse striatum. We found that Cx43 was up-
regulated at the needle wound as early as 2 days post lesion (dpl) and the 
elevated expression was maintained at 5 dpl. However at 10 dpl, the up-
regulation of Cx43 was significantly reduced and the needle wound was no 
longer obvious. Increased Cx43 expression was detected in both astrocytes 
and microglia surrounding the needle wound. We are in the process of 
examining the expression and localization of other connexins in these glial 
cells to determine the relative importance of gap junction proteins in wound 
healing. Specific up-regulation of gap junctions in glial cells indicates 
intercellular communication may be essential for a co-ordinated response to 
minor brain lesions. 
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Formation and plasticity of neural circuits require precise regulation of 
dendrite and receptive ending shapes. In vertebrates, dendrite shape 
development is regulated in part by glial cues. Dendritic spines are also 
remodeled in a controlled manner in adults during sensory deprivation, 
information processing (synaptic plasticity) or hormonal surges (e.g. 
ovulation). Perturbations to dendrite morphologies are correlated with 
cognitive disorders. Similarly the shapes of sensory receptive endings in C. 
elegans require glial interaction during development and are altered by 
sensory deprivation and pheromones post-embryonically. While glia are 
implicated in the control of neuronal receptive ending shape across species, 
a detailed molecular understanding of relevant glia-neuron interactions is 
lacking. 
We are using the C. elegans amphid sheath glia and AFD thermo-sensory 
neurons to identify genes underlying glial control of neuronal receptive 
ending architecture. Previous cell ablation studies from our lab suggest that 
sheath glia are required for development of the microvillar-like receptive 
endings of the AFD thermo-sensory neuron. We showed that transiently 
blocking exocytosis in glia by expressing a RAB-1 dominant negative 
protein promotes loss of AFD fingers, suggesting that an acute signal from 
glia is required for the maintenance of AFD receptive ending morphology. 
To identify genes involved in glia-AFD signaling, we conducted a forward 
genetic screen for mutants with defects in AFD receptive ending 
morphology. Three independent mutants lacking AFD microvilli have been 
isolated. Further characterization of these should shed light on the biology 
of glia, cell shape regulation, and cell-cell communication in the nervous 
system.  
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One of the important goals in the field of addiction research is to understand 
alterations in the brain gene expression profile related to rewarding and 
addictive properties of drugs of abuse. Therefore, we performed whole 
transcriptome analysis of the mouse striatum after the administration of six 
addictive substances (Korostynski et al., 2007; Piechota et al. 2010). We have 
identified serum and glucocorticoid-regulated kinase 1 (Sgk1) as one of the 
most strongly upregulated transcripts in the striatum after acute drug treatment.  
 
Here we carried out a more detailed study of drug-induced regulation of three 
transcriptional isoforms resulting from alternative splicing of Sgk1 gene 
(canonical Sgk1, neuron-specific Sgk1.1 and Sgk1.2). Using qPCR with 
variant-specific primers, we found robust increase in the abundance of the Sgk1 
and Sgk1.2 transcripts after the administration of morphine, heroin, ethanol, 
amphetamine, cocaine and nicotine. The strongest effect was observed 2h after 
opioid treatment. In contrast, the expression of Sgk1.1 isoform remained 
unaltered by the drugs.  
 
Furthermore, to investigate the brain-region specific regulation of individual 
isoforms we used in situ hybridization. Variant-specific probes revealed striking 
regional differences in their distribution: 1) Sgk1.1 isoform was mainly detected 
in the striatum and hippocampus, showing no change in the signal intensity 
independently of the treatment, 2) Sgk1 isoform was almost undetected in 
saline-treated animals, whereas upregulation was observed throughout the brain 
of morphine-treated animals, with the strongest signal in corpus callosum, 
anterior commisure and internal capsule, 3) the level of Sgk1.2 was below the 
detection threshold.  
 
To look for cellular specificity we tested expression of the isoforms in cell-type 
specific primary cultures. We show that Sgk1 and Sgk1.2 isoforms are 
constitutively expressed in glial cells, but not in neurons, and are strongly 
upregulated by the GR agonist - dexamethasone. Conversely, Sgk1.1 is 
expressed in neuronal, but not in glial cultures, and displays no GR-dependent 
upregulation.  
 
In summary, we describe Sgk1 and Sgk1.2 as glia-specific transcripts regulated 
by various drugs of addiction. Our data suggest that the overall change in the 
Sgk1 level reported previously may have originated from alterations in the glial 
isoforms. The observed alteration in expression of glial Sgk isoforms may 
represent the unspecific response to a chemical substance, being mediated f.e. 
via Toll-like receptors or may also be a part of glia-specific pathway involved in 
drug-induced neuronal plasticity.  
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NG2+ cells represent a quiescent oligodendrocyte progenitor (OPC) pool 
that is found throughout the postnatal brain. In models of immune-mediated 
demyelinating injuries, NG2+ cells differentiate into myelinating 
oligodendrocytes in the white matter, although astrocytic fate is also 
reported. However, the differentiation potential of NG2+ cells in the setting 
of white matter stroke is still largely unexplored. We investigated the fate of 
NG2+ cells using an in-vivo model of white matter stroke and an inducible 
OPC reporter line. Ischemic infarcts are produced by stereotaxic delivery of 
a potent inhibitor of endothelial cell NO synthase, L-NIO, directly into the 
white matter below forelimb motor cortex of adult mice. L-NIO injections 
produce focal ischemic stroke and adjacent demyelination confined to white 
matter with minimal cortical or striatal damage. Recordings of compound 
action potentials (CAPs) across the white matter infarcts demonstrated 
functional axon conduction deficit at 7 days post lesion (dpl). Additionally, 
mapping of mature oligodendrocytes in ipsilateral white matter identified 
progressive loss of CC1+ and transferrin+ cells upto 28 dpl. NG2+ cells 
were found in high numbers in the infarct core and periinfarct white matter 
within the first week of injury. Ischemic stroke elicited a persistent glial 
response, as the infarct core remained densely populated with pallisading 
astrocytes and Iba-1+ microglia/macrophages up to 60 dpl. BrdU pulse 
given after stroke showed NG2+ cells proliferated upon ischemic insult, and 
generated BrdU incorporated CC1+ cells as early as 7 dpl. NG2+ cells were 
mitotically active up to 14 dpl as indicated by Ki 67 immunoreactivity. 
Preliminary data suggests that some of the newly born oligodendrocytes 
survive by 28 dpl but the majority of NG2+/BrdU+ cells generated within 7 
dpl remain undifferentiated at day 28. Using a tamoxifen inducible NG2-
CreERT2/Rosa26-YFP mouse line, YFP gene expression was induced prior 
to white matter stroke and the phenotype of YFP+ cells was determined at 
7, 14 and 28 dpl. YFP+ cells were mostly positive for NG2 and/or PDGFRα 
during all time points and few YFP/CC1 double positive cells were 
observed. Despite the low levels of detectable oligodendrocyte 
differentiation, the YFP+/NG2+ cell population exhibited characteristics of 
maturing OPCs across the time points evidenced by long elaborate 
processes. Interestingly, the infarct core and the lesion/striatum border 
harbored some YFP+ cells with GFAP+ processes starting at 7 dpl. Our 
findings suggest NG2+ cells remain mostly undifferentiated within the 28 
days after white matter stroke with limited differentiation into 
oligodendrocytes. Astrocytic potential of NG2+ progenitors appear even 
more limited and possibly influenced by different micro-environments 
found in white matter stroke. 
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Myelination of peripheral nerves by Schwann cells depends upon a gene 
regulatory network controlled by Egr2/Krox20, which is specifically 
required for myelin formation and maintenance. A number of inherited 
human peripheral neuropathies including Charcot-Marie-Tooth (CMT) 
disease have been linked to mutations in major myelin genes such as 
Connexin-32 and Peripheral Myelin Protein 22 (PMP22), which are 
normally induced during myelination. Gene dosage appears to be critical as 
a gene duplication of PMP22 results in CMT1A, the most common 
inherited peripheral neuropathy. Many myelin genes are regulated by both 
Egr2 and Sox10, a transcription factor required for Schwann cell 
specification and other stages of Schwann cell development. To elucidate 
the mechanism by which Egr2 and Sox10 regulate gene expression during 
myelination, we have performed chromatin immunoprecipitation analysis 
on myelinating rat sciatic nerve in vivo. The resulting samples were applied 
to a tiled microarray consisting of a variety of genes that are deregulated in 
Egr2-deficient mice. A similar analysis with Sox10 showed substantial 
colocalization with Egr2 binding at control elements of several myelin 
genes. Finally, depleting Sox10 in Schwann cells resulted in 
downregulation of Pmp22 and other target genes suggesting direct 
regulation of myelin genes by Egr2 and Sox10 during myelin development. 
The results provide the first locus-wide profile of Egr2 and Sox10 binding 
patterns within myelin-associated genes, and serves to identify novel targets 
of Egr2/Sox10 coregulation during peripheral myelination. 
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Myelination is essential for proper saltatory nerve conduction, i.e., rapid 
transmission of nerve impulses, a process which is ultimately irreversibly 
interrupted in multiple sclerosis (MS). The biogenesis and maintenance of 
myelin membranes is regulated by extracellular matrix (ECM) molecules, 
neuronal signaling and axonal adhesion and depends on polarized transport 
of myelin specific proteins and lipids towards myelin membranes. As 
galectin-4, which specifically binds to β-galactoside present in glycolipids 
or glycoproteins, has the ability to regulate (de)adhesion of cells to ECM 
components and is in addition involved in inter- and intracellular signaling 
and polarized membrane trafficking, we anticipate that galectin-4 could play 
a role in (re)myelination. Indeed, here we show that receptor(s) for galectin-
4 appeared transiently on processes of immature, pre-myelinating primary 
oligodendrocytes (OLGs) and disappeared on mature, myelin-sheet forming 
OLGs. Furthermore, galectin-4 was developmentally downregulated in 
developing rat brains, i.e., just before the onset of myelination. 
Interestingly, we identified neurons as a possible source of (secreted) 
galectin-4, suggesting that neuronal galectin-4 could play a role in OLG 
myelination. Indeed, when immature OLGs were treated with galectin-4, 
further maturation and therefore myelin-sheet formation was inhibited, 
whereas hardly an effect on viability was observed. Moreover, galectin-4 
treated OLGs acquired a less complex, i.e., bipolar morphology and were 
able to proliferate. Intriguingly, neuronal galectin-4 is re-expressed in 
demyelinating lesions. However, whereas in cuprizone-induced 
demyelination galectin-4 expression is cleared upon remyelination, in MS 
lesions axonal galectin-4 expression is persistent. Thus, re-expression of 
galectin-4 in the adult CNS, as during developmental myelination, might 
hamper remyelination in MS. Taken together, these results identify galectin-
4 as a novel regulator of OLG differentiation and therefore myelination and 
warrants further research on underlying mechanisms of galectin-4 actions in 
order to find means to successfully direct remyelination processes under 
pathological conditions as observed in MS lesions. 
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During nervous system development, Sox proteins as transcription factors 
are critically involved in neural cell fate decisions and differentiation 
processes and function in intricate networks where they modulate each 
other’s activity. The SoxD proteins Sox5 and Sox6 are essential 
components of this network in developing oligodendrocytes. We have 
previously shown that Sox5 and Sox6 are co-expressed in uncommitted 
neural precursor cells of the ventricular zone and continue to be present 
after specification in oligodendrocyte progenitors before being 
downregulated during terminal differentiation in myelinating 
oligodendrocytes. In the developing mouse spinal cord, Sox5 and Sox6 
jointly repress oligodendroglial specification and terminal differentiation by 
antagonizing the activating functions of the SoxE proteins Sox9 and Sox10. 
Sox9 is essential for oligodendrocyte specification, whereas Sox10 is 
required for terminal differentiation. In the present study, we focus on the 
role of SoxD proteins in oligodendrocyte lineage progression between these 
events. By analyzing spinal cord and forebrain of constitutive and 
conditional SoxD compound mouse mutants we show that Sox5 and Sox6 
impair immature oligodendrocyte progenitor dispersal by regulating the 
expression of PDGF receptor alpha, an important migratory cue for 
oligodendrocyte progenitors. Our studies thus reveal that SoxD proteins are 
also crucial in immature oligodendrocyte progenitors for maintenance of 
PDGF signaling. As PDGF receptor alpha expression in oligodendrocyte 
progenitors is also dependent on SoxE proteins, SoxD proteins do not 
always antagonize the SoxE function. Some target genes are apparently 
activated by both SoxE and SoxD proteins. 
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Post-transcriptional regulation by microRNAs plays an important role in 
modulating rapid changes in gene expression profile in response to 
extracellular stimuli such as injury. Using microRNA array (Exiqon, Ver-
9.0) analysis on total RNA isolated from uninjured and 24 h post axotomy, 
sciatic nerve distal segments, we identified differentially expressed 
microRNAs stimulated by nerve injury. We show that the expression profile 
of 16 miRNAs changes by more than 50% within 24 h of injury when 
compared with uninjured nerve. The expression profile of a few 
microRNAs was validated by Northern analysis and qRT-PCR. In order to 
examine if the cohort of differentially regulated miRNAs in injury 
coordinately target a group of genes or processes we used miR-Ontology 
database. Data mining analysis revealed 20 target genes with potential 
target sites for all the miRNAs used as constraints. We report genes such as 
QKI, ADCY1, TSC1 and several transcription factors to be regulated by 
these microRNAs, which have been shown to play important roles in 
Schwann cell function. In particular, a correlation between miRNAs 
expression and putative gene targets involved in signaling pathways leading 
to cytoskeletal reorganization, repression of myelination and to initiation of 
de-differentiation of Schwann cells was identified. Comparison of the 
pattern of miRNAs observed in peripheral nerve injury to that reported in 
spinal cord injury reveals that the injury response mechanism in PNS and 
CNS differs in the regulation of certain miRNA population while some 
show similar expression pattern in both systems. 
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Gliotransmitters released by astrocytes can theoretically regulate neural 
circuits, however, the consequence of altered gliotransmission, especially in 
case of the elevated release of gliotransmitters, are largely unknown. In this 
study, we have examined the astrocyte specific disease model mice, which 
are known to be vulnerable to convulsant challenge, to explore why altered 
astrocytic function resulted in altered neural circuit function. 
Electrophysiological approaches using hippocampal slices revealed 
increased long-term potentiation due to the inhibition of GABA inhibitory 
transmission in the model mice. This effect was mimicked by the addition 
of 100 nM adenosine to wild type slices. We found that cultured astrocytes 
from model animals exhibited the increased frequency of ATP release in 
vitro and the level of adenosine in the cerebrospinal fluid was 
approximately 100 nM higher than that of wild type in vivo. Enhancement 
of long-term potentiation in the model mice was blocked by the addition of 
adenosine A1 antagonist, strengthening the idea that the elevated level of 
adenosine inhibited GABA transmission via adenosine receptors. 
Consequently, increase in ATP gliotransmitter release resulted in the 
suppression of inhibitory tone and increase in the excitability of 
hippocampal circuit. 
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Astrocytes play pivotal roles in maintaining normal brain functions. 
MicroRNAs (miRNAs) are posttranscriptional regulators of gene expression 
and have been implicated in cell differentiation and neuronal survival. 
However, the role of miRNAs in regulation of astroglial physiology remains 
unknown. Here we demonstrate that Dicer depletion in cerebellar astrocytes 
results in ataxia gait, massive cerebellar granule neuron apoptosis and 
Purkinje cell degeneration. Transcriptional profiling of pre-symptomatic 
stage cerebella indicates that loss of Dicer may lock the astroglial cells in a 
false reactive astrogliosis status while shutting down important house-
keeping functions, combination of which may lead to neuronal 
degeneration. Therefore our study provides in vivo evidence that miRNAs 
are indispensible regulators of astroglial homeostasis, malfunction of which 
might be involved in neurological disorders such as cerebellar ataxia. 
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Microglia are the immune cells of the brain. In the absence of pathological 
insult, their highly motile processes continually survey the brain 
parenchyma and transiently contact synaptic elements. Aside from 
monitoring, their physiological roles at synapses are not known. To gain 
insight into possible roles of microglia in the modification of synaptic 
structures, we used immunocytochemical electron microscopy (EM), serial 
section EM with three-dimensional reconstructions, and two-photon in vivo 
imaging to characterize microglial interactions with synapses during normal 
sensory experience and sensory deprivation, in the visual cortex of juvenile 
mice. During normal visual experience, most microglial processes displayed 
direct apposition with multiple synapse-associated elements, including 
synaptic clefts. Microglial processes were also distinctively surrounded by 
pockets of extracellular space. In terms of dynamics, microglial processes 
specifically targeted small and transiently growing dendritic spines, which 
were typically lost over two days. Following brief visual deprivation, 
microglial processes changed their morphology, displayed phagocytic 
structures, apposed synaptic clefts more frequently and enveloped synapse-
associated element more extensively. Their associated extracellular spaces 
also became more extended. While microglia became less motile, their 
preference of contact changed to a subset of larger dendritic spines that 
persistently shrank. Taken together, these findings reveal different 
modalities of microglial interactions with synapses that are subtly altered by 
sensory experience. These suggest that microglia may actively contribute to 
the experience-dependent modification or elimination of a specific subset of 
synapses in the healthy brain. 
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Activation of glia is seen in many neurodegenerative diseases including 
prion diseases. Prion diseases are fatal infectious neurodegenerative 
disorders that affect both humans and animals. A key event in the 
pathogenesis is the conformational change of a normal host protein (PrPsen, 
also known as PrPC) into an abnormal, partially protease-resistant, disease-
associated form (PrPres or PrPSc). The specific roles of glia in prion disease 
pathogenesis are still not clear. Activated glial cells produce cytokines as a 
protective response against certain pathogens, and as part of the host 
inflammatory response to brain damage. In addition, cytokines might also 
exacerbate tissue damage initiated by other processes. In the present work 
using multiplex assays to analyze protein levels of 24 cytokines in prion-
infected C57BL/10 mouse brains, we observed elevation of CCL2, CCL5, 
CXCL1, CXCL10, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-6, and IL-12p40. To 
study the role of astroglia and microglia in these cytokine responses, 
primary glial cultures were exposed to prion-infected brain homogenates. 
Microglia produced only IL-12p40 and CXCL10, whereas astroglia 
produced these cytokines plus CCL2, CCL3, CCL5, CXCL1, G-CSF, IL-
1β, IL-6, IL-12p70 and IL-13. PrPres is believed to cause 
neurodegeneration in prion diseases, and may also be involved in 
stimulation of cytokine release by glia. To identify the main stimulant for 
glial cell cytokine release, we fractionated prion-infected brain 
homogenates by decreasing molecular size based on differential 
centrifugation. Surprisingly, the fraction giving the highest glial stimulation 
was devoid of PrPres. Furthermore, purified PrPres was found not to 
stimulate cytokine release by either astroglia or microglia. Future work is in 
progress to identify other stimulators of glial cytokines present in prion 
disease brain. 
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The brain cytochromes P450 (CYP450s) are involved in the metabolism of 
drugs with or without CNS tropism. The toxicity impact of xenobiotics 
varies significantly depending on patients' age due to gene expression 
variability in children and adults. Glial cells dysfunction as well as some 
inflammatory mediators such as endothelin-1 (ET-1) are involved in 
neurodegenerative disorders. Glial cells are potential sources of ET-1 
release in response to cerebral injury. This could be expected in the very 
rare neuroinflammatory Rasmussen's disease (RD). CYP450s gene 
expression was compared in human primary glial cells isolated from brain 
parenchyma samples of 6 pediatric and 20 adults. Then, the in vitro 
modulation of CYP450s gene expression by the effect of ET-1 on primary 
glial cells was compared to CYP450s gene expression in RD patients.  
The mRNA expression of 16 CYP450 genes (CYP1A1, 1A2, 1B1, 2B6, 
2C8, 2C9, 2D6, 2E1, 2J2, 2U1, 3A4, 3A5, 4A11, 4F2, 11B2, 46A1) was 
studied by RT-PCR. These CYP450s are involved in exogenous (i.e. drugs) 
and endogenous substrates (i.e. arachidonic acid) metabolism. The mRNA 
expression profile of 7 transcription factors involved in the regulation of the 
CYP450s pathways (GR, LXRβ, PPARα, PPARγ, CAR, AhR and PXR) 
was also established. Wilcoxon and Spearman tests assessed statistical 
significance. 
Our findings indicate that 8 out of the 16 CYP450s are expressed in human 
primary glial cells of paediatric and adult patients and differences in the 
mRNA expression profiles were found for CYP450s [CYP1B1 (p<0.005), 
3A5 (p<0.005), 2E1 (p<0.001) and 2U1 (p<0.01)] as well as for 
transcription factors (LXRβ, PPARα, AhR) between both groups. In adult 
patients, CYP3A5 and 2E1 mRNA expression was correlated with AhR 
expression (p<0.01), while CYP2U1 mRNA expression was associated 
with GR, LXRβ, PPARγ and CAR (p<0.05), PPARα (p<0.001) expression. 
We demonstrated that exposure of human primary glial cells to ET-1 
downregulates CYP1B1, 3A5 and 2E1 mRNA. Findings on mRNA 
CYP2U1 expression tend to show an up or down regulation depending on 
ET-1 high or low concentrations, consistent with the CYP2U1 mRNA 
expression observed in glial cells isolated from RD patients. 
This is the first study highlighting CYP450s mRNA expression differences 
in human glial cells during brain development and pointing to the putative 
physiological impact of CYP2U1 in neuroinflammatory diseases. 
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Polyploidy is a widely used strategy in plants and animals to increase cell 
size, and the resulting increase in gene templates may facilitate robust gene 
expression. Through the examination of nuclear DNA content in situ, we 
found that the subperineurial glial cells of Drosophila melanogaster are 
polyploid. This demonstration of polyploid glial cells in the adult brain 
parallels previous observations that the surface glia in the larval ventral 
nerve cord (VNC) undergo DNA replication without cell division (1). 
However, the role of polyploidy in these glia is not known. Given that glial 
morphogenesis and its function in the mature nervous system are similar in 
Drosophila and vertebrates, elucidating the function of endoreplication of 
the Drosophila glia could provide a valuable comparative study towards the 
understanding of glia in both Drosophila and vertebrates. 
 
To define the function of glial polyploidy in Drosophila, we constructed a 
strain in which DNA replication can be blocked specifically in the 
subperineurial glia when they are undergoing endoreplication. We find that 
when DNA replication and polyploidy are inhibited in the subperineurial 
glia, larval lethality occurs. Current experiments are directed towards 
defining the impact of reduced ploidy on the function of these glial cells. 
 
 
References 
 
1) Prokop, A. and Technau G.M., Roux’s Arch Dev Biol (1994) 204:54-61 
 107 
PROTEOMIC ANALYSIS OF SIGNALING PROCESSES IN 
GLIOBLASTOMA CELLS SUBJECTED TO SUB-LETHAL 
PHOTODYNAMIC TREATMENT 
 
Anatoly B Uzdensky1,2, Asta Juzeniene2, Johan Moan2  
 
1Southern Federal University, Biophysics and Biocybernetics, Rostov-on-
Don, 344090, Russia, 2Institute for Cancer Research, Radiation biology, 
Oslo, 0310, Norway 
 
Numerous signalling processes in control cell responses to oxidative stress 
induced by photodynamic treatment (PDT). The Panorama Ab Cell 
Signaling Microarray (Sigma-Aldrich) contains antibodies against 224 
proteins involved in cell signalling, cell cycle, apoptosis, cytoskeleton, etc. 
We used it for the study of sub-lethal effect of 5-aminolevulinic acid-
mediated PDT (1 mM, 1 hour incubation, 1 min 410 nm irradiation; 95% 
cell survival) on cultured glioblastoma D54Mg cells in order to explore the 
processes occurring at the initial cell response stage. Such treatment 
induced diverse biochemical changes. The phosphorylation of adhesion-
related signaling proteins FAK and Pyk2 was especially high. The 
phosphorylation of Raf, a central component of the Ras/Raf/MEK/ERK 
pathway, and the expression of protein kinase C were also observed. 
Increase in the expression of microtubule protein MAP-1beta, the 
phosphorylation of microtubule-associated protein tau, and simultaneous 
down-regulation of dystrophin, vinculin, MAP2, and cytokeratins reflect 
cytoskeleton reorganization probably associated with changes in cell 
adhesion. The level of proteins regulating cell cycle was also changed. At 
30 min after PDT, the levels of cyclin D1, c-Myc, checkpoint proteins chk1 
and chk2 were reduced that could arrest G0/G1, G1/S and G2/M transitions. 
At 1 hour after PDT cyclins A and D3, protein kinases cdk6 and cdc27 were 
down-regulated. This could also delay G0/G1, G1/S and G2/M transitions. 
However, simultaneous increase in cyclin D1, transcription factors E2F1 
and Smad4 could facilitate G0/G1 and G1/S transitions. We also observed 
up-regulation of anti-apoptotic protein Bcl-xL and simultaneous decrease in 
the level of caspase 9 promoting apoptosis that have demonstrated the 
protective cell response. Neuro-specific proteins S100-beta, CNPase and 
increase in the expression of beta-synuclein and proapoptotic NGF receptor 
p75 were down-regulated. Thus, the complex response of glioblastoma cells 
to sub-lethal PDT treatment included dynamic changes in the expression of 
signaling proteins associated with cell adhesion and cytoskeleton 
reorganization, cell cycle control and apoptosis. Supported by RFBR grant 
No 08-04-01322 and Minobrnauki RF grant No 2.1.1/6185. 
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In order to explore neuroglial relationships in a simple nervous system, the 
ultrastructure of crayfish stretch receptor (CSR) that consists of only two 
mechanoreceptor neurons (MRN) enveloped by glial cells (GC) was 
studied. After isolation and control registration of neuron firing the 
preparations were fixed by glutaraldehide, stained with OsO4 and uranyl 
acetate, embedded into an epon, and studied with the electron microscope 
Tecnai Spirit 12 (Phillips, Netherlands). MRN envelope consists of 10-30 
glial layers separated by collagen. Intercellular space is usually no more 
than 10-15 nm width that facilitates diffusion between these cells but limits 
MRN communication with the external medium. Microtubule bundles 
passing from dendrites to axon form the fibrillar envelope around the 
neuron perikaryon, which reduces vesicular transport to the plasma 
membrane and glial cells. Numerous glial protrusions into the neuron 
cytoplasm up to 1 μm deep shorten the diffusion pathway between GC and 
MRN perikaryon through the fibrillar layer. The neuron cytoplasm also 
contains double-wall vesicles, which may represent the captured parts of 
these protrusions. They contain fragments of glial but not neuronal 
cytoplasm. Specific structural triads consisting of flattened submembrane 
cisterns, vesicles and mitochondria are present in the peripheral neuron 
regions contacting to glial cells. These triads are presumably involved in 
formation of invaginations in the neuronal membrane and double-wall 
vesicles. They are typically associated with these structures and presumably 
participate in the neuroglial exchange. The tubular lattice in glial cells can 
participate in the transfer of ions and metabolites between glial layers. In 
some places the integrity of neuroglial membranes is impaired but free 
neuroglial passage is prevented by the dense diffuse material accumulated 
in these regions. Thus, the neuroglial exchange with some cell components 
may be mediated by diffusion through glial protrusions and submembrane 
cisterns, by formation of double-walled vesicles, in which big glial masses 
are captured, and by transfer through tubular lattices.  
Supported by RFBR grant No 08-04-01322 and Minobrnauki RF grant No 
2.1.1/6185.  
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Demyelinating diseases, such as multiple sclerosis (MS), are characterized 
by trauma to the myelin membrane and oligodendrocytes. Whereas 
demyelination impedes nerve conduction, ultimate failure of remyelination 
by oligodendrocytes leads to neurodegeneration. An altered 
microenvironment, as a result of chronic inflammation, likely contributes to 
remyelination failure. For example, the extracellular matrix molecule 
fibronectin (Fn), which is virtually absent in healthy adult CNS, 
accumulates in MS lesions, and inhibits myelin-like formation in vitro. Our 
recent findings indicate that also in a healthy environment plasma and 
astrocyte-derived Fn accumulate in demyelinated lesions, however, and in 
contrast to MS lesions, Fn is subsequently cleared upon remyelination. The 
underlying mechanism of persistent Fn expression in MS lesions appears to 
be astrocyte-mediated Fn aggregation, which might render Fn more 
resistant to proteolytic degradation.  
Our current research focuses on the underlying mechanism(s) of Fn 
aggregation. As a model for micro-environmental changes induced by 
inflammation, the role of various cytokines and TLR agonists on astrocyte-
mediated Fn aggregation are examined. Furthermore, the contribution of 
plasma Fn , as well as the role of astrocyte-derived Fn splice variants is 
determined. In parallel, the effect of the different Fn matrixes on myelin like 
membrane formation is analyzed. Evidently, knowledge on the underlying 
mechanism of Fn aggregation, will add to our understanding of 
remyelination failure in MS lesions.  
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Unilateral axotomy of the magnocellular hypothalamo-neurophypophysial tract 
(HNT) results in an initial period of axonal degeneration followed by collateral 
sprouting of uninjured axons resulting in the restoration of the neurosecretory 
axonal density within the rat neurohypophysis (NH) to normal values by 30 
days post-lesion. However, the specific factors that initiate and maintain axonal 
sprouting of magnocellular neurons remain ill-defined. In this regard, we have 
reported previously that partial denervation of the rat NH results in a significant 
increase in the number of perivascular cells immunoreactive for ciliary 
neurotrophic factor (CNTF). Furthermore, this increase was sustained 
throughout the period during which axonal sprouting of magnocellular 
neurosecretory axons occurs. Magnocellular neurons express CNTF receptor 
alpha and this expression is upregulated during the sprouting event, concurrent 
with the increase in CNTF-immunoreactive perivascular cells. Therefore, we 
hypothesized that CNTF derived from phagocytically-active perivascular cells 
acts as a target derived sprouting factor. However, a causal link between 
phagocytic activity and increased CNTF expression has not yet been 
established. Therefore, in the present study, we sought to; 1) establish a link 
between phagocytic activity and the up-regulation of CNTF by perivascular 
cells; 2) identify whether or not perivascular cells are neuronophagic in the 
injured MNS and, 3) further characterize the immunophenotype of perivascular 
cells in the NL following endogenously and exogenously induced phagocytic 
activity. We used unilateral lesion of the HNT and LPS injections to induce 
neuronophagic and phagocytic activity, respectively. Subsequent dual label 
immunoperoxidase experiments revealed an increased co-localization of CNTF 
and ED1 immunoreactive profiles within phagocytically active perivascular 
cells. In contrast, phagocytically active OX-42-immunoreactive microglial cells 
were not immunoreactive for CNTF, but were immunoreactive for CD4, ED1, 
interleukin 1 beta, and MHC I and II. The participation of perivascular cells in 
the process of neuronophagia was determined by iontophoretic injection of Mini 
Ruby (MR) resulted in anterograde labeling of neurosecretory axons. Following 
unilateral lesion of the HNT, MR labeled neurosecretory axons degenerated into 
small fluorescent granules. Subsequent dual immunofluorescence labeling 
revealed incorporation of these small MR fluorescent granules within CNTF-
immunoreactive perivascular cells. Taken together, our results provide novel 
evidence for a link between neuronophagia and CNTF upregulation by 
perivascular cells indicating their role in providing trophic support of neuronal 
sprouting in the magnocellular neurosecretory system. 
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Kynurenic acid (KYNA) has been implicated in the pathophysiology of 
schizophrenia. Elevated levels of KYNA that have been reported in the 
prefrontal cortex and CSF of schizophrenia patients could produce altered 
glutamatergic and/or cholinergic transmission and negatively affect 
cognition. Kynurenic acid (KYNA) is produced by the irreversible 
transamination of L-kynurenine, by the action of multiple kynurenine 
aminotransferases (KATs). KAT II, present in astrocytes, is responsible for 
the majority of KYNA synthesis in the brain. Therefore, an inhibitor of 
KATII may provide may provide a therapeutic benefit to the cognitive 
deficits in schizophrenia. Screening strategy for our KATII program 
includes a high throughput whole cell assay in 96 well format to confirm 
potencies from our primary purified enzyme assay. The whole cell assay 
utilizes the human hepatocellular carcinoma cell line HEPG2 which 
expresses high levels of KAT II. The assay demonstrates KYNA 
accumulation over time and is responsive to L-kynurenine concentration in 
agreement with the literature. We have also optimized a whole cell assay in 
primary human hepatocytes and primary human astrocytes, the target cells 
in the brain. In addition, we have developed a robust, rapid, and sensitive 
LC/MS/MS analytical method for KYNA to support this assay. Our KAT II 
inhibitor has an IC50 of 28 nM in HEPG2 cells, 49nM in primary human 
hepatocytes, and 50 nM in primary human astrocytes. This assay allows us 
to compare potencies across multiple cells types and in several different 
formats. The whole cell assay for KAT II inhibitors has proven a valuable 
second tier screening platform to help drive compound selection for the 
KAT II program  
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Peripheral nerve myelin allows rapid impulse conduction and normal nerve 
homeostasis, and mutations affecting a variety of its constituents cause 
neuropathies. However, knowledge of myelin protein composition has 
remained sketchy. Combining gel-based and gel-free proteomic approaches 
we have identified 545 proteins in purified sciatic nerve myelin, including 
38 known myelin proteins. By mass spectrometry-based quantification, P0, 
periaxin, and myelin basic protein constitute 21%, 16%, and 8% of total 
myelin protein, respectively. We suggest that their relative abundance was 
previously misestimated due to limitations regarding protein separation and 
visualization, and that the variety of myelin proteins is much larger than 
assumed. For validation that novel myelin constituents have been identified 
using this strategy, we have selected several of them for further 
characterization by immuno-based methods. Proteins that may stem from 
fraction contaminations such as blood cells or mitochondria were 
determined by bioinformatical comparison with mRNA abundance profiles 
and predicted subcellular localizations. Neuropathy candidate genes were 
suggested based on a systematic comparison of the positions of the 
corresponding genes in the human genome with neuropathy disease loci. 
Our compendium of integrated proteome, transcriptome, and genome data 
constitutes a versatile resource for further understanding of myelin 
biogenesis and metabolism, glia-axonal interactions, and hereditary 
neuropathies. 
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Epigenetic mechanisms regulate mature oligodendrocyte differentiation 
from oligodendrocyte precursor cells (OPCs). Histone deacetylation plays a 
critical role in this process and is regulated by the activity of histone 
deacetylases and histone acetytransferases. In this study we show that 
during oligodendrocyte progenitor differentiation, there is a progressive 
reduction of nucleus size, which is coupled with progressive chromatin 
compaction, as defined by electron microscopy. The profiles of histone 
deacetylation (AcH3K9 and AcH3K18) correlate with the nuclear size 
changes. Using lentiviruses to silence HDAC1, we define the critical role of 
this enzyme in chromatin compaction. Silencing HDAC1 prevents the 
nuclear size changes, and the deacetylation of AcH3K9 and AcH3K18. 
Conversely, silencing histone acetytransferases (i.e. PCAF) promotes 
oligodendrocyte differentiation and up-regulation of myelin basic protein 
(MBP) gene expression. These findings indicate that the equilibrium 
between histone deacetylases and histone acetytransferases initiates 
chromatin changes, leading to nuclear compaction and oligodendrocyte 
differentiation. 
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We developed a novel technique, coined pial loading, to reveal a cellular 
coupling network mediated by gap junctions (GJ) involving RG cells in the 
subventricular zone (SVZ), an important postnatal neurogenic niche. During 
the first postnatal week (P0, P4 and P6), widespread dye coupling is 
observed within the SVZ, as revealed by direct loading of ruptured pial 
processes of RG with a mixture of GJ permeant (0,5% lucifer yellow 
443Da, LY) and non permeant (0,5% rhodamine dextran 3KDa, RD) 
fluorochromes. Coupled cells (LY+RD-) were distributed in two strata, one 
lining the lateral ventricle and the other at the SVZ/WM (white matter) 
border. RG mediated cell coupling diminishes when animals were 
intraventricular injected with the pharmacological gap junction blocker 
flufenamic acid (FFA; 100µM) (control: 1.767± 0.0456 mean ± SEM; FFA: 
1.187± 0,01331 mean ± SEM; p value<0.0001; Mann Whitney test; n=9 
animals, 3 independent experiments). Exclusively LY labeled cells express 
a glial immunophenotypic profile (BLBP+; GFAP+; Nestin+; TuJ1-), 
suggesting restricted homocellular coupling networks. We also analyzed the 
expression of connexins (Cxs) 43 and 45 in the SVZ/RMS (rostral 
migratory stream), as well as by its major cell types. RG and 
neuroblasts/immature neurons were revealed by Cell Tracker Red™ 
(CMTPX; 10mM) injections at the pial surface or directly into SVZ. 
Although presented in both neuronal and glial cell types, Cx43 and Cx45 
levels seemed inversely related, with Cx45 prevailing in neuroblasts. To 
further discriminate single cell expression we dissociated the SVZ, 
separating the cortical (SVZc) and olfactory bulb (SVZb) regions, acute 
plated on Matrigel (15µM) and performed immunohistochemical assays. 
Double labeling with major SVZ cell phenotypic markers (TuJ1, PSA-
NCAM, GFAP and BLBP) and Cxs showed that all cell types express Cxs 
similarly. The percentage of SVZb cells expressing Cx45 (91.90 ± 1.33 
mean ± SEM) is significantly greater than in SVZc (87.48 ± 1.56; p 
value=0.03; Unpaired t test; 48 fields, n=9 animals, 3 independent 
experiments). In contrast, no significative difference is observed for Cx43 
expression (94.23 ± 0.79 and 92.52 ± 1.07; p value=0.20). Together, these 
results demonstrate the expression of connexins and GJ cell coupling in the 
neonatal SVZ/RMS, suggesting an important role of these proteins on cell 
migration and to the proliferative capacity in this notable neurogenic region. 
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In Drosophila and vertebrates, peripheral nerves share similar structures. 
Axons are centrally located and are wrapped by membrane processes from 
wrapping glial in fruitfly and Schwann cells (SCs) in vertebrates. The axons 
and inner glial cells are subsequently surrounded by superficial cellular 
layers, the Drosophila subperineurial and perineurial glia and vertebrate 
perineurial cells. Non-cellular layers composed of ECM components are 
formed on the surface of nerves, which are the Drosophila neural lamella 
and vertebrate epineurium respectively. A tubular sheath is established 
around axons by these glial cells and surrounding extracellular matrix and 
protects axons from physical damage and pathogens. Adhesion and 
interactions with the ECM is mediated in part by different integrin 
complexes. ECM-integrins interactions have been shown to play a role in 
the development of vertebrate glial layers and have diverse functions 
including: migration of neural crest cells, radial sorting and myelination of 
Schwann cells. However the identify and role of integrin complexes in the 
other classes of vertebrate glia and in the equivalent glial layers of the 
Drosophila peripheral nerve has not been determined. Here we show that 
Drosophila αPS2βPS1 and αPS3βPS1 integrins are expressed in different 
glial layers in the larval peripheral nerves. These integrins are located to 
cytoplasm membrane and form adhesion complexes with ILK and Talin. 
Inducible RNA interference technique was employed to knock down 
integrin expression specifically in glial cells and more importantly in 
specific glial subtypes. Expression of βPS1 RNAi in all glial cells results in 
animal lethality and glial defects. Specifically, induction of βPS1 RNAi in 
perineurial glia gives wrapping failure, which is phenocopied by 
degradation of neural lamella. Knocking down of βPS1 integrin in wrapping 
glia causes loss of membrane processes around axons. Our data suggest that 
integrin complexes are employed in different glial layers to mediate 
formation of glial ensheathment in larval peripheral nerves. 
 116 
SCULPTING CIRCUITS AND CLEANING UP MESSES: GLIAL CRK-
II/DOCK-180/ELMO REGULATE AXON PATHFINDING DURING 
DEVELOPMENT, AND CLEARANCE OF DEGENERATING AXONS 
FROM THE ADULT BRAIN. 
 
Jennifer S Ziegenfuss, Johnna Doherty1, Marc R Freeman  
 
UMass Medical School/HHMI, Neurobiology, Worcester, MA, 01605 
 
We are exploring molecular mechanisms how glia sense and respond to 
acute brain injury in Drosophila. Fly glia rapidly respond to axotomy by 
extending membranes to degenerating axons and phagocytosing axon 
debris. In draper (MEGF-10/Jedi) null mutants, glia fail to respond to axon 
injury: glial membranes are not recruited to degenerating axons, and axon 
debris persist in the CNS. During cell corpse engulfment in C. elegans, the 
CED-1/Draper pathway functions partially redundantly with a second 
pathway, which includes the Rac guanine nucleotide exchange factor (GEF) 
CED-2/CED5/CED-12 (CrkII/Dock-180/Elmo). Loss of either pathway 
partially suppresses cell corpse engulfment, but loss of both completely 
blocks clearance. Here we show that the Draper pathway and CrkII/Dock-
180/Elmo complex are essential, non-redundant signaling pathways that 
promote clearance of degenerating axons.  
 
We find that severed axons linger in the CNS for weeks after axotomy in 
draper mutants, indicating that Draper is absolutely essential for all axon 
clearance, and arguing against the presence of a redundant second pathway. 
In addition, we find that glial-specific knockdown of any component in the 
CrkII/Dock-180/Elmo complex suppresses clearance of degenerating axons, 
with axons lingering in the CNS for weeks after injury. Interestingly, each 
of these signaling pathways plays a unique functional role during clearance. 
While Draper is essential for the recruitment of glial membranes to severed 
axons (above), loss of CrkII/Dock-180/Elmo function, in contrast, does not 
affect the recruitment of glia to degenerating axons: glial membranes still 
accumulate on severed axons, remain on axons for ~5 days, and appear to 
leave the injury site. Thus, recruitment of glial membranes to sites of injury 
in the brain and phagocytosis of axon debris are genetically separable 
events, with Draper signaling modulating the former and CrkII/Dock-
180/Elmo regulating the latter.  
 
Surprisingly, we also found that glial-specific loss of CrkII/Dock-180/Elmo 
during development resulted in striking defects in axon pathfinding. Cell 
type and temporally-controlled RNAi, as well as conditional blockade of 
endocytosis, demonstrated a pivotal role for these genes in glia at the 
precise time when axons are projecting to their target sites. We are currently 
exploring whether axon wiring defects arise from defective phagocytic glial 
signaling during this stage, or whether this represents a novel (i.e. non-
engulfment) role for CrkII/Dock-180/Elmo in glia during axon pathfinding. 
 117 
CELLULAR AND MOLECULAR REGULATION OF THE BLOOD-
BRAIN BARRIER 
 
Richard Daneman  
 
UCSF, Anatomy, San Francisco, CA, 94143 
 
Vascular endothelial cells in the central nervous system (CNS) form a 
barrier that restricts the movement of molecules and ions between the blood 
and the brain. This blood-brain barrier (BBB) is crucial to ensure proper 
neuronal function and protect the CNS from injury and disease. Although 
the properties of the BBB are manifested in the endothelial cells, 
transplantation studies have demonstrated that the BBB is not intrinsic to 
the endothelial cells, but is induced by interactions with the neural cells. 
Here we use a genomic, genetic and molecular approach to elucidate the 
cellular and molecular mechanisms that regulate the formation of the BBB. 
We have developed methods to highly purify and gene profile endothelial 
cells from different tissues, and by comparing the transcriptional profile of 
brain endothelial cells with those purified from the liver and lung, we have 
generated a comprehensive resource of transcripts that are specific to the 
BBB forming endothelial cells of the brain. Through this comparison we 
have identified novel tight junction proteins, molecular transporters, 
metabolic enzymes, signaling components, and unknown transcripts that are 
expressed specifically by CNS endothelial cells. This analysis has identified 
that Wnt/beta-catenin signaling is critical for BBB formation. 
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The blood-brain barrier (BBB) plays a crucial role in insulating the nervous 
system against the surrounding hemolymph and is established by surface 
glia during embryonic development in Drosophila. We have previously 
identified Moody, a novel G protein-coupled receptor (GPCR), as a key 
factor in the development and maintenance of the BBB. However, the 
precise mechanism underlying GPCR signaling during BBB development 
has remained unclear. Here we show that cAMP-dependent protein kinase 
(PKA), a major effector of cAMP, is required for the insulation of the 
nervous system and plays a critical role in the Moody signaling pathway. At 
the cellular level, PKA not only regulates cell shape by reorganization of 
the actin and microtubule cytoskeleton, but also affects the expression and 
proper localization of SJ components to the interface with neighboring 
surface glia, which are required for effective insulation. Strikingly, the PKA 
catalytic subunit DC0 shows highly polarized localization in the surface 
glia, and both over- and underactivity of PKA result in severe insulation 
defects, indicating that the cAMP/PKA pathway produces a local signal 
within the cell. Our study demonstrates a novel role of cAMP/PKA 
signaling in the regulation of the intercellular SJ organization that generates 
BBB integrity, and provides new insights into the molecular and cellular 
mechanism of Moody-regulated BBB development and maintenance. 
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Neural stem cells are intimately associated with capillary endothelial cells 
in the lateral ventricle walls of the CNS. Functionally, members of the 
vascular endothelial growth factor (VEGF) family can stimulate 
neurogenesis as well as angiogenesis, but it remains unclear if they act 
directly via VEGF receptors expressed by neurons, or indirectly via release 
of growth factors from angiogenic capillaries. Here, we show that the 
lymphangiogenic receptor VEGFR-3 is expressed by slowly dividing type B 
neural stem cells in the adult subventricular zone (SVZ) and is required for 
postnatal neurogenesis. Neurosphere assays and adeno-associated virus 
(AAV)-mediated VEGF-C overexpression in the adult SVZ promote SVZ 
cell survival. Finally, neural-specific Vegfr3 deletion using a Cre/lox 
approach impairs SVZ and olfactory bulb neurogenesis, without affecting 
angiogenesis. Thus, neural stem cells in the postnatal forebrain require 
VEGF-C/VEGFR-3 signaling, demonstrating that this lymphangiogenic 
growth factor-receptor system is essential for murine CNS neurogenesis.  
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The neuronal doctrine, developed a century ago, regards the neuronal 
networks as a sole substrate for the higher brain function. Recent advances 
in glial physiology promoted an alternative hypothesis, which places 
information processing in the brain into the integrated neuronal-glial 
circuitries that utilize both binary (neuronal action potentials) and analogue 
(glial Ca2+ waves) signal encoding. The feed-forward and feed-back 
communications between two cellular circuits are accomplished by the 
release of neuro- and gliotransmitters that are believed to control 
information transfer and processing. There remain, however, important 
questions and controversies that need further probing.  
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We have investigated the roles of connexin32 (Cx32) and Cx47 in 
oligodendrocyte:astrocyte (O:A) coupling by whole-cell patch clamp 
studies in acute brain slices from P15-P32 Gjb1/Cx32-null, Gjc2/Cx47-null 
mice, Gjb1- // Gjc2-double-null mice, or their littermates. Because the Egfp 
gene had been “knocked into” the Gjc2 locus, oligodendrocytes could be 
directly visualized owing to their expression of EGFP. EGFP-positive cells 
were patched with an electrode containing 0.1% Sulforhodamine-B (SR-B), 
and the dye was allowed to diffuse for 20 minutes, then the section was 
analyzed optically to determine whether nearby EGFP-positive and/or –
negative cells were labeled by SR-B.  
• In the corpus callosum of Gjb1+/+ // Gjc2+/- mice, SR-B labeled EGFP-
positive cells (but not EGFP-negative cells); in the neocortex, SR-B labeled 
EGFP-positive and -negative (presumed to be astrocytes) cells.  
• In the corpus callosum of Gjb1-/- // Gjc2+/- mice, SR-B did not label 
EGFP-positive cells (or EGFP-negative cells); in the neocortex, SR-B 
labeled EGFP-positive and -negative cells.  
• In the corpus callosum of Gjb1+/+// Gjc2-/- mice, SR-B labeled EGFP-
positive cells (but not EGFP-negative cells); in the neocortex, SR-B did not 
label EGFP-positive or -negative cells.  
• In the corpus callosum and the neocortex of Gjb1-/- // Gjc2-/- mice, SR-B 
did not label EGFP-positive or -negative cells.  
These data demonstrate that O:A coupling is mediated by Cx47 in the 
neocortex, and suggests that Cx32 may mediate O:O coupling in the corpus 
callosum. The loss of O:A and possibly O:O coupling could be the basis of 
the severe myelinopathy in Gjb1- // Gjc2-double-null mice, which are an 
animal model of Pelizaeus-Merzbacher-like disease of humans.  
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Approximately one in 20 Americans will suffer from depression in a given 
year, and one in 10 Americans will suffer from major depression at least 
once in their lifetime. Current pharmacological treatments take weeks for 
efficacy limiting the ability to bring instant relief to suicidal patients. One 
non-pharmacological intervention that rapidly alleviates symptoms of 
depression is sleep deprivation (SD) for one or more nights. This treatment 
is effective in approximately 60% of all depressed patients, and in about 
70% of those patients diagnosed with “endogenous” depression. In stark 
contrast to pharmacological agents, SD produces a rapid improvement in 
mood. The mechanism by which SD can produce these rapid and dramatic 
improvements in depressive symptoms remains unknown. 
Recent work in our laboratory has discovered that astrocytes regulate 
behavioral responses to SD including changes in NREM slow wave activity 
as well as increased sleep time and cognitive impairments that follow SD. 
The conditional expression of the SNARE domain of the vesicle protein 
VAMP2 within astrocytes reduces the extracellular adenosine level as 
assessed by changes in the tonic activation of neuronal A1 receptors. This 
reduced activation of A1 receptors leads to a reduction in the pressure to 
sleep as well as reduced responses to SD. We have asked whether this 
astrocytic modulation of the sleep homeostat contributes to anti-depressive 
effects of a total night of SD. 
C57Bl/6J mice, the genetic background of dnSNARE mice, are considered 
to exhibit depressive-like behaviors as measured in two models of 
behavioral despair. A total night of SD produces a robust reduction of 
murine depressive-like behaviors as measured by immobility time in both 
the tail suspension test (TST) and forced swim task (FST) models of 
depression. Inhibition of the glial sleep homeostat by astrocytic dn-SNARE 
expression prevents SD changing immobility times suggesting that the 
SNARE-sensitive accumulation of adenosine mediates these anti-
depressive-like actions. This hypothesis is supported by the observation that 
the beneficial effects of SD are prevented in A1R-/- mice, and in mice 
treated with the A1 receptor antagonist cyclopentyltheophylline (CPT; 
4mM in osmotic mini-pump). These data suggest that the beneficial effects 
of SD are mediated by a glial-dependent adenosine A1R pathway and 
provides a unique opportunity to develop novel, fast acting therapeutic 
strategies to treat depression. 
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Although the effect of neuronal activity on astrocytic function is well 
documented, it remains unclear whether or how astrocytes influence 
neuronal circuit function. We have explored potential circuit-wide effects of 
astrocytes and investigate how astrocytic activity affects coherent neuronal 
activity in a cortical mouse slice, using UP states as a measure of neuronal 
synchronization. We use simultaneous whole-cell patch clamping of 
neurons and astrocytes, and find that cortical astrocytes become depolarized 
during UP states, with an amplitude that is correlated with the duration of 
the UP states in the neurons. Further, we depolarize individual astrocytes 
and observe that this depolarization increases the probability that neurons in 
the circuit will undergo an UP state transition. We also use two-photon 
microscopy to visualize calcium dynamics in astrocytic networks, and find a 
significant increase in calcium transients in surrounding astrocytes when a 
single astroycte in the syncytium is depolarized. In addition, spontaneous 
and evoked astrocytic calcium transients tend to precede UP states, and 
blocking these transients significantly reduces the number of UP states we 
observe, demonstrating that calcium increases throughout the astrocytic 
network are causally linked to the subsequent UP state. These experiments 
indicate that astrocytic stimulation can trigger synchronized neuronal 
activity in cortical circuits. 
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The active role that astrocytes play in brain development and function have 
been brought to the forefront by several seminal studies in recent years. 
Despite these advances, however, many fundamental properties of 
astrocytes still remain a mystery. In order to answer these questions, we 
have developed a novel immunopanning method to purify relatively mature 
postnatal astrocytes from P7 to P14 rodent forebrains. We found that these 
highly purified astrocytes rapidly undergo apoptosis in culture. We 
analyzed their gene profiles to determine which signalling receptors were 
highly expressed, and then screened their cognate ligands to identify one 
trophic factor that is sufficient to strongly promote their survival in a 
defined, serum-free media. We have validated that the gene profile of these 
astrocytes in culture is close to that of acutely purified astrocytes, and thus 
more representative of the in vivo state than the previous McCarthy-de 
Vellis method of preparing and culturing neonatal astrocytes. By studying 
co-cultures of neurons and astrocytes, we show that these astrocytes 
strongly promote neuronal survival and synapse formation. Together, the 
data suggests that we have developed a culture system that is more 
representative of the in vivo state and will be helpful for future in vitro 
studies of neuron-glial interactions and astrocyte function. 
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Although reactive astrogliosis is a ubiquitous feature of the CNS response 
to all forms of injury and disease, until recently this response has been 
poorly defined and its mechanisms poorly understood. Genetic tools are 
now enabling the molecular dissection of the functions and mechanisms of 
reactive astrogliosis in vivo. This presentation will examine findings from 
our and other laboratories indicating that reactive astrogliosis is a complex, 
multifaceted process comprising numerous potential cellular and molecular 
changes with a wide range of potential effects regulated by different 
signaling molecules. It is now clear that reactive astrogliosis is not a simple 
all-or-none phenomenon but is a finely gradated continuum of changes that 
occur in context dependent manners regulated by specific signaling events. 
These changes range from reversible alterations in gene expression and cell 
hypertrophy with preservation of cellular domains and tissue structure, to 
long lasting scar formation with rearrangement of tissue structure. Although 
reactive astrocytes have often been regarded as uniformly detrimental to 
clinical outcome, it is now clear that reactive astrogliosis, including scar 
formation, can exert both beneficial and detrimental effects in a context-
dependent manner determined by specific molecular signaling cascades. In 
addition, increasing evidence points towards the potential that reactive 
astrogliosis may play either primary or contributing roles in a wide variety 
of CNS disorders via loss of normal astrocyte functions or gain of abnormal 
effects. A better understanding of astrocyte signaling mechanisms and the 
mechanisms of reactive astrogliosis has the potential to open the door to 
identifying molecules that might serve as novel therapeutic targets for a 
wide range of neurological disorders. 
 
For recent reviews see: 
Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial 
scar formation. Trends Neurosci 32:638-647. 
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta 
Neuropathol 119:7-35. 
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Glaucoma is a neurodegenerative disease affecting 70 million worldwide. 
Vision loss in glaucoma is caused by the death of retinal ganglion cells (RGCs). 
Studies in humans and primates established that early damage occurs to RGC 
axons in the lamina cribrosa, located at the optic nerve head (ONH). The lamina 
cribrosa is comprised of extracellular matrix (ECM) plates that are lined with 
astrocytes. Mice do not have an ECM-based lamina, but do have a similar 
robust network of astrocytes. We provided the first functional evidence that an 
early insult occurs to RGC axons at the ONH in DBA/2J mice, a widely used 
mouse model of glaucoma. Although RGCs are the most susceptible to damage, 
changes also occur to glial cells including astrocytes, microglia and Muller glia. 
Astrocytes and Muller glia become gliotic and responding microglia accumulate 
at the junction of myelination in the optic nerve. Currently, it is not clear what 
the molecular changes are that underlie these morphological changes in glial 
cells, or whether targeting these changes will be beneficial.  
 
To identify molecular events in glaucoma, we used microarray-generated gene 
expression data and a series of clustering methods to identify early stages of 
glaucoma in both the ONH and retina in DBA/2J mice. Our methods 
successfully subdivided eyes with no detectable glaucoma by conventional 
assays into molecularly defined stages of disease. Events identified as early 
include (i) upregulation of ECM-receptor interactions in the ONH, (ii) 
upregulation of pro-inflammatory cytokines in the ONH and retina, (iii) 
complement activation in ONH and retina and (iv) Endothelin-2 upregulation in 
retina. Immunohistochemistry and RNA in situ hybridization shows these 
events are occurring in different populations of glial cells. Since targeting early 
changes is likely to provide effective new treatments, we are testing the efficacy 
of manipulating pathways that we have found to change early in the disease. 
Targeting pro-inflammatory cytokines by administering anti-inflammatory 
drugs does not significantly protect DBA/2J eyes from glaucoma. In fact, they 
appear to make glaucoma worse under certain conditions. To assess the 
complement cascade, we generated DBA/2J mice with a mutation in the 
complement component 1a gene (C1qa) and importantly, these mice develop 
substantially less glaucoma than wild–type littermates.  
 
Our successful implementation of clustering methodologies to discover early 
events in an inherited, later-onset, complex glaucoma suggests that similar 
approaches will prove valuable for uncovering early processes in other diseases 
and for identifying novel therapeutic targets. 
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Amyotrophic Lateral Sclerosis (ALS) is a result of the selective dysfunction 
and progressive degeneration of motor neurons. Although the underlying 
disease mechanisms remain unknown, recent in vivo and cell culture 
experiments have implicated glial cells in motor neuron degeneration in 
ALS.  
We have made use of the SOD1 mouse model of ALS to study the effect of 
glial cells bearing the mutant SOD1 transgene on motor neuron viability in 
cell culture. Specifically, we have studied the gene expression profiles of 
co-cultured mouse embryonic stem (ES) cell derived motor neurons and 
primary glia using the Illumina deep sequencing platform (RNAseq). In this 
study, we vary both the genotype of the motor neurons and glia, as well as 
time in culture as a means of examining both cell autonomous and non-cell 
autonomous effects of the mutant transgene. In addition, we carry out 
parallel studies with spinal cord samples from mutant and wildtype SOD1 
mice, and compare both the in vivo and in vitro derived data sets with laser 
capture microdissection studies of both the ALS mouse model and human 
ALS patient samples.  
We have detected significant cell autonomous and non-autonomous changes 
in gene expression in both motor neurons and glia, indicating that the two 
cell types profoundly affect each other’s gene expression. In addition, we 
find a remarkable concordance between the different data sets mentioned 
above, thus validating the in vitro approach. We are currently analyzing 
these data sets to identify changes in the expression of specific genes and 
signaling pathways that may contribute to motor neuron degeneration in 
ALS. 
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Cancer is a disease of genetic mosaicism. “Mosaicism” as a genetic term 
describes the phenomenon that cells within a multi-cellular organism harbor 
distinct genomic content. In the case of cancer, it refers to the distinct 
genotype in cancerous cells from normal ones in the same individual. 
Cancerous mosaicism in human is often initiated by the loss of 
heterozygosity (LOH) of tumor suppressor genes (TSGs) in as few as a 
single cell. The TSG null mutant cell then evolves through acquiring further 
gene mutations and via interactions with its normal stromal niche to 
eventually develop into malignant tumors. 
To study the cancerous process in vivo, a genetic mosaic animal model 
should be ideal. Previously, Drosophila geneticists have developed a 
powerful mosaic system to address these problems. Many elegant and 
otherwise unachievable studies have been carried out with the mosaic 
system, such as mutant-WT cell competition behavior, cell and organ size 
control mechanisms, recessive genetic screening for tumor suppressor genes 
or metastasis-promoting genes. Based on a similar design principle to the 
Drosophila system, we established a mouse genetic mosaic system termed 
MADM (Mosaic Analysis with Double Markers) [Zong et al 2005 Cell]. 
Through Cre-loxP mediated inter-chromosomal mitotic recombination, the 
MADM system can generate homozygous mutant cells that are 
unequivocally labeled by green fluorescent protein (GFP) and their sibling 
WT cells labeled by red fluorescent protein (RFP) within a heterozygous 
colorless mouse. Due to the low probability of the recombination between 
chromosomes, mutant cells generated by MADM are very sparse (0.1-1% 
or much lower). The sparseness of mutant cells, although not as few as the 
monoclonal origin of human cancers, allow them to be dispersed among 
normal surrounding cells to mimic the heterotypic interactions during 
tumorigenesis. Furthermore, the dependence of cell type-specific Cre for 
mutant cell generation provides us a precise control to study the cell of 
origin problem. With the permanent GFP-labeling, progeny of mutant cells 
can be studied along each and every lineages for their tumorigenic 
potentials. Last but not least, the RFP-labeled WT sibling cells provide an 
excellent internal control for in vivo phenotypic analysis. Here I will 
present our recent work in glioma modeling with the MADM system, which 
revealed the involvement of a specific glial cell lineage in gliomagenesis. 
Finally, it is important to point out that MADM can be applied to study 
other diseases and normal development for in-depth mechanistic studies. 
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The p53 tumor suppressor and some of its downstream target genes have 
been shown to suppress self-renewal of adult neural stem cells. In murine 
neural progenitors, the lineage-restricted bHLH transcription factor Olig2 
promotes cell survival and functionally opposes p53-mediated responses to 
genotoxic damage. This cross-antagonistic relationship between Olig2 and 
p53 is also observed in malignant neural progenitors and in human glioma-
derived progenitor lines. The data sheds light on the pervasive expression of 
Olig2 in human diffuse gliomas and may, in part, explain why these tumors 
are notoriously resistant to radiation and chemotherapy. In the absence of 
Olig2, even attenuated levels of p53 function (seen for example in p53 null 
heterozygotes or p19Arf null cells) are sufficient to initiate biological 
responses to genotoxic damage. Olig2-mediated vulnerability to malignant 
transformation might be the price paid by the adult central nervous system 
to maintain replication competence in these cells and sustain a reserve of 
neural progenitors for response to injury and for normal turnover of certain 
neural populations. 
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Identifying the cells that give rise to glioblastomas (GBMs) and defining the 
molecular/genetic alterations that are needed to transform these cells have 
important implications for understanding the genesis and progression of 
brain tumors. In this study we examine the tumorigenic potential of 
progenitors that reside in subcortical white matter. To this end, we 
performed stereotactic injection of PDGF–IRES-CRE (PIC) retrovirus into 
the brains of adult mice that harbor floxed tumor suppressors (PTEN, p53 or 
both), and stop-flox reporter systems (YFP or luciferase). Fate mapping 
showed that injecting control retrovirus into the lateral white matter 
selectively infects local glial progenitors that give rise to a mixture of 
astrocytes, oligodendrocytes and NG2 glia. In contrast, injection with PIC 
retrovirus gives rise to brain tumors that harbored genetic deletion in PTEN 
and/or p53. Tumors showing the histological features of glioblastoma form 
with 100% penetrance, although the rate of tumor formation depends on the 
initial genetic alterations, with combined deletion of PTEN and p53 
inducing the most rapid tumor formation. Expression profiling showed that 
all tumors had a similar phenotype defined by a set of “proneural” genes 
that are known to regulate oligodendrocyte progenitor proliferation and 
differentiation. Array CGH and sequencing analysis revealed that the mouse 
tumors consistently accumulate additional genomic alterations. A 
comprehensive comparison with the TCGA data on human GBMs showed 
that a subset of genetic alterations seen in the mouse models is also found in 
the “proneural” subtype of human GBM. Thus, the PDGF driven mouse 
tumors recapitulate both the phenotype and genomic alteration seen in a 
specific subset of human GBMs and provide a powerful tool to study the 
molecular/genetic alterations that occur during the evolution from glial 
PROGENITOR TO GLIOBLASTOMA. 
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The NG2 proteoglycan is expressed by oligodendrocyte progenitor cells (OPC). 
In order to understand the function of the protein we are defining its binding 
partners. NG2 has a PSD95/Discs Large/ZhO-1 (PDZ) binding domain at the 
intracellular C terminus: in a yeast two-hybrid screen, we identified the PDZ 
mitochondrial serine protease Omi/HtrA2 as a potential NG2 binding partner. 
Biochemical analysis confirmed this interaction in OPC in vitro as well as in 
cells transfected with constructs for Omi/HtrA2 and NG2. Omi/HtrA2 is 
imported into mitochondria where it is processed and then retained in the 
intermembrane space. It is thought to function in mitochondrial homeostasis and 
may act as a chaperone. Omi possesses a serine protease domain and loss of 
function mutations of this leads to neuromuscular disease in mice (1). Upon 
cellular stress, Omi/HtrA2 is released from the mitochondria and enters the 
cytosol. Here it binds to the inhibitor of apoptosis proteins (IAPs), leading the 
cell into caspase-dependent apoptosis. The Omi/HtrA2 serine protease domain 
can also degrade the IAPs. In the presence of hydrogen peroxiode, which is a 
model of cellular stress, increased amounts of released Omi/HtrA2 bind to NG2 
in OPC. Binding of NG2 to Omi/HtrA2 may thus be a way to sequester Omi 
released from mitochondria to protect the cells from apoptosis. In the absence of 
NG2, OPC would be expected to be more sensitive to cellular stress. 
We have generated a knock-out mouse for NG2 by inserting the EYFP 
chromophore into the first exon of the endogeneous NG2 gene (2). The most 
striking feature of the homozygous knock-out mouse is an increased synthesis 
of GFAP indicating gliosis. This increases with age and may represent an 
astrocytic reaction to a altered turnover of OPC, or an altered differentiation of 
astrocytes. OPC are known to be particularly sensitive to cellular stress and 
white matter disease of the newborn is a major pathology in situations where 
premature infants are exposed to hypoxia. The ability of the NG2 protein to 
bind Omi/HtrA2 may help protect OPC from cellular stress. 
Financed by the Deutsche Forschungs Gemeinschaft. 
1) Jones, J.M. et al. (2003) Loss of Omi mitochondrial protease activity causes the 
neuromuscular disorder of mnd2 mutant mice. Nature 405: 721-727. 
2) Karram K, Goebbels S, Schwab M, Steinhäuser C, Seifert G, Nave KA and 
Trotter J. (2008) NG2-expressing cells in adult and developing nervous system 
revealed by the NG2-EYFP-knockin mouse. Genesis 46:743-757. 
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Injury to the central nervous system (CNS) induces proliferation of 
ensheathing glia, leading to axonal re-enwrapment and functional recovery. 
The glial regenerative response is found across species, from insects to 
humans, invoking an underlying genetic mechanism. However the gene 
network controlling the glial regenerative proliferation is unknown. It is a 
key to unravel how glial proliferation might be controlled to promote repair 
while avoiding tumorigenesis. Using stabbing injury and in vivo gene 
manipulation in glial cells, here we show that the proliferative glial 
response to injury critically depends on the gene prospero (pros/Prox1) in 
the Drosophila larval CNS. While Pros-positive ensheathing glia rarely 
proliferate in the unstabbed CNS, injury signals conveyed by Eiger/TNF 
through Dorsal/NFκB trigger their proliferation. We demonstrate that two 
positive feedback loops, one involving Pros and Notch, and another one 
Pros and Dorsal/NFκB, enable this response. Pros negatively regulates the 
cell cycle and promotes glial differentiation, while Notch and Dorsal/NFκB 
positively promote proliferation, and they maintaining each other through 
positive feedback. The balance of opposing functions enables the glial cells 
(1) to maintains them on the brink of dividing, (2) to respond to injury, and 
subsequently, (3) to re-establish cell cycle arrest. Breakdown of these 
feedback loops resulted in loss of the injury response and tumourigenesis. 
In pros egr double mutants, there was no injury response and wounds were 
larger. Gain of function of Notch increased glial number, whilst 
concomitantly reducing wound size, the extent of injury-induced apoptosis 
and vacuolisation. Time-lapse analysis in wild-type CNS showed that 
vacuoles emerged in axonal bundles after stabbing, some of which were 
filled with glial projections and subsequently repaired. These results show 
that the proliferative glial response is regenerative and that manipulating the 
gene network in glial cells can facilitate neuropile repair. We have thus 
identified a gene network underlying the glial regenerative response, which 
is favourable for repair. Our findings are likely to provide valuable insights 
for mammalian models of CNS regeneration. 
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Recent studies indicate that region-restricted expression of transcription 
factors regulate astrogenesis in the ventral neural tube according to a 
segmental template, providing a putative model for generation of astroglial 
diversity. Here we investigate the long-term consequences of this 
“segmental model” for glial cell organization and diversity throughout the 
postnatal spinal cord in vivo. Using a genetic lineage tracing approach, we 
delineate multiple embryonic origins for astrocytes along the dorsal-ventral 
(DV) axis. We show that developing astrocytes migrate in strictly radial 
fashion and permanently settle in stereotypic “wedge-shaped” territories, 
reflecting their derivation from radial glia and cell-intrinsic restrictions on 
migration patterns. Although some ventrally-derived oligodendrocytes 
exhibit multi-modal migration, and tangential astrocyte migration has been 
reported in brain, our findings show that mature astrocytes in all spinal cord 
domains migrate radially but not tangentially. We find that DV domains 
differ dramatically in their allocation of oligodendrocyte versus astrocyte 
precursors, but that region-restricted fibrous and protoplasmic astrocytes 
arise from similar domains from precursors that are largely Olig2-negative. 
These findings indicate that the spatial arrangement of astrocytes in the 
mature spinal cord, which delimits their range of influence and cell-cell 
interactions, is determined by patterning of the embryonic neural tube. 
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The intimate and continued interactions between Schwann cells and their 
associated axons drive the development, maintenance and regeneration of 
the peripheral nervous system. One major function of Schwann cells is the 
elaboration and maintenance of the myelin sheath that surrounds the axons 
which in turn allows for rapid saltatory propagation of electric impulses.  
 
Previous studies have shown that Oct-6, a POU – homeodomain 
transcription factor is a major regulator of Schwann cells, driving the timely 
progression of cell differentiation from promyelinating to the myelinating 
stage. Oct-6 is one of the first transcription factors in the genetic hierarchy 
of myelination. In Oct-6 deficient mice, Schwann cells are transiently 
arrested at the promyelinating stage of cell-differentiation. Understanding 
the regulation of oct-6 gene expression would help uncover the identity of 
yet unknown axon mediated signals that drive its expression.  
 
Previously we have identified a cis-acting regulatory element downstream 
of the Oct-6 gene promoter, the Oct-6 Schwann cell enhancer (SCE), which 
is sufficient to drive the expression of Oct-6 in Schwann cell lineage both 
spatially and temporally. Phylogenetic analysis of the SCE revealed the 
presence of two highly conserved regions named homology region 1 (HR1) 
and 2 (HR2). Deletion analysis showed that both elements contribute to full 
enhancer activity in vivo and in primary Rat Schwann cells. 
 
We further narrowed down the 4.5kb SCE to a 1kb mini SCE element, 
which recapitulates Oct6 expression in time and space. This expression is 
independent of the promoter used, to drive the LacZ reporter, as the Oct6 
promoter and hsp68 promoter worked equally well. Within the 1kb mini 
SCE, a highly evolutionarily conserved 38bp element of HR1 was found to 
be absolutely essential for the function of the SCE. Mutating the 38bp 
element (block1) abolishes enhancer activity. Extending our phylogenetic 
analysis to Opossum, we further narrowed down the 1kb mini SCE to a 
300bp micro SCE containing 4 core elements, which are essential and 
sufficient for the enhancer function. Mass spectrometry of proteins binding 
to core element block1 identified Sox10. Taken together our 
characterization of the Schwann cell enhancer reveals an evolutionarily 
conserved, Sox10 binding, 38bp core element within a 300bp functional 
Schwann cell enhancer that is capable of regulating the expression of Oct6 
in a tissue and time specific manner. 
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Olfactory ensheathing cells (OECs) are a unique class of glial cells with 
exceptional translational potential because of their ability to support axon 
regeneration in the central nervous system. Current dogma holds that OECs 
arise from the olfactory epithelium. OECs for use in cell transplantation 
therapy for spinal cord repair are generally cultured from explants of the 
olfactory mucosa, but this tissue also includes antigenically-similar 
Schwann cells, making it difficult to identify OECs reliably in such 
cultures. Here, using fate-mapping techniques in chick embryos and genetic 
lineage-tracing in mice, we show that OECs originate from the neural crest, 
hence share a common developmental heritage (including expression of the 
transcription factor Sox10) with Schwann cells. This explains the 
similarities between OECs and Schwann cells, overturns the existing dogma 
on the developmental origin of OECs, and opens up a new area of research 
in neural crest and glial cell biology, i.e., the control of neural crest cell 
differentiation into OECs. Since neural crest stem cells persist in adult 
tissue, including skin and hair follicles, our results also raise the possibility 
that patient-derived neural crest stem cells could in future provide an 
abundant and accessible source of autologous OECs for cell transplantation 
therapy for the injured central nervous system. 
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HELPING TO START AND STOP MYELINATION: CSK HAS DUAL 
REGULATORY FUNCTIONS DURING OLIGODENDROCYTE 
DEVELOPMENT 
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The ability of oligodendrocyte progenitors (OPCs) to generate sufficient 
numbers of myelinating oligodendrocytes is critical both for developmental 
myelination and for repair following demyelination. The timing and 
location of gliogenesis are tightly controlled but the molecular mechanisms 
that underlie this control are poorly understood. Here we report that the C-
terminal Src Kinase (Csk) acts as a molecular switch for Src Family Kinase 
activity in oligodendrocytes, with distinct and opposing roles for Csk in 
early versus late stages of development. Early in development Csk is critical 
for the appropriate onset of oligodendrocyte progenitor differentiation. Csk 
suppresses OPC proliferation such that Csk depletion in OPCs in vitro and 
in vivo led to proliferation under conditions that normally promoted cell 
cycle exit. Hyperproliferation of Csk-deficient OPCs resulted in delayed 
oligodendrocyte maturation accompanied by delayed myelination onset, 
while survival of newly-formed oligodendrocytes was increased. These data 
suggest that, during myelination onset, Csk is a pro-differentiation factor 
that promotes timely OPC cell cycle exit. Adult Csk null mice, however, 
developed hypermyelination, suggesting that Csk also contributes to 
myelination arrest. Thus, Csk deletion caused increased levels of myelin 
basic protein as well as increased myelination in the cortex, cerebellum and 
spinal cord, although there was no change in the number of mature 
oligodendrocytes. Further analysis of myelin ultrastructure using 
transmission electron microscopy revealed increased numbers of myelin 
wraps such that the g-ratio was significantly decreased, particularly in small 
caliber axons. To address a putative role for Csk during myelin repair we 
have recently begun to evaluate the response of Csk null mice to cuprizone-
induced demyelination. Preliminary analyses reveal that during 
remyelination Csk mutant animals exhibit increased numbers of OPCs and 
mature oligodendrocytes, increased myelin content, and lower g-ratio as 
well as decreased axonal degeneration. We propose that Csk is a novel 
regulator of oligodendrocyte development with two distinct roles: 
generating appropriate numbers of oligodendrocytes at the onset of 
myelination, and terminating wrapping during myelination. 
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HISTONE DEACETYLASES BETWEEN DAMAGE AND REPAIR 
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Oligodendrocytes are the myelin-forming cells of the CNS and are essential 
for trophic neuronal support. Previous studies have supported the existence 
of an obligatory relationship between cell cycle exit and the initiatiorenders 
the chromatin transcriptionally inactive, decreasing the levels of the 
inhibitors, and favoring myelin gene expression. Similar mechanisms are 
implemented during repair of cuprizone-induced demyelination in young 
adults, but not in old mice. Histones, however, are not the only substrates of 
HDACs, and distinct effects can be detected in diverse cell types in 
response to HDAC activity. We propose that the combined use of HDAC 
inhibitors and small molecules may promote repair in demyelinating 
disorders and overcome the age-related changes. Supported by R01NS-
42925-08 and ARRA R01NS-42925-07-S1n of the transcriptional program 
of differentiation. In this presentation we shall discuss experimental 
evidence supporting the hypothesis that epigenetic mechanisms of 
repression involving post-translational changes of nucleosomal histones, 
histone variants and microRNAs are necessary for differentiation. 
Progenitors are characterized by high levels of inhibitors and histone 
acetylation favors a transcriptionally competent chromatin at their 
promoters. As progenitors begin differentiating, histone deacetylation 
(MEDIATED BY HDACS) 
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Histone deacetylases (HDACs) are major epigenetic regulators. We show 
that HDAC1 and HDAC2 functions are critical for myelination and 
integrity of the peripheral nervous system. Using mouse genetics, we have 
ablated Hdac1 and Hdac2 specifically in Schwann cells resulting in 
virtually no myelin in mutant sciatic nerves and massive Schwann cell loss. 
Expression of Krox20, the main transcriptional regulator of Schwann cell 
myelination, was strongly reduced. We demonstrate that HDAC1/2 control 
the myelination program at the transcriptional level. In a highly redundant 
and compensation-competent milieu, HDAC2 regulates myelination while 
HDAC1 controls Schwann cell survival. 
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Peripheral nerve myelination requires the interaction of the Early growth 
response 2 (Egr2/Krox20) transcription factor with the Nab1/ Nab2 
corepressors. We have recently shown that these corepressors interact with 
the chromodomain helicase DNA-binding protein 4 (Chd4) subunit of the 
nucleosome remodeling and deacetylase (NuRD) complex. To understand 
the developmental importance of Chd4 in peripheral nerve myelination, we 
generated mice with a conditional gene ablation in cells of the Schwann cell 
lineage (Chd4f/f P0-CRE). Chd4 conditional null mice were found to have a 
general delay in myelination, hypomyelination, and the persistence of 
promyelinating Schwann cells. Furthermore, as development progresses 
Chd4-deficient peripheral nerves display evidence of axon/myelin 
degeneration. Expression analysis indicates that loss of Chd4 leads to 
reduced expression of myelin genes and elevated expression of the 
promyelinating Schwann cell gene, Oct6/Pou3f1. These data provide the 
first demonstration that a chromatin remodeling complex is required for 
efficient peripheral nerve myelination by Schwann cells. 
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GLIAL CELL DIFFERENTIATION AND NEURAL STEM 
REPROGRAMMING IN DROSOPHILA MELANOGASTER 
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The molecular and epigenetic pathways controlling neural stem cells 
plasticity and differentiation towards a specific fate are still poorly 
understood.  
In Drosophila, the Gcm/Glide (Glial cell missing/Glial Cell Deficient) 
transcription factor constitutes the glial determinant. In its absence, glia 
transform into neurons and its overexpression triggers ectopic glial markers.  
We here show that Gcm produces ectopic glia by reprogramming neural 
stem cells, even in the absence of cell division. Strikingly, a pulse of Gcm 
expression is sufficient to induce a complete and irreversible cell fate 
transformation.  
Reprogramming involves an initial metastable state and subsequent 
consolidation, which relies on threshold Gcm levels and produces a stable 
glial fate. Gcm thus competes for the general transcription machinery in 
order to activate its own targets and trigger the glial pathway. 
Gcm-dependent reprogramming is regulated by the CBP co-activator, a 
histone acetyl transferase (HAT) that targets lysine 9 and 56 of H3, and is 
associated with overall changes in such epigenetic landmarks.  
These in vivo data demonstrate that a single transcription factor is sufficient 
to direct a multipotent cell towards a specific fate via epigenetic 
mechanisms that stably modify the endogenous developmental program. 
Data from microarrays and from recent molecular and genetics screens 
performed in the laboratory support this hypothesis and have consequence 
onto the evolutionary conservation of Gcm function.  
The different aspects of the Gcm cascade will be discussed as a model to 
understand the molecular and epigenetic pathways driving cell 
differentiation in the nervous system during evolution. 
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historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
